tokens,ner_tags,id,nct_id,text,ner_manual_ct_target
"['ECASS', 'III', '-', 'European', 'Cooperative', 'Acute', 'Stroke', 'Study', 'III', ':', 'A', 'Placebo', 'Controlled', 'Trial', 'of', 'Alteplase', '(', 'Rt', '-', 'PA', ')', 'in', 'Acute', 'Ischemic', 'Hemispheric', 'Stroke', 'Where', 'Thrombolysis', 'is', 'Initiated', 'Between', '3', 'and', '4', 'Hours', '30', 'Minutes', 'After', 'Stroke', 'Onset', '|', 'To', 'collect', 'additional', 'confirmatory', 'data', 'on', 'alteplase(rt', '-', 'PA', ')', 'in', 'the', 'European', 'setting', 'and', 'to', 'demonstrate', 'that', 'the', 'treatment', 'of', 'patients', 'between', '3', 'and', '4.30', 'hours', 'of', 'onset', 'of', 'symptoms', 'of', 'acute', 'ischemic', 'stroke', 'with', 'rt', '-', 'PA', 'compared', 'to', 'placebo', '-', 'treated', 'patients', 'will', 'result', 'in', 'an', 'improved', 'clinical', 'outcome', 'without', 'increase', 'of', 'fatality', 'rate', '.']","['O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00153036,NCT00153036,ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset | To collect additional confirmatory data on alteplase(rt-PA) in the European setting and to demonstrate that the treatment of patients between 3 and 4.30 hours of onset of symptoms of acute ischemic stroke with rt-PA compared to placebo-treated patients will result in an improved clinical outcome without increase of fatality rate.,"[(33, 45, 'CONDITION', 'Acute Stroke'), (59, 66, 'CONTROL', 'Placebo'), (87, 96, 'DRUG', 'Alteplase'), (98, 103, 'DRUG', 'Rt-PA'), (108, 141, 'CONDITION', 'Acute Ischemic Hemispheric Stroke'), (213, 219, 'CONDITION', 'Stroke'), (271, 287, 'DRUG', 'alteplase(rt-PA)'), (411, 432, 'CONDITION', 'acute ischemic stroke'), (438, 443, 'DRUG', 'rt-PA'), (456, 463, 'CONTROL', 'placebo')]"
"['Effect', 'of', 'Vibration', 'Exercise', 'on', 'Upper', 'Limb', 'Strength', ',', 'Function', ',', 'and', 'Pain', '|', 'The', 'primary', 'purpose', 'of', 'this', 'study', 'is', 'to', 'explore', 'the', 'benefits', 'of', 'vibration', 'dumbbell', 'resistance', 'training', 'over', 'standard', 'dumbbell', 'resistance', 'training', 'for', 'improving', 'upper', 'limb', 'strength', ',', 'function', 'and', 'pain', 'among', 'manual', 'wheelchair', 'users', 'with', 'paraplegia', '.']","['O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT02998021,NCT02998021,"Effect of Vibration Exercise on Upper Limb Strength, Function, and Pain | The primary purpose of this study is to explore the benefits of vibration dumbbell resistance training over standard dumbbell resistance training for improving upper limb strength, function and pain among manual wheelchair users with paraplegia.","[(10, 28, 'PHYSICAL', 'Vibration Exercise'), (67, 71, 'CONDITION', 'Pain'), (138, 176, 'PHYSICAL', 'vibration dumbbell resistance training'), (182, 219, 'CONTROL', 'standard dumbbell resistance training'), (268, 272, 'CONDITION', 'pain'), (308, 318, 'CONDITION', 'paraplegia')]"
"['Identification', 'of', 'Pre', '-', 'Malignant', 'Lesions', 'In', 'Pediatric', 'Patients', 'With', 'Neurofibromatosis', 'Type', '1', 'Using', 'Novel', 'Magnetic', 'Resonance', 'Imaging', 'Techniques', 'Paired', 'With', 'Artificial', 'Intelligence', '|', 'This', 'is', 'a', 'single', 'arm', 'pilot', 'trial', 'of', 'a', 'novel', 'whole', '-', 'body', 'Magnetic', 'Resonance', 'Imaging', 'paired', 'with', 'artificial', 'intelligence', 'intervention', ',', 'to', 'evaluate', 'feasibility', 'defined', 'as', 'scan', '-', 'rescan', 'reliability', ',', 'and', 'to', 'estimate', 'the', 'positive', 'predictive', 'value', 'of', 'changes', 'in', 'Magnetic', 'Resonance', 'Imaging', 'scans', 'from', 'baseline', 'to', '12', '-', 'month', 'visit', 'using', 'an', 'Artificial', 'Intelligence', 'algorithm', ',', 'among', '15', 'pediatric', 'patients', 'with', 'neurofibromatosis', 'type', '1', 'at', 'Cedars', '-', 'Sinai', 'Medical', 'Center', '.']","['O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04763109,NCT04763109,"Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence | This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.","[(18, 39, 'CONDITION', 'Pre-Malignant Lesions'), (67, 91, 'CONDITION', 'Neurofibromatosis Type 1'), (574, 598, 'CONDITION', 'neurofibromatosis type 1')]"
"['Nicotine', 'Replacement', 'Therapy', 'in', 'the', 'Intensive', 'Care', 'Unit', ':', 'a', 'Randomized', ',', 'Controlled', 'Pilot', 'Study', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'whether', 'transdermal', 'nicotine', 'replacement', 'therapy', 'is', 'safe', 'and', 'effective', 'for', 'treating', 'nicotine', 'withdrawal', 'symptoms', 'in', 'the', 'critically', 'ill', 'smoking', 'patient', '.']","['B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'B-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O']",NCT01362959,NCT01362959,"Nicotine Replacement Therapy in the Intensive Care Unit: a Randomized, Controlled Pilot Study | The purpose of this study is to determine whether transdermal nicotine replacement therapy is safe and effective for treating nicotine withdrawal symptoms in the critically ill smoking patient.","[(0, 8, 'DRUG', 'Nicotine'), (158, 166, 'DRUG', 'nicotine'), (222, 230, 'DRUG', 'nicotine'), (231, 241, 'CONDITION', 'withdrawal'), (258, 272, 'CONDITION', 'critically ill')]"
"['RISE', '(', 'Rehabilitation', 'Intervention', 'for', 'People', 'With', 'Schizophrenia', 'in', 'Ethiopia', '):', 'a', 'Cluster', '-', 'randomised', 'Trial', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'whether', 'community', '-', 'based', 'rehabilitation', 'plus', 'facility', '-', 'based', 'care', 'is', 'superior', 'to', 'facility', '-', 'based', 'care', 'alone', 'in', 'reducing', 'disability', 'related', 'to', 'schizophrenia', 'in', 'rural', 'Ethiopia', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O']",NCT02160249,NCT02160249,RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia): a Cluster-randomised Trial | The purpose of this study is to determine whether community-based rehabilitation plus facility-based care is superior to facility-based care alone in reducing disability related to schizophrenia in rural Ethiopia.,"[(6, 33, 'OTHER', 'Rehabilitation Intervention'), (50, 63, 'CONDITION', 'Schizophrenia'), (157, 187, 'OTHER', 'community-based rehabilitation'), (193, 212, 'OTHER', 'facility-based care'), (228, 253, 'CONTROL', 'facility-based care alone'), (288, 301, 'CONDITION', 'schizophrenia')]"
"['Deep', 'Brain', 'Stimulation', 'in', 'Laryngeal', 'Dystonia', 'and', 'Voice', 'Tremor', '|', 'The', 'goals', 'of', 'this', 'project', 'are', '1', ')', 'to', 'determine', 'the', 'incidence', 'of', 'neurological', 'voice', 'disorders', 'in', 'patients', 'with', 'dystonia', 'and', 'essential', 'tremor', 'undergoing', 'deep', 'brain', 'stimulation', '(', 'DBS', ')', ',', '2', ')', 'investigate', 'the', 'neuroimaging', 'and', 'intracranial', 'neurophysiology', 'correlates', 'of', 'voice', 'dysfunction', 'in', 'these', 'subjects', ',', 'and', 'subsequently', '3', ')', 'determine', 'the', 'effects', 'of', 'DBS', 'on', 'voice', 'function', '.']","['B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O']",NCT05150093,NCT05150093,"Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor | The goals of this project are 1) to determine the incidence of neurological voice disorders in patients with dystonia and essential tremor undergoing deep brain stimulation (DBS), 2) investigate the neuroimaging and intracranial neurophysiology correlates of voice dysfunction in these subjects, and subsequently 3) determine the effects of DBS on voice function.","[(0, 22, 'OTHER', 'Deep Brain Stimulation'), (26, 44, 'CONDITION', 'Laryngeal Dystonia'), (49, 61, 'CONDITION', 'Voice Tremor'), (127, 155, 'CONDITION', 'neurological voice disorders'), (173, 181, 'CONDITION', 'dystonia'), (186, 202, 'CONDITION', 'essential tremor'), (214, 236, 'OTHER', 'deep brain stimulation'), (238, 241, 'OTHER', 'DBS'), (323, 340, 'CONDITION', 'voice dysfunction'), (405, 408, 'OTHER', 'DBS')]"
"['Telehealth', 'Virtual', 'Reality', 'Exergaming', 'and', 'Peer', 'Networking', 'Among', 'People', 'With', 'Spinal', 'Cord', 'Injury', '|', 'This', 'pilot', 'feasibility', 'study', 'aims', 'to', 'test', 'whether', 'youth', 'and', 'adults', 'with', 'spinal', 'cord', 'injury', 'can', 'use', 'a', 'group', 'virtual', 'reality', 'gaming', 'intervention', 'to', 'exercise', '.', 'A', 'second', 'purpose', 'is', 'to', 'examine', 'whether', 'there', 'are', 'potential', 'benefits', 'to', 'cardiometabolic', 'health', 'and', 'psychosocial', 'health', '.']","['B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05318079,NCT05318079,Telehealth Virtual Reality Exergaming and Peer Networking Among People With Spinal Cord Injury | This pilot feasibility study aims to test whether youth and adults with spinal cord injury can use a group virtual reality gaming intervention to exercise. A second purpose is to examine whether there are potential benefits to cardiometabolic health and psychosocial health.,"[(0, 37, 'PHYSICAL', 'Telehealth Virtual Reality Exergaming'), (42, 57, 'OTHER', 'Peer Networking'), (76, 94, 'CONDITION', 'Spinal Cord Injury'), (169, 187, 'CONDITION', 'spinal cord injury'), (198, 251, 'PHYSICAL', 'group virtual reality gaming intervention to exercise')]"
"['A', 'Phase', '3', ',', 'Randomized', ',', 'Multi', '-', 'Center', ',', 'Multi', '-', 'National', ',', 'Double', '-', 'Blind', 'Study', 'to', 'Evaluate', 'the', 'Efficacy', ',', 'Safety', 'and', 'Pharmacokinetics', 'of', 'Once', 'Daily', 'Versus', 'Twice', 'Daily', 'Dosing', 'of', 'Genz-112638', 'in', 'Patients', 'With', 'Gaucher', 'Disease', 'Type', '1', 'Who', 'Have', 'Demonstrated', 'Clinical', 'Stability', 'on', 'a', 'Twice', 'Daily', 'Dose', 'of', 'Genz-112638', '|', 'The', 'primary', 'objective', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'the', 'efficacy', 'and', 'safety', 'of', 'once', 'daily', '(', 'QD', ')', 'versus', 'twice', 'daily', '(', 'BID', ')', 'dosing', 'of', 'eliglustat', 'tartrate', '(', 'Genz-112638', ')', 'in', 'participants', 'with', 'Gaucher', 'disease', 'type', '1', 'who', 'had', 'demonstrated', 'clinical', 'stability', 'on', 'BID', 'dosing', 'of', 'eliglustat', 'tartrate', '(', 'Genz-112638', ')', '.', 'The', 'secondary', 'objective', 'was', 'to', 'evaluate', 'the', 'pharmacokinetics', '(', 'PK', ')', 'of', 'Genz-99067', 'when', 'eliglustat', 'tartrate', '(', 'Genz-112638', ')', 'was', 'administered', 'QD', 'and', 'BID', 'in', 'participants', 'with', 'Gaucher', 'disease', 'type', '1', 'who', 'had', 'demonstrated', 'clinical', 'stability', 'on', 'BID', 'dosing', 'of', 'eliglustat', 'tartrate', '(', 'Genz-112638', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O']",NCT01074944,NCT01074944,"A Phase 3, Randomized, Multi-Center, Multi-National, Double-Blind Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once Daily Versus Twice Daily Dosing of Genz-112638 in Patients With Gaucher Disease Type 1 Who Have Demonstrated Clinical Stability on a Twice Daily Dose of Genz-112638 | The primary objective of this study was to evaluate the efficacy and safety of once daily (QD) versus twice daily (BID) dosing of eliglustat tartrate (Genz-112638) in participants with Gaucher disease type 1 who had demonstrated clinical stability on BID dosing of eliglustat tartrate (Genz-112638). The secondary objective was to evaluate the pharmacokinetics (PK) of Genz-99067 when eliglustat tartrate (Genz-112638) was administered QD and BID in participants with Gaucher disease type 1 who had demonstrated clinical stability on BID dosing of eliglustat tartrate (Genz-112638).","[(169, 180, 'DRUG', 'Genz-112638'), (198, 220, 'CONDITION', 'Gaucher Disease Type 1'), (287, 298, 'DRUG', 'Genz-112638'), (431, 450, 'DRUG', 'eliglustat tartrate'), (452, 463, 'DRUG', 'Genz-112638'), (486, 508, 'CONDITION', 'Gaucher disease type 1'), (566, 585, 'DRUG', 'eliglustat tartrate'), (587, 598, 'DRUG', 'Genz-112638'), (670, 680, 'DRUG', 'Genz-99067'), (686, 705, 'DRUG', 'eliglustat tartrate'), (707, 718, 'DRUG', 'Genz-112638'), (769, 791, 'CONDITION', 'Gaucher disease type 1'), (849, 868, 'DRUG', 'eliglustat tartrate'), (870, 881, 'DRUG', 'Genz-112638')]"
"['Phase', 'IIA', 'Open', '-', 'Label', ',', 'to', 'Evaluate', 'the', 'Safety', ',', 'Tolerability', ',', 'and', 'Efficacy', 'Trend', 'of', 'SCI', '-110', 'in', 'Patients', 'With', 'AD', 'and', 'Agitation', '|', 'As', 'of', 'today', ',', 'there', 'is', 'no', 'FDA', '-', 'approved', 'treatment', 'for', 'agitation', 'in', 'AD', '.', 'Hence', ',', 'it', 'is', 'still', 'considered', 'an', 'unmet', 'need', '.', '\n\n', 'Sporadic', 'observation', 'in', 'healthy', 'or', 'diagnosed', 'individuals', 'indicated', 'that', 'cannabis', 'products', ',', 'in', 'particular', ',', 'THC', 'have', 'calming', 'and', 'anti', '-', 'anxiety', 'effects', '.', 'These', 'observations', 'are', 'supported', 'by', 'basic', 'science', 'data', 'as', 'well', 'as', 'animal', 'experiments', '.', '\n\n', 'SCI', '-110', 'is', 'a', 'combination', 'of', '(', '1', ')', 'dronabinol', ',', 'the', 'active', 'ingredient', 'in', 'an', 'FDA', '-', 'approved', 'synthetic', 'analog', 'of', 'tetrahydrocannabinol', ',', 'the', 'psychoactive', 'molecule', 'in', 'the', 'cannabis', 'plant', ',', 'and', '(', '2', ')', 'palmitoylethanolamide', '.', '\n\n', 'In', 'the', 'present', 'study', ',', 'the', 'starting', 'daily', 'dose', 'for', 'all', 'subjects', 'is', '2.5', 'mg', 'dronabinol', 'and', '800', 'mg', 'PEA', 'and', 'will', 'be', 'gradually', 'increased', '(', 'every', '3', 'days', 'an', 'addition', 'of', '2.5', 'mg', 'dronabinol', 'per', 'day', ',', 'with', 'no', 'change', 'in', 'the', 'PEA', 'dose', ')', 'to', 'a', 'maximum', 'of', '12.5', 'mg', 'Dronebinol', 'and', '800', 'mg', 'PEA', 'per', 'day', '.', 'The', 'study', 'product', 'will', 'be', 'given', 'orally', ',', 'twice', 'daily', ',', 'to', 'add', '-', 'on', 'the', 'medical', 'treatment', '.', '\n\n', 'Study', 'Duration', 'per', 'patient', 'is', 'up', 'to', '64', 'days', ':', 'a.', 'screening', '(', '3', '-', '21', 'days', ')', ';', 'b.', 'treatment', 'phase', ':', '(', '1', ')', 'titration', '(', '15', '-', '23', 'days', ')', 'of', 'dronabinol', 'from', '2.5', 'to', '12.5', 'mg', 'or', 'up', 'to', 'the', 'maximal', 'subject', ""'s"", 'tolerated', 'dose', '(', '2', ')', 'Stabilization', 'phase', '(', '10', 'days', ')', 'until', 'end', 'of', 'treatment', 'on', 'the', 'highest', 'subject', ""'s"", 'daily', 'tolerated', 'dose', '.', 'c.', 'follow', '-', 'up', 'phase', '(', '7', 'days', ')', '-', 'until', 'the', 'end', '-', 'of', '-', 'study', '.', '\n\n', 'During', 'the', 'study', ',', 'the', 'tolerability', 'of', 'the', 'drug', ',', 'its', 'safety', '(', 'vital', 'signs', ',', 'physical', 'examinations', ',', 'blood', ',', 'and', 'urine', 'tests', 'and', 'side', 'effects', 'follow', '-', 'up', ')', 'as', 'well', 'as', 'changes', 'in', 'subject', ""'s"", 'condition', '(', 'using', 'CMAI', ',', 'MMSE', ',', 'SIB-8', 'questionnaires', ')', ',', 'appetite', 'and', 'sleep', 'quality', '(', 'SDI', ')', 'will', 'be', 'followed', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05239390,NCT05239390,"Phase IIA Open-Label, to Evaluate the Safety, Tolerability, and Efficacy Trend of SCI -110 in Patients With AD and Agitation | As of today, there is no FDA-approved treatment for agitation in AD. Hence, it is still considered an unmet need.

Sporadic observation in healthy or diagnosed individuals indicated that cannabis products, in particular, THC have calming and anti-anxiety effects. These observations are supported by basic science data as well as animal experiments.

SCI -110 is a combination of (1) dronabinol, the active ingredient in an FDA-approved synthetic analog of tetrahydrocannabinol, the psychoactive molecule in the cannabis plant, and (2) palmitoylethanolamide.

In the present study, the starting daily dose for all subjects is 2.5 mg dronabinol and 800 mg PEA and will be gradually increased (every 3 days an addition of 2.5 mg dronabinol per day, with no change in the PEA dose) to a maximum of 12.5 mg Dronebinol and 800 mg PEA per day. The study product will be given orally, twice daily, to add-on the medical treatment.

Study Duration per patient is up to 64 days: a. screening (3-21 days); b. treatment phase: (1) titration (15-23 days) of dronabinol from 2.5 to 12.5 mg or up to the maximal subject's tolerated dose (2) Stabilization phase (10 days) until end of treatment on the highest subject's daily tolerated dose. c. follow-up phase (7 days) - until the end-of-study.

During the study, the tolerability of the drug, its safety (vital signs, physical examinations, blood, and urine tests and side effects follow-up) as well as changes in subject's condition (using CMAI, MMSE, SIB-8 questionnaires), appetite and sleep quality (SDI) will be followed.","[(82, 90, 'DRUG', 'SCI -110'), (108, 110, 'CONDITION', 'AD'), (115, 124, 'CONDITION', 'Agitation'), (179, 188, 'CONDITION', 'agitation'), (192, 194, 'CONDITION', 'AD'), (314, 322, 'OTHER', 'cannabis'), (348, 351, 'DRUG', 'THC'), (478, 486, 'DRUG', 'SCI -110'), (511, 521, 'DRUG', 'dronabinol'), (584, 604, 'DRUG', 'tetrahydrocannabinol'), (639, 647, 'OTHER', 'cannabis'), (663, 684, 'DRUG', 'palmitoylethanolamide'), (760, 770, 'DRUG', 'dronabinol'), (782, 785, 'DRUG', 'PEA'), (854, 864, 'DRUG', 'dronabinol'), (896, 899, 'DRUG', 'PEA'), (930, 940, 'DRUG', 'Dronebinol'), (952, 955, 'DRUG', 'PEA'), (1173, 1183, 'DRUG', 'dronabinol')]"
"['Dexmedetomidine', 'Versus', 'Triamcinolone', 'Local', 'Injection', 'for', 'Pain', 'Alleviation', 'in', 'Patients', 'With', 'Carpal', 'Tunnel', 'Syndrome', ';', 'A', 'Randomized', 'Clinical', 'Trial', '.', '|', 'Carpal', 'tunnel', 'syndrome', '(', 'CTS', ')', 'is', 'a', 'common', 'mononeuropathy', 'due', 'to', 'entrapment', 'of', 'the', 'median', 'nerve', 'in', 'the', 'carpal', 'tunnel', '.', 'a', 'lot', 'of', 'modalities', 'are', 'available', 'for', 'treatment', 'of', 'mild', 'to', 'moderate', 'CTS', '.']","['B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT05624866,NCT05624866,Dexmedetomidine Versus Triamcinolone Local Injection for Pain Alleviation in Patients With Carpal Tunnel Syndrome; A Randomized Clinical Trial. | Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modalities are available for treatment of mild to moderate CTS.,"[(0, 15, 'DRUG', 'Dexmedetomidine'), (23, 36, 'DRUG', 'Triamcinolone'), (57, 61, 'CONDITION', 'Pain'), (91, 113, 'CONDITION', 'Carpal Tunnel Syndrome'), (146, 168, 'CONDITION', 'Carpal tunnel syndrome'), (170, 173, 'CONDITION', 'CTS'), (187, 201, 'CONDITION', 'mononeuropathy'), (313, 333, 'CONDITION', 'mild to moderate CTS')]"
"['Functional', 'Navigation', 'in', 'Surgery', 'of', 'Cerebral', 'Tumors', 'and', 'Vascular', 'Malformations', ':', 'a', 'Prospective', ',', 'Single', 'Arm', 'Clinical', 'Trial', '|', 'The', 'purpose', 'of', 'the', 'study', 'is', 'to', 'assess', 'accuracy', ',', 'advantages', 'of', 'functional', 'neuronavigation', 'and', 'calculate', 'safe', 'distance', 'from', 'motor', 'areas', 'to', 'brain', 'tumors', 'and', 'vascular', 'malformations', 'in', 'image', '-', 'guided', 'surgery', '.']","['B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O']",NCT05484219,NCT05484219,"Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations: a Prospective, Single Arm Clinical Trial | The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery.","[(0, 32, 'SURGICAL', 'Functional Navigation in Surgery'), (36, 51, 'CONDITION', 'Cerebral Tumors'), (56, 78, 'CONDITION', 'Vascular Malformations'), (185, 211, 'SURGICAL', 'functional neuronavigation'), (260, 272, 'CONDITION', 'brain tumors'), (277, 299, 'CONDITION', 'vascular malformations'), (303, 323, 'SURGICAL', 'image-guided surgery')]"
"['A', 'Phase', '3', ',', 'Open', '-', 'label', 'Extension', 'Study', 'to', 'Assess', 'the', 'Safety', ',', 'Tolerability', ',', 'and', 'Efficacy', 'of', 'RAD011', '(', 'Cannabidiol', 'Oral', 'Solution', ')', 'in', 'Patients', 'With', 'Prader', '-', 'Willi', 'Syndrome', '|', 'This', 'is', 'a', 'Phase', '3', 'open', '-', 'label', 'extension', '(', 'OLE', ')', 'study', 'in', 'patients', 'diagnosed', 'with', 'Prader', '-', 'Willi', 'Syndrome', '(', 'PWS', ')', 'who', 'completed', 'the', 'Maintenance', 'Period', 'of', 'the', 'randomized', ',', 'placebo', '-', 'controlled', 'Phase', '2/3', 'study', 'SCOUT-015', '.', '\n\n', 'The', 'primary', 'objective', 'of', 'this', 'study', 'is', 'to', 'assess', 'the', 'long', '-', 'term', 'safety', 'and', 'tolerability', 'of', 'RAD011', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O']",NCT05387798,NCT05387798,"A Phase 3, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome | This is a Phase 3 open-label extension (OLE) study in patients diagnosed with Prader-Willi Syndrome (PWS) who completed the Maintenance Period of the randomized, placebo-controlled Phase 2/3 study SCOUT-015.

The primary objective of this study is to assess the long-term safety and tolerability of RAD011.","[(90, 96, 'DRUG', 'RAD011'), (98, 109, 'DRUG', 'Cannabidiol'), (142, 163, 'CONDITION', 'Prader-Willi Syndrome'), (244, 265, 'CONDITION', 'Prader-Willi Syndrome'), (267, 270, 'CONDITION', 'PWS'), (465, 471, 'DRUG', 'RAD011')]"
"['We', 'Walk', 'Plus', 'Study', ':', 'A', 'Walking', 'Program', 'Using', 'Physical', 'Activity', 'Monitors', 'and', 'Social', 'Networking', 'for', 'Older', 'Adults', 'With', 'Intellectual', 'Disabilities', '|', 'Determine', 'the', 'feasibility', 'and', 'acceptability', 'of', 'We', 'Walk', 'Plus', 'intervention', 'to', 'promote', 'physical', 'activity', 'and', 'improve', 'cognition', 'for', 'older', 'adults', 'with', 'intellectual', 'disabilities', '(', 'ID', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT04573530,NCT04573530,We Walk Plus Study: A Walking Program Using Physical Activity Monitors and Social Networking for Older Adults With Intellectual Disabilities | Determine the feasibility and acceptability of We Walk Plus intervention to promote physical activity and improve cognition for older adults with intellectual disabilities (ID).,"[(22, 92, 'OTHER', 'Walking Program Using Physical Activity Monitors and Social Networking'), (115, 140, 'CONDITION', 'Intellectual Disabilities'), (190, 215, 'OTHER', 'We Walk Plus intervention'), (289, 314, 'CONDITION', 'intellectual disabilities'), (316, 318, 'CONDITION', 'ID')]"
"['Safety', 'and', 'Tolerability', 'of', 'a', 'Protocol', 'of', 'Targeted', 'Temperature', 'Management', 'After', 'Intracerebral', 'Hemorrhage', '|', 'Early', 'hematoma', 'growth', '(', 'HG', ')', 'after', 'spontaneous', 'intra', '-', 'cerebral', '/', 'intra', '-', 'parenchymal', 'hemorrhage', '(', 'IPH', ')', 'is', 'common', 'and', 'associated', 'with', 'neurological', 'deterioration', 'and', 'poor', 'clinical', 'outcome', '.', 'Temperature', 'modulation', 'to', 'hypothermia', '(', 'Temperature', ',', '32', '-', '34', '째', 'C', ')', 'has', 'been', 'associated', 'with', 'reduction', 'or', 'improvement', 'of', 'physiopathologic', 'processes', 'associated', 'with', 'inflammatory', 'activation', 'and', 'degradation', 'of', 'blood', '-', 'brain', 'barrier', 'after', 'all', 'types', 'of', 'brain', 'injury', '.', 'In', 'this', 'sense', ',', 'we', 'believe', 'that', 'the', 'initiation', 'of', 'an', 'ultra', '-', 'early', 'protocol', 'of', 'active', 'temperature', 'modulation', 'or', 'Targeted', 'Temperature', 'Management', '(', 'TTM', ')', 'to', 'mild', 'induced', 'hypothermia', '(', 'MIH', ',', '32', '-', '34', '째', 'C', ')', 'may', 'be', 'associated', 'with', 'good', 'safety', 'and', 'tolerability', 'profile', ',', 'less', 'HG', 'and', 'cerebral', 'edema', 'after', 'IPH', 'by', 'modulation', 'of', 'systemic', 'and', 'local', 'inflammatory', 'responses', ',', 'so', 'we', 'hypothesize', 'that', 'TTM', 'to', 'MIH', 'will', 'be', 'a', 'safe', '/', 'tolerable', 'and', 'effective', 'therapy', 'to', 'limit', 'HG', 'and', 'cerebral', 'edema', 'after', 'IPH', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O']",NCT01866384,NCT01866384,"Safety and Tolerability of a Protocol of Targeted Temperature Management After Intracerebral Hemorrhage | Early hematoma growth (HG) after spontaneous intra-cerebral/intra-parenchymal hemorrhage (IPH) is common and associated with neurological deterioration and poor clinical outcome. Temperature modulation to hypothermia (Temperature, 32-34째C) has been associated with reduction or improvement of physiopathologic processes associated with inflammatory activation and degradation of blood-brain barrier after all types of brain injury. In this sense, we believe that the initiation of an ultra-early protocol of active temperature modulation or Targeted Temperature Management (TTM) to mild induced hypothermia (MIH, 32-34째C) may be associated with good safety and tolerability profile, less HG and cerebral edema after IPH by modulation of systemic and local inflammatory responses, so we hypothesize that TTM to MIH will be a safe/tolerable and effective therapy to limit HG and cerebral edema after IPH.","[(41, 72, 'OTHER', 'Targeted Temperature Management'), (79, 103, 'CONDITION', 'Intracerebral Hemorrhage'), (106, 127, 'CONDITION', 'Early hematoma growth'), (129, 131, 'CONDITION', 'HG'), (139, 194, 'CONDITION', 'spontaneous intra-cerebral/intra-parenchymal hemorrhage'), (196, 199, 'CONDITION', 'IPH'), (285, 307, 'OTHER', 'Temperature modulation'), (311, 322, 'OTHER', 'hypothermia'), (647, 678, 'OTHER', 'Targeted Temperature Management'), (680, 683, 'OTHER', 'TTM'), (688, 712, 'OTHER', 'mild induced hypothermia'), (714, 717, 'OTHER', 'MIH'), (794, 796, 'CONDITION', 'HG'), (801, 815, 'CONDITION', 'cerebral edema'), (822, 825, 'CONDITION', 'IPH'), (909, 912, 'OTHER', 'TTM'), (916, 919, 'OTHER', 'MIH'), (976, 978, 'CONDITION', 'HG'), (983, 997, 'CONDITION', 'cerebral edema'), (1004, 1007, 'CONDITION', 'IPH')]"
"['Efficacy', 'of', 'Lacosamide', 'in', 'Neonatal', 'Status', 'Epilepticus', ':', 'A', 'Randomized', 'Controlled', 'Study', '|', 'Lacosamide', 'in', 'neonatal', 'status', 'epilepticus']","['O', 'O', 'B-DRUG', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'B-COND', 'I-COND']",NCT05291455,NCT05291455,Efficacy of Lacosamide in Neonatal Status Epilepticus: A Randomized Controlled Study | Lacosamide in neonatal status epilepticus,"[(12, 22, 'DRUG', 'Lacosamide'), (35, 53, 'CONDITION', 'Status Epilepticus'), (87, 97, 'DRUG', 'Lacosamide'), (110, 128, 'CONDITION', 'status epilepticus')]"
"['Short', '-', 'Term', 'Effects', 'of', 'Whole', '-', 'Body', 'Vibration', 'on', 'Upper', 'Extremity', 'Function', 'in', 'Subjects', 'With', 'Poststroke', 'Hemiplegia', '|', 'To', 'investigate', 'the', 'effect', 'of', 'whole', 'body', 'vibration', 'on', 'upper', 'limb', 'motor', 'function', 'in', 'hemiplegic', 'patients', 'with', 'subacute', 'stroke']","['O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND']",NCT03963258,NCT03963258,Short-Term Effects of Whole-Body Vibration on Upper Extremity Function in Subjects With Poststroke Hemiplegia | To investigate the effect of whole body vibration on upper limb motor function in hemiplegic patients with subacute stroke,"[(22, 42, 'OTHER', 'Whole-Body Vibration'), (88, 109, 'CONDITION', 'Poststroke Hemiplegia'), (141, 161, 'OTHER', 'whole body vibration'), (194, 204, 'CONDITION', 'hemiplegic'), (219, 234, 'CONDITION', 'subacute stroke')]"
"['Randomised', 'Controlled', 'Trial', 'to', 'Compare', 'Two', 'Methods', 'of', 'Constraint', 'Induced', 'Movement', 'Therapy', 'to', 'Improve', 'Functional', 'Ability', 'in', 'the', 'Affected', 'Upper', 'Limb', 'in', 'Pre', '-', 'school', 'Children', 'With', 'Hemiplegic', 'Cerebral', 'Palsy', '|', 'Cerebral', 'palsy', 'remains', 'a', 'major', 'cause', 'of', 'lifelong', 'disability', 'affecting', 'approximately', '2', 'per', '1,000', 'children', '.', 'Of', 'those', 'about', '30', '%', 'have', 'hemiplegic', 'cerebral', 'palsy', '(', 'HPC),a', 'unilateral', 'impairment', ',', 'which', 'can', 'often', 'lead', 'to', 'major', 'difficulties', 'with', 'manual', 'dexterity', 'and', 'upper', 'limb', ',', 'functional', 'ability', 'and', 'independence', '.', 'Therapists', 'employ', 'a', 'number', 'of', 'strategies', 'in', 'upper', 'limb', 'rehabilitation', 'however', 'they', 'are', 'poorly', 'understood', 'and', 'their', 'efficacy', 'has', 'been', 'questioned', '.', 'Constraint', 'induced', 'movement', 'therapy', '(', 'CIMT)has', 'been', 'found', 'to', 'be', 'an', 'effective', 'intervention', 'with', 'HCP', 'however', 'its', 'use', 'in', 'the', 'preschool', 'child', 'within', 'a', 'national', 'health', 'service', '(', 'NHS', ')', 'setting', 'has', 'not', 'been', 'evaluated', '.', 'The', 'investigators', 'aim', 'is', 'to', 'compare', 'CIMT', 'using', 'prolonged', 'restraint', 'with', 'CIMT', 'using', 'brief', 'manual', 'restraint', 'which', 'may', 'be', 'standard', 'practice', 'and', 'acts', 'as', 'the', 'control', '.', 'This', 'age', 'group', 'has', 'been', 'targeted', 'as', 'there', 'may', 'be', 'greatest', 'neural', 'plasticity', '(', 'change)and', 'minimal', 'disruption', 'to', 'compulsory', 'education', '.', 'The', 'investigators', 'intend', 'to', 'recruit', '60', 'patients', 'from', 'treatment', 'databases', 'of', 'participating', 'trusts', '.', 'Patients', 'will', 'be', 'randomised', 'following', 'baseline', 'assessments', 'which', 'will', 'include', '2', 'upper', 'limb', 'assessments(The', 'Assisting', 'Hand', 'Assessment', 'and', 'the', 'Quality', 'of', 'Upper', 'Extremity', 'Skills', 'Test', ')', 'and', 'a', 'quality', 'of', 'life', 'questionnaire', '(', 'PedsQL', 'Generic', 'Core', 'Scales', 'and', 'the', 'Cerebral', 'Palsy', 'Module', ')', 'for', 'parents', '.', 'The', 'intervention', 'period', 'will', 'be', 'for', '6', 'weeks', 'offered', 'intermittently', '(', '2week', 'blocks', ')', 'over', '10', 'weeks', '.', 'Parents', '/guardians', 'and', 'possibly', 'preschool', 'workers', 'will', 'be', 'expected', 'to', 'carry', 'out', 'a', 'therapy', 'guided', 'programme', '.', 'The', 'amount', 'of', 'intervention', 'and', 'compliance', 'will', 'be', 'recorded', 'by', 'parents', '/', 'guardians', 'and', 'therapists', '.', 'Assessments', 'will', 'be', 'repeated', 'at', '10', 'weeks', 'and', '24', 'weeks', 'from', 'the', 'beginning', 'of', 'the', 'trial', '.', 'The', 'results', 'of', 'the', 'trial', 'will', 'contribute', 'to', 'the', 'evidence', 'on', 'the', 'effectiveness', 'of', 'CIMT', 'in', 'the', 'preschool', 'child', 'with', 'HCP', ',', 'and', 'will', 'also', 'provide', 'evidence', 'on', 'the', 'implementation', 'of', 'CIMT', 'delivery', 'within', 'the', 'current', 'NHS', 'therapy', 'services', '.', '\n\n', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT01770678,NCT01770678,"Randomised Controlled Trial to Compare Two Methods of Constraint Induced Movement Therapy to Improve Functional Ability in the Affected Upper Limb in Pre-school Children With Hemiplegic Cerebral Palsy | Cerebral palsy remains a major cause of lifelong disability affecting approximately 2 per 1,000 children. Of those about 30% have hemiplegic cerebral palsy (HPC),a unilateral impairment, which can often lead to major difficulties with manual dexterity and upper limb,functional ability and independence. Therapists employ a number of strategies in upper limb rehabilitation however they are poorly understood and their efficacy has been questioned. Constraint induced movement therapy (CIMT)has been found to be an effective intervention with HCP however its use in the preschool child within a national health service (NHS) setting has not been evaluated. The investigators aim is to compare CIMT using prolonged restraint with CIMT using brief manual restraint which may be standard practice and acts as the control. This age group has been targeted as there may be greatest neural plasticity (change)and minimal disruption to compulsory education. The investigators intend to recruit 60 patients from treatment databases of participating trusts. Patients will be randomised following baseline assessments which will include 2 upper limb assessments(The Assisting Hand Assessment and the Quality of Upper Extremity Skills Test) and a quality of life questionnaire (PedsQL Generic Core Scales and the Cerebral Palsy Module) for parents. The intervention period will be for 6 weeks offered intermittently (2week blocks) over 10 weeks. Parents /guardians and possibly preschool workers will be expected to carry out a therapy guided programme. The amount of intervention and compliance will be recorded by parents/guardians and therapists. Assessments will be repeated at 10 weeks and 24 weeks from the beginning of the trial. The results of the trial will contribute to the evidence on the effectiveness of CIMT in the preschool child with HCP, and will also provide evidence on the implementation of CIMT delivery within the current NHS therapy services.

.","[(54, 89, 'OTHER', 'Constraint Induced Movement Therapy'), (175, 200, 'CONDITION', 'Hemiplegic Cerebral Palsy'), (203, 217, 'CONDITION', 'Cerebral palsy'), (333, 358, 'CONDITION', 'hemiplegic cerebral palsy'), (652, 687, 'OTHER', 'Constraint induced movement therapy'), (746, 749, 'CONDITION', 'HCP'), (896, 926, 'OTHER', 'CIMT using prolonged restraint'), (932, 965, 'OTHER', 'CIMT using brief manual restraint'), (2010, 2014, 'OTHER', 'CIMT'), (2043, 2046, 'CONDITION', 'HCP'), (2104, 2108, 'OTHER', 'CIMT')]"
"['Spine', 'Stereotactic', 'Body', 'Radiation', 'Therapy', 'for', 'Metastatic', 'Epidural', 'Spinal', 'Cord', ':', 'Prospective', 'Phase', 'II', 'Study', '|', 'Metastatic', 'epidural', 'spinal', 'cord', 'compression', '(', 'MESCC', ')', 'is', 'a', 'frequent', 'oncologic', 'emergency', 'that', 'requires', 'to', 'be', 'treated', 'promptly', '.', 'Although', 'direct', 'decompressive', 'surgery', 'is', 'the', 'most', 'effective', 'treatment', ',', 'surgery', 'is', 'only', 'used', 'in', 'selected', 'patients', 'because', 'most', 'patients', 'have', 'a', 'poor', 'overall', 'condition', 'and', 'short', 'life', 'expectancy', '.', 'Radiation', 'therapy', '(', 'RT', ')', ',', 'therefore', ',', 'is', 'the', 'most', 'commonly', 'used', 'for', 'patients', 'with', 'MESCC', ',', 'but', 'conventional', 'RT', 'alone', 'can', 'achieve', 'modest', 'neurologic', 'outcomes', '.', '\n\n', 'The', 'hypothesis', 'to', 'use', 'stereotactic', 'body', 'radiation', 'therapy', '(', 'SBRT', ')', 'for', 'MESCC', 'is', 'that', 'the', 'rapid', 'decompression', 'of', 'epidural', 'mass', ',', 'durable', 'local', 'control', 'and', 'subsequently', 'improved', 'neurologic', 'outcomes', 'compared', 'to', 'conventional', 'RT', 'are', 'expected', 'when', 'MESCC', 'is', 'treated', 'with', 'SBRT', '.']","['B-RADIO', 'I-RADIO', 'I-RADIO', 'I-RADIO', 'I-RADIO', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RADIO', 'I-RADIO', 'O', 'B-RADIO', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RADIO', 'I-RADIO', 'I-RADIO', 'I-RADIO', 'O', 'B-RADIO', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'B-RADIO', 'O']",NCT01826058,NCT01826058,"Spine Stereotactic Body Radiation Therapy for Metastatic Epidural Spinal Cord: Prospective Phase II Study | Metastatic epidural spinal cord compression (MESCC) is a frequent oncologic emergency that requires to be treated promptly. Although direct decompressive surgery is the most effective treatment, surgery is only used in selected patients because most patients have a poor overall condition and short life expectancy. Radiation therapy (RT), therefore, is the most commonly used for patients with MESCC, but conventional RT alone can achieve modest neurologic outcomes.

The hypothesis to use stereotactic body radiation therapy (SBRT) for MESCC is that the rapid decompression of epidural mass, durable local control and subsequently improved neurologic outcomes compared to conventional RT are expected when MESCC is treated with SBRT.","[(0, 41, 'RADIOTHERAPY', 'Spine Stereotactic Body Radiation Therapy'), (46, 77, 'CONDITION', 'Metastatic Epidural Spinal Cord'), (108, 151, 'CONDITION', 'Metastatic epidural spinal cord compression'), (153, 158, 'CONDITION', 'MESCC'), (424, 441, 'RADIOTHERAPY', 'Radiation therapy'), (443, 445, 'RADIOTHERAPY', 'RT'), (503, 508, 'CONDITION', 'MESCC'), (514, 535, 'CONTROL', 'conventional RT alone'), (599, 634, 'RADIOTHERAPY', 'stereotactic body radiation therapy'), (636, 640, 'RADIOTHERAPY', 'SBRT'), (646, 651, 'CONDITION', 'MESCC'), (782, 797, 'CONTROL', 'conventional RT'), (816, 821, 'CONDITION', 'MESCC'), (838, 842, 'RADIOTHERAPY', 'SBRT')]"
"['Applications', 'of', 'Nanotechnology', 'and', 'Chemical', 'Sensors', 'for', 'the', 'Detection', 'and', 'Identification', 'of', 'Multiple', 'Sclerosis', ',', 'In', 'Comparison', 'to', 'Other', 'Autoimmune', 'and', 'Neurological', 'Diseases', 'by', 'Exhalation', 'Samples', '|', 'Multiple', 'Sclerosis', '(', 'MS', ')', 'is', 'a', 'complex', 'multi', '-', 'factorial', 'disease', ',', 'with', 'underlying', 'both', 'genetic', 'and', 'environmental', 'factors', '.', 'Different', 'populations', 'have', 'different', 'susceptibility', 'to', 'MS', '.', 'The', 'disease', 'is', 'characterized', 'by', '2', 'main', 'phenotypes', ':', 'relapsing', '-', 'remitting', 'or', 'progressive', 'course', '.', 'Clinical', 'disability', 'is', 'due', 'to', 'distraction', 'of', 'the', 'central', 'nervous', 'system', '(', 'CNS', ')', 'myelin', '.', '\n\n', 'Repair', 'processes', 'are', 'mainly', 'noted', 'after', 'the', 'acute', 'relapse', '-', 'and', 'recovery', 'of', 'function', 'can', 'be', 'spontaneous', '.', 'However', ',', 'in', 'severe', 'relapses', 'sometimes', 'there', 'is', 'need', 'for', 'STEROID', 'TREATMENT', '.', '\n\n', 'For', 'the', 'long', 'term', 'prophylaxis', '-', 'following', 'the', 'increased', 'understanding', 'of', 'the', 'disease', ',', 'in', 'the', 'last', '10', '-', '15', 'years', ',', 'there', 'are', 'new', 'immunotherapies', 'available', '(', 'COPAXON', '/', 'TEVA', ';', 'Interferon', '-beta', ')', '.', 'However', 'these', 'can', 'attenuate', 'the', 'disease', '(', 'reduce', 'the', 'number', 'of', 'relapses', 'per', 'year', ')', 'but', 'can', 'not', 'cure', 'it', '.', 'Also', ',', 'they', 'are', 'beneficial', 'in', 'only', '~40', '%', 'of', 'the', 'Relapsing', '-Remitting', 'patients', '.', '\n\n', 'Currently', 'there', 'are', 'no', 'biomarkers', 'available', 'for', 'MS', '(', 'other', 'than', 'oligoclonal', 'Immunoglobulin', 'G', '(', 'IgG', ')', 'in', 'the', 'cervical', 'spine', 'fluid', '(', 'CSF', ')', '-', 'which', 'helps', 'confirm', 'diagnosis', 'but', 'require', 'an', 'invasive', 'procedure', 'and', 'are', 'not', 'correlated', 'with', 'disease', 'activity', 'nor', 'response', 'to', 'therapy', ')', 'and', 'monitoring', 'of', 'MS', 'and', 'its', 'treatment', 'is', 'by', 'magnetic', 'resonance', 'Imaging', '(', 'MRI', ')', '-', 'which', 'is', 'an', 'expensive', 'procedure', '.', '\n\n', 'Dr', 'Hossam', 'Haick', 'from', 'the', 'Technion', 'developed', 'an', 'electronic', 'nose', 'based', 'on', 'nanomaterials', 'for', 'diagnosis', 'of', 'diseases', '(', 'e.g.', ',', 'cancer', ',', 'kidney', 'failure', ',', 'etc', '.', ')', 'via', 'breath', 'samples', '.', 'The', 'research', 'hypothesis', 'is', 'that', 'Biomarkers', 'of', 'CNS', 'inflammation', 'and/or', 'neurodegeneration', 'and/or', 'CNS', 'repair', 'in', 'persons', 'with', 'MS', 'can', 'be', 'detected', 'by', 'the', '""', 'electronic', 'nose', '""', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT01465087,NCT01465087,"Applications of Nanotechnology and Chemical Sensors for the Detection and Identification of Multiple Sclerosis, In Comparison to Other Autoimmune and Neurological Diseases by Exhalation Samples | Multiple Sclerosis (MS) is a complex multi-factorial disease, with underlying both genetic and environmental factors. Different populations have different susceptibility to MS. The disease is characterized by 2 main phenotypes: relapsing-remitting or progressive course. Clinical disability is due to distraction of the central nervous system (CNS) myelin.

Repair processes are mainly noted after the acute relapse - and recovery of function can be spontaneous. However, in severe relapses sometimes there is need for STEROID TREATMENT.

For the long term prophylaxis - following the increased understanding of the disease, in the last 10-15 years, there are new immunotherapies available (COPAXON / TEVA; Interferon -beta). However these can attenuate the disease (reduce the number of relapses per year) but cannot cure it. Also, they are beneficial in only ~40 % of the Relapsing -Remitting patients.

Currently there are no biomarkers available for MS (other than oligoclonal Immunoglobulin G (IgG) in the cervical spine fluid (CSF) - which helps confirm diagnosis but require an invasive procedure and are not correlated with disease activity nor response to therapy) and monitoring of MS and its treatment is by magnetic resonance Imaging (MRI) - which is an expensive procedure.

Dr Hossam Haick from the Technion developed an electronic nose based on nanomaterials for diagnosis of diseases (e.g., cancer, kidney failure, etc.) via breath samples.The research hypothesis is that Biomarkers of CNS inflammation and/or neurodegeneration and/or CNS repair in persons with MS can be detected by the ""electronic nose"".","[(92, 110, 'CONDITION', 'Multiple Sclerosis'), (196, 214, 'CONDITION', 'Multiple Sclerosis'), (216, 218, 'CONDITION', 'MS'), (369, 371, 'CONDITION', 'MS'), (1150, 1152, 'CONDITION', 'MS'), (1388, 1390, 'CONDITION', 'MS'), (1774, 1776, 'CONDITION', 'MS')]"
"['Precision', 'Gait', 'Retraining', 'for', 'Children', 'With', 'Cerebral', 'Palsy', '|', 'This', 'project', 'will', 'develop', 'the', 'first', 'sensor', '-', 'based', 'mobile', 'Pelvic', 'Assist', 'Device', '(', 'mPAD', ')', 'that', 'can', 'deliver', 'precise', ',', 'adaptable', ',', 'pelvic', 'control', 'to', 'restore', 'natural', 'coordination', 'of', 'upper-', 'and', 'lower', '-', 'limb', 'movements', 'during', 'gait', 'in', 'children', 'with', 'Cerebral', 'Palsy']","['B-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND']",NCT04717323,NCT04717323,"Precision Gait Retraining for Children With Cerebral Palsy | This project will develop the first sensor-based mobile Pelvic Assist Device (mPAD) that can deliver precise, adaptable, pelvic control to restore natural coordination of upper- and lower-limb movements during gait in children with Cerebral Palsy","[(0, 25, 'PHYSICAL', 'Precision Gait Retraining'), (44, 58, 'CONDITION', 'Cerebral Palsy'), (97, 137, 'OTHER', 'sensor-based mobile Pelvic Assist Device'), (139, 143, 'OTHER', 'mPAD'), (293, 307, 'CONDITION', 'Cerebral Palsy')]"
"['An', 'Open', '-', 'label', 'Naturalistic', 'Pragmatic', 'Study', 'to', 'Assess', 'the', 'Long', 'Term', 'Safety', 'of', 'BF2.649', '(', 'Pitolisant', ')', 'in', 'the', 'Treatment', 'of', 'Excessive', 'Daytime', 'Sleepiness', '(', 'EDS', ')', 'in', 'Narcolepsy', '(', '12', 'Months', 'Follow', '-', 'up', ',', 'Followed', 'by', 'a', 'Prolonged', 'Follow', 'up', ')', '|', 'This', 'is', 'a', 'multicentric', 'International', 'Phase', 'III', ',', 'Long', 'term', 'open', 'label', 'study(12', 'months)assessing', 'the', 'long', '-', 'term', 'safety', 'and', 'efficacy', 'of', 'BF2.649', '(', 'Pitolisant)in', 'the', 'treatment', 'of', 'Excessive', 'Daytime', 'Sleepiness', '(', 'EDS', ')', 'in', 'narcoleptic', 'patients', 'with', 'or', 'without', 'cataplexy', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT01399606,NCT01399606,"An Open-label Naturalistic Pragmatic Study to Assess the Long Term Safety of BF2.649 (Pitolisant) in the Treatment of Excessive Daytime Sleepiness (EDS) in Narcolepsy (12 Months Follow-up, Followed by a Prolonged Follow up) | This is a multicentric International Phase III,Long term open label study(12 months)assessing the long-term safety and efficacy of BF2.649 (Pitolisant)in the treatment of Excessive Daytime Sleepiness (EDS) in narcoleptic patients with or without cataplexy.","[(77, 84, 'DRUG', 'BF2.649'), (86, 96, 'DRUG', 'Pitolisant'), (118, 146, 'CONDITION', 'Excessive Daytime Sleepiness'), (148, 151, 'CONDITION', 'EDS'), (156, 166, 'CONDITION', 'Narcolepsy'), (357, 364, 'DRUG', 'BF2.649'), (397, 425, 'CONDITION', 'Excessive Daytime Sleepiness'), (427, 430, 'CONDITION', 'EDS'), (435, 446, 'CONDITION', 'narcoleptic'), (472, 481, 'CONDITION', 'cataplexy')]"
"['Examining', 'the', 'Effects', 'of', 'Transcranial', 'Direct', 'Current', 'Stimulation', 'and', 'Task', '-', 'specific', 'Practice', 'on', 'Cortical', 'Modulation', 'Among', 'Individuals', 'With', 'Unilateral', 'Spatial', 'Neglect', 'Post', 'Stroke', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'test', 'the', 'effects', 'of', 'three', 'different', 'rehabilitation', 'training', 'sessions', 'that', 'combine', 'non', '-', 'invasive', 'brain', 'stimulation', '(', 'transcranial', 'direct', 'current', 'stimulation', ',', 'tDCS', ')', 'with', 'arm', 'rehabilitation', 'training', '(', 'repetitive', 'task', '-', 'specific', 'practice', ',', 'RTP', ')', 'for', 'individuals', 'with', 'unilateral', 'spatial', 'neglect', 'following', 'stroke', '.', 'This', 'study', 'is', 'designed', 'to', 'determine', 'the', 'effects', 'of', 'tDCS', '+', 'RTP', 'on', 'the', 'excitability', 'in', 'the', 'brain', ',', 'attention', 'to', 'the', 'affected', 'side', ',', 'and', 'arm', 'movement', 'ability', '.']","['O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02892097,NCT02892097,"Examining the Effects of Transcranial Direct Current Stimulation and Task-specific Practice on Cortical Modulation Among Individuals With Unilateral Spatial Neglect Post Stroke | The purpose of this study is to test the effects of three different rehabilitation training sessions that combine non-invasive brain stimulation (transcranial direct current stimulation, tDCS) with arm rehabilitation training (repetitive task-specific practice, RTP) for individuals with unilateral spatial neglect following stroke. This study is designed to determine the effects of tDCS + RTP on the excitability in the brain, attention to the affected side, and arm movement ability.","[(25, 64, 'OTHER', 'Transcranial Direct Current Stimulation'), (69, 91, 'PHYSICAL', 'Task-specific Practice'), (138, 164, 'CONDITION', 'Unilateral Spatial Neglect'), (170, 176, 'CONDITION', 'Stroke'), (293, 323, 'OTHER', 'non-invasive brain stimulation'), (325, 364, 'OTHER', 'transcranial direct current stimulation'), (366, 370, 'OTHER', 'tDCS'), (377, 404, 'PHYSICAL', 'arm rehabilitation training'), (406, 439, 'PHYSICAL', 'repetitive task-specific practice'), (441, 444, 'PHYSICAL', 'RTP'), (467, 493, 'CONDITION', 'unilateral spatial neglect'), (504, 510, 'CONDITION', 'stroke'), (563, 567, 'OTHER', 'tDCS'), (570, 573, 'PHYSICAL', 'RTP')]"
"['Treatment', 'of', 'Periodontitis', 'to', 'Prevent', 'Dementia', 'in', 'Older', 'Adults', 'With', 'Asymptomatic', 'Carotid', 'Artery', 'Stenosis', 'and', 'Mild', 'Cognitive', 'Impairment', '|', 'Periodontal', 'Disease', '(', 'PD', ')', 'is', 'present', 'in', '60+%', 'of', 'adults', '>', '65', 'years', 'and', 'is', 'associated', 'with', 'tobacco', 'smoking', ',', 'diabetes', ',', 'and', 'atherosclerosis', 'that', 'worsen', 'inflammation', ',', 'comorbidities', 'common', 'in', 'older', 'people', 'with', 'mild', 'to', 'moderate', 'cognitive', 'impairment', '(', 'MCI', ')', '.', 'Older', 'MCI', 'patients', 'are', 'prone', 'to', 'poor', 'oral', 'hygiene', 'and', 'dental', 'health', ',', 'which', 'if', 'untreated', 'worsens', 'inflammation', '-', 'mediated', 'brain', 'and', 'nervous', 'system', 'function', ',', 'and', 'accelerates', 'progression', 'to', 'dementia', '.', 'Asymptomatic', 'carotid', 'artery', 'stenosis', '(', 'ACAS', ')', 'is', 'often', 'a', 'silent', 'disease', 'detected', 'in', 'only', '~10', '%', 'of', 'older', 'adults', ',', 'and', 'may', 'have', 'a', 'strong', 'association', 'with', 'MCI', '.', 'This', 'study', 'examines', 'the', 'effects', 'of', 'intensive', 'therapy', 'for', 'periodontitis', 'on', 'cognition', 'in', 'high', '-', 'risk', 'older', 'people', 'with', 'ACAS', '.', 'Results', 'could', 'highlight', 'PD', 'as', 'a', 'readily', 'modifiable', 'risk', 'factor', 'for', 'dementia', '.']","['B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT03755362,NCT03755362,"Treatment of Periodontitis to Prevent Dementia in Older Adults With Asymptomatic Carotid Artery Stenosis and Mild Cognitive Impairment | Periodontal Disease (PD) is present in 60+% of adults >65 years and is associated with tobacco smoking, diabetes, and atherosclerosis that worsen inflammation, comorbidities common in older people with mild to moderate cognitive impairment (MCI). Older MCI patients are prone to poor oral hygiene and dental health, which if untreated worsens inflammation-mediated brain and nervous system function, and accelerates progression to dementia. Asymptomatic carotid artery stenosis (ACAS) is often a silent disease detected in only ~10% of older adults, and may have a strong association with MCI. This study examines the effects of intensive therapy for periodontitis on cognition in high-risk older people with ACAS. Results could highlight PD as a readily modifiable risk factor for dementia.","[(0, 26, 'OTHER', 'Treatment of Periodontitis'), (38, 46, 'CONDITION', 'Dementia'), (68, 104, 'CONDITION', 'Asymptomatic Carotid Artery Stenosis'), (109, 134, 'CONDITION', 'Mild Cognitive Impairment'), (137, 156, 'CONDITION', 'Periodontal Disease'), (158, 160, 'CONDITION', 'PD'), (339, 376, 'CONDITION', 'mild to moderate cognitive impairment'), (378, 381, 'CONDITION', 'MCI'), (390, 393, 'CONDITION', 'MCI'), (568, 576, 'CONDITION', 'dementia'), (578, 614, 'CONDITION', 'Asymptomatic carotid artery stenosis'), (616, 620, 'CONDITION', 'ACAS'), (726, 729, 'CONDITION', 'MCI'), (766, 801, 'OTHER', 'intensive therapy for periodontitis'), (846, 850, 'CONDITION', 'ACAS'), (876, 878, 'CONDITION', 'PD'), (919, 927, 'CONDITION', 'dementia')]"
"['Effect', 'of', 'Heparinization', 'on', 'Intracranial', 'Aneurysm', '|', 'The', 'goal', 'of', 'this', 'clinical', 'trial', 'is', 'to', 'compare', 'intracranial', 'aneurysm', 'patients', '.', 'The', 'main', 'question', 'it', 'aims', 'to', 'answer', 'are', ':', 'Which', 'heparinization', 'regimen', 'is', 'most', 'beneficial', 'to', 'patients', 'during', 'surgery', 'for', 'intracranial', 'aneurysms', '.', 'Participants', 'will', 'be', 'randomized', 'to', 'different', 'intraoperative', 'heparinization', 'regimens', ':', '(', 'i', ')', '50', 'U', '/', 'kg', 'intravenous', '(', 'IV', ')', 'at', '1', '-', 'h', 'intervals', 'reduced', 'by', 'half', 'to', 'a', 'minimum', 'of', '1000', 'u', '/', 'h', ';', '(', 'ii', ')', '60', 'U', '/', 'kg', 'IV', 'at', '1', '-', 'h', 'intervals', 'reduced', 'by', 'half', 'to', 'a', 'minimum', 'of', '1000', 'u', '/', 'h', ';', '(', 'iii', ')', '70', 'U', '/', 'kg', 'IV', 'at', '1', '-', 'h', 'intervals', 'reduced', 'by', 'half', 'to', 'a', 'minimum', 'of', '1000', 'u', '/', 'h.', 'MRI', 'will', 'be', 'performed', 'within', '72', 'h', 'after', 'surgery', ',', 'and', 'the', 'DWI', 'sequence', 'of', 'MRI', 'will', 'be', 'analyzed', '.', 'If', 'there', 'is', 'a', 'comparison', 'group', ':', 'Researchers', 'will', 'compare', 'different', 'intraoperative', 'heparinization', 'protocol', 'groups', 'to', 'see', 'which', 'dose', 'of', 'intraoperative', 'heparin', 'has', 'the', 'best', 'prognosis', 'for', 'use', '.']","['O', 'O', 'B-DRUG', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05749393,NCT05749393,"Effect of Heparinization on Intracranial Aneurysm | The goal of this clinical trial is to compare intracranial aneurysm patients. The main question it aims to answer are: Which heparinization regimen is most beneficial to patients during surgery for intracranial aneurysms. Participants will be randomized to different intraoperative heparinization regimens: (i) 50 U/kg intravenous (IV) at 1-h intervals reduced by half to a minimum of 1000 u/h; (ii) 60 U/kg IV at 1-h intervals reduced by half to a minimum of 1000 u/h; (iii) 70 U/kg IV at 1-h intervals reduced by half to a minimum of 1000 u/h. MRI will be performed within 72 h after surgery, and the DWI sequence of MRI will be analyzed. If there is a comparison group: Researchers will compare different intraoperative heparinization protocol groups to see which dose of intraoperative heparin has the best prognosis for use.","[(10, 24, 'DRUG', 'Heparinization'), (28, 49, 'CONDITION', 'Intracranial Aneurysm'), (98, 119, 'CONDITION', 'intracranial aneurysm'), (177, 191, 'DRUG', 'heparinization'), (238, 245, 'CONDITION', 'surgery'), (250, 272, 'CONDITION', 'intracranial aneurysms'), (334, 348, 'DRUG', 'heparinization'), (775, 789, 'DRUG', 'heparinization'), (842, 849, 'DRUG', 'heparin')]"
"['Effects', 'of', 'Improvisational', 'Dance', 'on', 'Cognition', 'and', 'Daily', 'Function', 'Among', 'People', 'With', 'Parkinson', 'Disease', '|', 'The', 'long', '-', 'term', 'goal', 'of', 'this', 'work', 'is', 'to', 'maintain', 'or', 'improve', 'daily', 'function', 'of', 'people', 'with', 'PD', 'by', 'addressing', 'cognition', '.', 'The', 'overall', 'objective', 'is', 'to', 'discover', 'interventions', 'that', 'aid', 'in', 'cognitive', 'functioning', '.', 'The', 'central', 'hypothesis', 'is', 'that', 'engagement', 'in', 'an', 'improvisational', 'dance', '(', 'ID', ')', 'class', 'will', 'benefit', 'cognition', 'among', 'people', 'with', 'PD', '.', 'Improvisational', 'dance', 'involves', 'spontaneously', 'generated', 'movement', ',', 'similar', 'to', 'how', 'one', 'moves', 'in', 'everyday', 'life', '.', 'The', 'literature', 'shows', 'that', 'ID', 'classes', 'positively', 'impact', 'motor', 'impairments', 'associated', 'with', 'PD', ',', 'such', 'as', 'balance', ',', 'gait', ',', 'and', 'functional', 'mobility', '.', 'Along', 'with', 'being', 'physically', 'demanding', ',', 'ID', 'requires', 'the', 'use', 'and', 'coordination', 'of', 'a', 'number', 'of', 'cognitive', 'capacities', 'to', 'properly', 'execute', 'movements', '.', 'This', 'type', 'of', 'activity', 'challenges', ',', 'and', 'thus', 'may', 'strengthen', ',', 'cognitive', 'processes', 'such', 'as', 'motor', 'planning', ',', 'decision', 'making', ',', 'flexible', 'thinking', ',', 'initiation', ',', 'and', 'execution', ',', 'which', 'may', 'give', 'people', 'cognitive', 'based', 'strategies', 'to', 'be', 'utilized', 'in', 'various', 'aspects', 'of', 'daily', 'life', '.', 'By', 'improving', 'motor', 'function', 'and/or', 'cognition', ',', 'ID', 'may', 'also', 'contribute', 'to', 'improved', 'daily', 'functioning', ',', 'or', 'the', 'ability', 'to', 'perform', 'and', 'participate', 'in', 'daily', 'activities', '.', 'Despite', 'these', 'theoretical', 'links', ',', 'evidence', 'for', 'the', 'effect', 'of', 'ID', 'on', 'cognition', 'and', 'overall', 'daily', 'function', 'is', 'limited', '.', 'The', 'current', 'project', 'objective', 'is', 'to', 'address', 'this', 'gap', 'and', 'better', 'understand', 'the', 'effects', 'of', 'ID', 'for', 'people', 'with', 'PD', '.', 'Specifically', ',', 'it', 'will', 'test', 'the', 'effect', 'of', 'IMPROVment', '짰', ',', 'a', 'method', 'of', 'ID', 'designed', 'for', 'people', 'with', 'PD', ',', 'on', 'cognition', 'and', 'daily', 'function', '.', '\n\n', 'Participants', ""'"", 'cognition', 'will', 'be', 'assessed', 'at', 'baseline', '(', 'T1', ')', 'using', 'the', 'NIH', 'Toolbox', 'Cognitive', 'Battery', ',', 'the', 'Alternate', 'Uses', 'Task', ',', 'and', 'the', 'Weekly', 'Calendar', 'Planning', 'Activity', '.', 'Global', 'cognition', 'will', 'be', 'assessed', 'using', 'the', 'Montreal', 'Cognitive', 'Assessment', '.', 'They', 'then', 'will', 'be', 'randomly', 'assigned', 'to', 'either', 'the', 'immediate', 'intervention', '(', 'ID', ')', 'or', 'waitlist', '-', 'control', '(', 'WC', ')', 'group', '.', 'The', 'ID', 'group', 'will', 'start', 'the', '12', '-', 'week', 'IMPROVment', '짰', 'intervention', ',', 'which', 'consists', 'of', 'weekly', 'ID', 'classes', 'that', 'progress', 'according', 'to', 'a', 'standardized', 'method', 'while', 'the', 'WC', 'group', 'will', 'receive', 'no', 'intervention', 'and', 'continue', 'with', 'their', 'regular', 'daily', 'routine', 'and', 'activity', 'level', '.', 'After', '12', 'weeks', ',', 'both', 'groups', 'will', 'complete', 'cognitive', 'testing', 'again', '(', 'T2', ')', '.', 'Cognitive', 'test', 'scores', 'will', 'be', 'compared', 'across', 'time', 'points', 'and', 'between', 'groups', 'using', 'a', 'mixed', 'model', 'repeated', 'measures', 'ANOVA', '.', 'The', 'investigators', 'hypothesize', 'that', 'IMPROVment', '짰', 'will', 'have', 'positive', 'effects', 'on', 'the', 'cognitive', 'abilities', 'of', 'people', 'with', 'PD', '.', 'Participants', 'will', 'also', 'complete', 'two', 'questionnaires', 'to', 'assess', 'daily', 'function', 'at', 'T1', 'and', 'T2', ':', 'Older', 'Americans', 'Resources', 'and', 'Services', 'Scale-', 'Extended', 'Version', 'and', 'PROMIS', 'Satisfaction', 'with', 'Participation', 'in', 'Discretionary', 'Social', 'Activities', '.', 'These', 'scores', 'will', 'be', 'compared', 'similar', 'to', 'the', 'above', 'aim', '.', 'The', 'investigators', 'hypothesize', 'that', 'IMPROVment', '짰', 'will', 'have', 'positive', 'effects', 'on', 'daily', 'function', 'in', 'people', 'with', 'PD', '.', '\n\n', 'Participant', 'mood', 'will', 'be', 'assessed', 'in', 'two', 'different', 'ways', '.', 'The', 'first', 'being', 'to', 'investigate', 'the', 'immediate', 'effect', 'of', 'participating', 'in', 'an', 'IMPROVment', '짰', 'class', 'on', 'mood', ',', 'fatigue', ',', 'and', 'anxiety', '.', 'The', 'investigators', 'hypothesize', 'that', 'mood', 'will', 'positively', 'improve', 'from', 'pre', 'to', 'post', 'of', 'each', 'class', '.', 'To', 'assess', 'this', ',', 'participants', 'will', 'respond', 'to', 'a', 'scale', 'assessing', 'mood', ',', 'specifically', 'sadness', ',', 'nervousness', ',', 'energy', ',', 'and', 'overall', 'well', '-', 'being', 'before', 'and', 'after', 'each', 'class', 'every', 'week', '.', 'The', 'second', 'measurement', 'is', 'to', 'investigate', 'the', 'effect', 'of', 'IMPROVment', '짰', 'on', 'anxiety', ',', 'fatigue', ',', 'and', 'depression', '.', 'The', 'investigators', 'hypothesize', 'that', 'IMPROVment', '짰', 'class', 'will', 'decrease', 'feelings', 'of', 'depression', 'for', 'those', 'with', 'PD', '.', 'All', 'participants', 'will', 'fill', 'out', 'the', 'Parkinson', ""'s"", 'Anxiety', 'Scale', ',', 'the', 'Parkinson', ""'s"", 'Disease', 'Fatigue', 'Scale', ',', 'and', 'the', 'Geriatric', 'Depression', 'Scale', 'short', 'form', 'before', 'and', 'after', 'participating', 'in', 'the', '12', '-', 'week', 'IMPROVment', '짰', 'program', '.', '\n\n', 'Achievement', 'of', 'these', 'aims', 'will', 'provide', 'further', 'support', 'for', 'the', 'IMPROVment', '짰', 'method', 'for', 'people', 'with', 'PD', 'experiencing', 'cognitive', 'deficits', '.', 'The', 'long', '-', 'term', 'impact', 'will', 'better', 'cognition', 'and', 'daily', 'functioning', 'in', 'people', 'with', 'PD', ',', 'and', 'thus', 'enhanced', 'everyday', 'lives', '.']","['O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04354298,NCT04354298,"Effects of Improvisational Dance on Cognition and Daily Function Among People With Parkinson Disease | The long-term goal of this work is to maintain or improve daily function of people with PD by addressing cognition. The overall objective is to discover interventions that aid in cognitive functioning. The central hypothesis is that engagement in an improvisational dance (ID) class will benefit cognition among people with PD. Improvisational dance involves spontaneously generated movement, similar to how one moves in everyday life. The literature shows that ID classes positively impact motor impairments associated with PD, such as balance, gait, and functional mobility. Along with being physically demanding, ID requires the use and coordination of a number of cognitive capacities to properly execute movements. This type of activity challenges, and thus may strengthen, cognitive processes such as motor planning, decision making, flexible thinking, initiation, and execution, which may give people cognitive based strategies to be utilized in various aspects of daily life. By improving motor function and/or cognition, ID may also contribute to improved daily functioning, or the ability to perform and participate in daily activities. Despite these theoretical links, evidence for the effect of ID on cognition and overall daily function is limited. The current project objective is to address this gap and better understand the effects of ID for people with PD. Specifically, it will test the effect of IMPROVment짰, a method of ID designed for people with PD, on cognition and daily function.

Participants' cognition will be assessed at baseline (T1) using the NIH Toolbox Cognitive Battery, the Alternate Uses Task, and the Weekly Calendar Planning Activity. Global cognition will be assessed using the Montreal Cognitive Assessment. They then will be randomly assigned to either the immediate intervention (ID) or waitlist-control (WC) group. The ID group will start the 12-week IMPROVment짰 intervention, which consists of weekly ID classes that progress according to a standardized method while the WC group will receive no intervention and continue with their regular daily routine and activity level. After 12 weeks, both groups will complete cognitive testing again (T2). Cognitive test scores will be compared across time points and between groups using a mixed model repeated measures ANOVA. The investigators hypothesize that IMPROVment짰 will have positive effects on the cognitive abilities of people with PD. Participants will also complete two questionnaires to assess daily function at T1 and T2: Older Americans Resources and Services Scale- Extended Version and PROMIS Satisfaction with Participation in Discretionary Social Activities. These scores will be compared similar to the above aim. The investigators hypothesize that IMPROVment짰 will have positive effects on daily function in people with PD.

Participant mood will be assessed in two different ways. The first being to investigate the immediate effect of participating in an IMPROVment짰 class on mood, fatigue, and anxiety. The investigators hypothesize that mood will positively improve from pre to post of each class. To assess this, participants will respond to a scale assessing mood, specifically sadness, nervousness, energy, and overall well-being before and after each class every week. The second measurement is to investigate the effect of IMPROVment짰 on anxiety, fatigue, and depression. The investigators hypothesize that IMPROVment짰 class will decrease feelings of depression for those with PD. All participants will fill out the Parkinson's Anxiety Scale, the Parkinson's Disease Fatigue Scale, and the Geriatric Depression Scale short form before and after participating in the 12-week IMPROVment짰 program.

Achievement of these aims will provide further support for the IMPROVment짰 method for people with PD experiencing cognitive deficits. The long-term impact will better cognition and daily functioning in people with PD, and thus enhanced everyday lives.","[(11, 32, 'PHYSICAL', 'Improvisational Dance'), (83, 100, 'CONDITION', 'Parkinson Disease'), (191, 193, 'CONDITION', 'PD'), (353, 374, 'PHYSICAL', 'improvisational dance'), (376, 378, 'PHYSICAL', 'ID'), (427, 429, 'CONDITION', 'PD'), (431, 452, 'PHYSICAL', 'Improvisational dance'), (565, 567, 'PHYSICAL', 'ID'), (628, 630, 'CONDITION', 'PD'), (719, 721, 'PHYSICAL', 'ID'), (1133, 1135, 'PHYSICAL', 'ID'), (1310, 1312, 'PHYSICAL', 'ID'), (1455, 1457, 'PHYSICAL', 'ID'), (1474, 1476, 'CONDITION', 'PD'), (1519, 1529, 'PHYSICAL', 'IMPROVment'), (1544, 1546, 'PHYSICAL', 'ID'), (1572, 1574, 'CONDITION', 'PD'), (1926, 1928, 'PHYSICAL', 'ID'), (1933, 1949, 'CONTROL', 'waitlist-control'), (1951, 1953, 'CONTROL', 'WC'), (1966, 1968, 'PHYSICAL', 'ID'), (1998, 2008, 'PHYSICAL', 'IMPROVment'), (2049, 2051, 'PHYSICAL', 'ID'), (2119, 2121, 'CONTROL', 'WC'), (2452, 2462, 'PHYSICAL', 'IMPROVment'), (2533, 2535, 'CONDITION', 'PD'), (2860, 2870, 'PHYSICAL', 'IMPROVment'), (2932, 2934, 'CONDITION', 'PD'), (3069, 3079, 'PHYSICAL', 'IMPROVment'), (3096, 3103, 'CONDITION', 'fatigue'), (3109, 3116, 'CONDITION', 'anxiety'), (3444, 3454, 'PHYSICAL', 'IMPROVment'), (3459, 3466, 'CONDITION', 'anxiety'), (3468, 3475, 'CONDITION', 'fatigue'), (3481, 3491, 'CONDITION', 'depression'), (3528, 3538, 'PHYSICAL', 'IMPROVment'), (3572, 3582, 'CONDITION', 'depression'), (3598, 3600, 'CONDITION', 'PD'), (3795, 3805, 'PHYSICAL', 'IMPROVment'), (3880, 3890, 'PHYSICAL', 'IMPROVment'), (3915, 3917, 'CONDITION', 'PD'), (4031, 4033, 'CONDITION', 'PD')]"
"['An', 'Open', 'Label', ',', 'Single', '-', 'dose', ',', 'Single', '-', 'period', 'Study', 'Designed', 'to', 'Assess', 'the', 'Mass', 'Balance', 'Recovery', ',', 'Metabolite', 'Profile', 'and', 'Metabolite', 'Identification', 'of', 'Carbon-14', 'BIA', '28', '-', '6156', 'in', 'Healthy', 'Male', 'Subjects', '|', 'The', 'study', 'is', 'designed', 'to', 'determine', 'the', 'absorption', ',', 'distribution', ',', 'metabolism', 'and', 'elimination', '(', 'ADME', ')', 'of', 'BIA', '28', '-', '6156', 'in', 'humans', ',', 'further', 'explore', 'the', 'PK', 'of', 'BIA', '28', '-', '6156', ',', 'evaluate', 'the', 'extent', 'of', 'distribution', 'of', 'total', 'radioactivity', 'into', 'blood', 'cells', ',', 'provide', 'additional', 'safety', 'and', 'tolerability', 'information', 'and', 'collect', 'samples', 'for', 'metabolite', 'profiling', 'and', 'structural', 'identification', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05220072,NCT05220072,"An Open Label, Single-dose, Single-period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of Carbon-14 BIA 28-6156 in Healthy Male Subjects | The study is designed to determine the absorption, distribution, metabolism and elimination (ADME) of BIA 28-6156 in humans, further explore the PK of BIA 28-6156, evaluate the extent of distribution of total radioactivity into blood cells, provide additional safety and tolerability information and collect samples for metabolite profiling and structural identification.","[(146, 167, 'DRUG', 'Carbon-14 BIA 28-6156'), (297, 308, 'DRUG', 'BIA 28-6156'), (346, 357, 'DRUG', 'BIA 28-6156')]"
"['Building', 'Online', 'Community', 'to', 'Improve', 'Patient', 'and', 'Caregiver', 'Outcomes', 'in', 'Parkinson', 'Disease', ',', 'Lewy', 'Body', 'Dementia', 'and', 'Related', 'Disorders', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'learn', 'more', 'about', 'the', 'effectiveness', 'of', 'palliative', 'care', 'training', 'for', 'community', 'physicians', 'and', 'telemedicine', 'support', 'services', 'for', 'patients', 'and', 'carepartners', 'with', 'Parkinson', ""'s"", 'disease', 'and', 'Lewy', 'Body', 'Dementia', '(', 'LBD', ')', 'or', 'related', 'conditions', 'and', 'their', 'care', 'partners', '.', 'Palliative', 'care', 'is', 'a', 'treatment', 'approach', 'focused', 'on', 'improving', 'quality', 'of', 'life', 'by', 'relieving', 'suffering', 'in', 'the', 'areas', 'of', 'physical', 'symptoms', 'such', 'as', 'pain', ',', 'psychiatric', 'symptoms', 'such', 'as', 'depression', ',', 'psychosocial', 'issues', 'and', 'spiritual', 'needs', '.', 'Telemedicine', 'is', 'the', 'use', 'of', 'technology', 'that', 'allows', 'participants', 'to', 'interact', 'with', 'a', 'health', 'care', 'provider', 'without', 'being', 'physically', 'near', 'the', 'provider', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05222386,NCT05222386,"Building Online Community to Improve Patient and Caregiver Outcomes in Parkinson Disease, Lewy Body Dementia and Related Disorders | The purpose of this study is to learn more about the effectiveness of palliative care training for community physicians and telemedicine support services for patients and carepartners with Parkinson's disease and Lewy Body Dementia (LBD) or related conditions and their care partners. Palliative care is a treatment approach focused on improving quality of life by relieving suffering in the areas of physical symptoms such as pain, psychiatric symptoms such as depression, psychosocial issues and spiritual needs. Telemedicine is the use of technology that allows participants to interact with a health care provider without being physically near the provider.","[(71, 88, 'CONDITION', 'Parkinson Disease'), (90, 108, 'CONDITION', 'Lewy Body Dementia'), (203, 252, 'BEHAVIOURAL', 'palliative care training for community physicians'), (257, 286, 'OTHER', 'telemedicine support services'), (322, 341, 'CONDITION', ""Parkinson's disease""), (346, 364, 'CONDITION', 'Lewy Body Dementia'), (366, 369, 'CONDITION', 'LBD'), (418, 433, 'OTHER', 'Palliative care'), (648, 660, 'OTHER', 'Telemedicine')]"
"['Neuromodulation', 'Technique', 'for', 'the', 'Rehabilitation', 'of', 'Social', 'Skills', 'in', 'Childhood', 'Ataxia', '|', 'The', 'present', 'study', 'aims', 'to', 'define', 'a', 'protocol', 'of', 'electrical', 'stimulation', 'of', 'the', 'cerebellum', 'via', 'transcranial', 'direct', 'current', 'stimulation', '(', 'tDCS', ')', 'combined', 'with', 'a', 'virtual', 'reality', 'protocol', 'to', 'assist', 'the', 'rehabilitation', 'of', 'social', 'skills', 'in', 'adolescents', 'and', 'young', 'adults', 'with', 'childhood', 'ataxia', '.', '\n\n', 'Taking', 'into', 'account', 'the', 'high', 'neuronal', 'density', 'of', 'the', 'cerebellum', ',', 'its', 'strong', 'connection', 'with', 'the', 'cerebral', 'cortex', ',', 'and', 'its', 'involvement', 'in', 'motor', ',', 'cognitive', 'and', 'affective', 'processes', ',', 'as', 'well', 'its', 'involvement', 'in', 'social', 'prediction', 'abilities', ',', 'the', 'investigators', 'hypothesized', 'that', 'excitatory', 'stimulation', 'of', 'the', 'cerebellum', 'might', 'improve', 'social', 'prediction', 'abilities', 'in', 'adolescents', 'and', 'young', 'adults', 'with', 'childhood', 'ataxia', '.', 'Moreover', ',', 'as', 'suggested', 'by', 'previous', 'studies', 'investigating', 'the', 'effect', 'of', 'tDCS', 'in', 'paediatric', 'population', ',', 'the', 'investigators', 'expected', 'that', 'tDCS', 'will', 'be', 'safe', 'and', 'well', 'tolerated', '.', 'Such', 'a', 'result', 'would', 'encourage', 'the', 'use', 'of', 'non', '-', 'invasive', 'brain', 'stimulation', 'in', 'the', 'rehabilitation', 'of', 'social', 'skills', 'in', 'childhood', 'ataxia', '.']","['B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT04297540,NCT04297540,"Neuromodulation Technique for the Rehabilitation of Social Skills in Childhood Ataxia | The present study aims to define a protocol of electrical stimulation of the cerebellum via transcranial direct current stimulation (tDCS) combined with a virtual reality protocol to assist the rehabilitation of social skills in adolescents and young adults with childhood ataxia.

Taking into account the high neuronal density of the cerebellum, its strong connection with the cerebral cortex, and its involvement in motor, cognitive and affective processes, as well its involvement in social prediction abilities, the investigators hypothesized that excitatory stimulation of the cerebellum might improve social prediction abilities in adolescents and young adults with childhood ataxia. Moreover, as suggested by previous studies investigating the effect of tDCS in paediatric population, the investigators expected that tDCS will be safe and well tolerated. Such a result would encourage the use of non-invasive brain stimulation in the rehabilitation of social skills in childhood ataxia.","[(0, 25, 'OTHER', 'Neuromodulation Technique'), (79, 85, 'CONDITION', 'Ataxia'), (135, 175, 'OTHER', 'electrical stimulation of the cerebellum'), (180, 219, 'OTHER', 'transcranial direct current stimulation'), (221, 225, 'OTHER', 'tDCS'), (243, 267, 'OTHER', 'virtual reality protocol'), (361, 367, 'CONDITION', 'ataxia'), (640, 680, 'OTHER', 'excitatory stimulation of the cerebellum'), (770, 776, 'CONDITION', 'ataxia'), (849, 853, 'OTHER', 'tDCS'), (912, 916, 'OTHER', 'tDCS'), (991, 1021, 'OTHER', 'non-invasive brain stimulation'), (1074, 1080, 'CONDITION', 'ataxia')]"
"['Effect', 'of', 'Nitric', 'Oxide', '(', 'NO', ')', 'Supplementation', 'on', 'Neurocognitive', 'Measures', 'in', 'Argininosuccinate', 'Lyase', 'Deficiency', '(', 'ASLD', ')', '|', 'This', 'is', 'a', 'study', 'involving', 'a', 'dietary', 'supplement', '.', 'Patients', 'with', 'argininosuccinate', 'lyase', 'deficiency', '(', 'ASLD', ')', 'will', 'be', 'randomly', 'assigned', 'to', 'receive', 'either', 'a', 'nitric', 'oxide', 'dietary', 'supplement', 'or', 'placebo', 'for', '24', 'weeks', ',', 'and', 'then', 'crossed', '-', 'over', 'to', 'receive', 'the', 'other', 'treatment', 'for', '24', 'weeks', '.', 'The', 'investigators', 'will', 'assess', 'the', 'effects', 'of', 'the', 'supplement', 'in', 'domains', 'of', 'general', 'cognition', ',', 'memory', ',', 'executive', 'functioning', ',', 'and', 'fine', 'motor', 'functioning', 'in', 'individuals', 'with', 'ASLD', '.']","['O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT03064048,NCT03064048,"Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD) | This is a study involving a dietary supplement. Patients with argininosuccinate lyase deficiency (ASLD) will be randomly assigned to receive either a nitric oxide dietary supplement or placebo for 24 weeks, and then crossed-over to receive the other treatment for 24 weeks. The investigators will assess the effects of the supplement in domains of general cognition, memory, executive functioning, and fine motor functioning in individuals with ASLD.","[(10, 22, 'DRUG', 'Nitric Oxide'), (24, 26, 'DRUG', 'NO'), (74, 108, 'CONDITION', 'Argininosuccinate Lyase Deficiency'), (110, 114, 'CONDITION', 'ASLD'), (180, 214, 'CONDITION', 'argininosuccinate lyase deficiency'), (216, 220, 'CONDITION', 'ASLD'), (268, 280, 'DRUG', 'nitric oxide'), (303, 310, 'CONTROL', 'placebo'), (563, 567, 'CONDITION', 'ASLD')]"
"['Comparative', 'Low', 'and', 'High', 'Dose', 'of', 'Dexmedethomidine', 'Can', 'Stabilize', 'Hemodynamics', 'and', 'Blood', 'Loss', 'in', 'Pituitary', 'Tumor', 'Removal', 'by', 'Transphenoid', 'Approach', '|', 'Transnasal', 'transsphenoidal', '(', 'TNTS', ')', 'resection', 'of', 'pituitary', 'tumors', 'involves', 'wide', 'fluctuation', 'in', 'hemodynamic', 'parameter', 'and', 'causes', 'hypertension', 'and', 'tachycardia', 'due', 'to', 'intense', 'noxious', 'stimuli', 'during', 'various', 'stages', 'of', 'surgery', '.', 'None', 'of', 'routinely', 'used', 'anesthetic', 'agents', 'effectively', 'blunts', 'the', 'undesirable', 'hemodynamic', 'responses', ',', 'and', 'therefore', 'usually', 'there', 'is', 'a', 'need', 'to', 'use', 'increased', 'doses', 'of', 'anesthetic', 'agents', '.', 'Dexmedetomidine', '(', 'DEX', ')', 'an', '慣-2', 'adrenergic', 'receptor', 'agonist', ',', 'because', 'its', 'sympatholytic', 'and', 'antinociceptive', 'properties', 'may', 'ensure', 'optimal', 'intraoperative', 'hemodynamic', 'stability', 'during', 'critical', 'moments', 'of', 'surgical', 'manipulation', '.', 'In', 'addition', ',', 'DEX', 'reduced', 'the', 'anesthetic', 'requirement', 'with', 'rapid', 'recovery', 'at', 'the', 'end', 'of', 'surgery', '.', 'The', 'main', 'aim', 'of', 'the', 'study', 'was', 'to', 'evaluate', 'the', 'effect', 'of', 'DEX', 'on', 'perioperative', 'hemodynamics', ',', 'anesthetic', 'requirements']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03132259,NCT03132259,"Comparative Low and High Dose of Dexmedethomidine Can Stabilize Hemodynamics and Blood Loss in Pituitary Tumor Removal by Transphenoid Approach | Transnasal transsphenoidal (TNTS) resection of pituitary tumors involves wide fluctuation in hemodynamic parameter and causes hypertension and tachycardia due to intense noxious stimuli during various stages of surgery. None of routinely used anesthetic agents effectively blunts the undesirable hemodynamic responses, and therefore usually there is a need to use increased doses of anesthetic agents. Dexmedetomidine (DEX) an 慣-2 adrenergic receptor agonist, because its sympatholytic and antinociceptive properties may ensure optimal intraoperative hemodynamic stability during critical moments of surgical manipulation. In addition, DEX reduced the anesthetic requirement with rapid recovery at the end of surgery. The main aim of the study was to evaluate the effect of DEX on perioperative hemodynamics, anesthetic requirements","[(33, 49, 'DRUG', 'Dexmedethomidine'), (95, 143, 'CONDITION', 'Pituitary Tumor Removal by Transphenoid Approach'), (146, 209, 'CONDITION', 'Transnasal transsphenoidal (TNTS) resection of pituitary tumors'), (272, 284, 'CONDITION', 'hypertension'), (289, 300, 'CONDITION', 'tachycardia'), (548, 563, 'DRUG', 'Dexmedetomidine'), (565, 568, 'DRUG', 'DEX'), (573, 604, 'DRUG', '慣-2 adrenergic receptor agonist'), (782, 785, 'DRUG', 'DEX'), (920, 923, 'DRUG', 'DEX')]"
"['Central', 'Mechanisms', 'of', 'Calmare', ':', 'an', 'fMRI', 'Trial', '|', 'Pilot', 'one', '-', 'treatment', 'and', 'extended', '10', '-', 'treatment', 'studies', 'are', 'carried', 'out', 'on', 'participants', 'with', 'peripheral', 'neuropathy', 'comparing', 'traditional', 'TENS', 'and', 'Calmare', 'stimulation', 'protocols', 'using', 'a', 'double', '-', 'blind', 'apparatus', '.', 'Resting', 'fMRI', 'scans', 'are', 'obtained', 'before', 'and', 'after', 'the', 'treatment', ',', 'as', 'well', 'as', 'after', 'most', 'of', 'the', 'pain', 'has', 'returned', '.']","['O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'B-CTRL', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O']",NCT04242797,NCT04242797,"Central Mechanisms of Calmare: an fMRI Trial | Pilot one-treatment and extended 10-treatment studies are carried out on participants with peripheral neuropathy comparing traditional TENS and Calmare stimulation protocols using a double-blind apparatus. Resting fMRI scans are obtained before and after the treatment, as well as after most of the pain has returned.","[(22, 29, 'OTHER', 'Calmare'), (138, 159, 'CONDITION', 'peripheral neuropathy'), (182, 186, 'CONTROL', 'TENS'), (191, 198, 'OTHER', 'Calmare'), (346, 350, 'CONDITION', 'pain')]"
"['Sleep', '-', 'dependent', 'Memory', 'Processing', 'in', 'Schizophrenia', '|', 'The', 'investigators', 'will', 'test', 'the', 'hypothesis', 'that', 'the', 'sleep', 'medication', ',', 'eszopiclone', ',', 'can', 'normalize', 'brain', 'activity', 'during', 'sleep', 'and', 'improve', 'memory', 'in', 'patients', 'with', 'schizophrenia', '.', 'The', 'investigators', 'will', 'do', 'this', 'by', 'measuring', 'sleep', 'and', 'memory', 'performance', 'on', 'two', 'conditions', 'separated', 'by', 'one', 'week', ':', 'taking', '3', 'mg', 'of', 'eszopiclone', 'and', 'taking', 'placebo', '.', 'The', 'investigators', 'will', 'study', 'healthy', 'subjects', 'and', 'chronic', ',', 'medicated', 'outpatients', 'with', 'schizophrenia', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT01641900,NCT01641900,"Sleep-dependent Memory Processing in Schizophrenia | The investigators will test the hypothesis that the sleep medication, eszopiclone, can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance on two conditions separated by one week: taking 3 mg of eszopiclone and taking placebo. The investigators will study healthy subjects and chronic, medicated outpatients with schizophrenia.","[(37, 50, 'CONDITION', 'Schizophrenia'), (123, 134, 'DRUG', 'eszopiclone'), (214, 227, 'CONDITION', 'schizophrenia'), (358, 369, 'DRUG', 'eszopiclone'), (381, 388, 'CONTROL', 'placebo'), (476, 489, 'CONDITION', 'schizophrenia')]"
"['PNOC023', ':', 'Open', 'Label', 'Phase', '1', 'and', 'Target', 'Validation', 'Study', 'of', 'ONC206', 'in', 'Children', 'and', 'Young', 'Adults', 'With', 'Newly', 'Diagnosed', 'or', 'Recurrent', 'Diffuse', 'Midline', 'Glioma', '(', 'DMG', ')', ',', 'and', 'Other', 'Recurrent', 'Primary', 'Malignant', 'Central', 'Nervous', 'System', '(', 'CNS', ')', 'Tumors', '|', 'This', 'phase', 'I', 'trial', 'studies', 'the', 'effects', 'and', 'best', 'dose', 'of', 'ONC206', 'alone', 'or', 'in', 'combination', 'with', 'radiation', 'therapy', 'in', 'treating', 'patients', 'with', 'diffuse', 'midline', 'gliomas', 'that', 'is', 'newly', 'diagnosed', 'or', 'has', 'come', 'back', '(', 'recurrent', ')', 'or', 'other', 'recurrent', 'primary', 'malignant', 'CNS', 'tumors', '.', 'ONC206', 'is', 'a', 'recently', 'discovered', 'compound', 'that', 'may', 'stop', 'cancer', 'cells', 'from', 'growing', '.', 'This', 'drug', 'has', 'been', 'shown', 'in', 'laboratory', 'experiments', 'to', 'kill', 'brain', 'tumor', 'cells', 'by', 'causing', 'a', 'so', 'called', '""', 'stress', 'response', '""', 'in', 'tumor', 'cells', '.', 'This', 'stress', 'response', 'causes', 'cancer', 'cells', 'to', 'die', ',', 'but', 'without', 'affecting', 'normal', 'cells', '.', 'ONC206', 'alone', 'or', 'in', 'combination', 'with', 'radiation', 'therapy', 'may', 'be', 'effective', 'in', 'treating', 'newly', 'diagnosed', 'or', 'recurrent', 'diffuse', 'midline', 'gliomas', 'and', 'other', 'recurrent', 'primary', 'malignant', 'CNS', 'tumors', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-RADIO', 'I-RADIO', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-RADIO', 'I-RADIO', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT04732065,NCT04732065,"PNOC023: Open Label Phase 1 and Target Validation Study of ONC206 in Children and Young Adults With Newly Diagnosed or Recurrent Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors | This phase I trial studies the effects and best dose of ONC206 alone or in combination with radiation therapy in treating patients with diffuse midline gliomas that is newly diagnosed or has come back (recurrent) or other recurrent primary malignant CNS tumors. ONC206 is a recently discovered compound that may stop cancer cells from growing. This drug has been shown in laboratory experiments to kill brain tumor cells by causing a so called ""stress response"" in tumor cells. This stress response causes cancer cells to die, but without affecting normal cells. ONC206 alone or in combination with radiation therapy may be effective in treating newly diagnosed or recurrent diffuse midline gliomas and other recurrent primary malignant CNS tumors.","[(59, 65, 'DRUG', 'ONC206'), (100, 151, 'CONDITION', 'Newly Diagnosed or Recurrent Diffuse Midline Glioma'), (153, 156, 'CONDITION', 'DMG'), (169, 232, 'CONDITION', 'Recurrent Primary Malignant Central Nervous System (CNS) Tumors'), (291, 297, 'DRUG', 'ONC206'), (327, 344, 'RADIOTHERAPY', 'radiation therapy'), (371, 394, 'CONDITION', 'diffuse midline gliomas'), (457, 495, 'CONDITION', 'recurrent primary malignant CNS tumors'), (497, 503, 'DRUG', 'ONC206'), (552, 558, 'CONDITION', 'cancer'), (638, 649, 'CONDITION', 'brain tumor'), (700, 705, 'CONDITION', 'tumor'), (741, 747, 'CONDITION', 'cancer'), (798, 804, 'DRUG', 'ONC206'), (834, 851, 'RADIOTHERAPY', 'radiation therapy'), (881, 933, 'CONDITION', 'newly diagnosed or recurrent diffuse midline gliomas'), (944, 982, 'CONDITION', 'recurrent primary malignant CNS tumors')]"
"['Prospective', 'Randomized', 'Evaluation', 'of', 'the', 'WATCHMAN', 'LAA', 'Closure', 'Device', 'in', 'Patients', 'With', 'Atrial', 'Fibrillation', '(', 'AF', ')', 'Versus', 'Long', 'Term', 'Warfarin', 'Therapy', '|', 'This', 'was', 'a', 'prospective', ',', 'randomized', ',', 'multicenter', 'study', 'to', 'provide', 'additional', 'information', 'on', 'the', 'safety', 'and', 'efficacy', 'of', 'the', 'WATCHMAN', 'LAA', 'Closure', 'Technology', '.', 'The', 'purpose', 'of', 'the', 'PREVAIL', 'study', 'was', 'to', 'confirm', 'the', 'efficacy', 'endpoint', 'as', 'demonstrated', 'in', 'the', 'PROTECT', 'AF', 'pivotal', 'study', 'and', 'to', 'further', 'demonstrate', 'that', 'the', 'WATCHMAN', 'LAA', 'Closure', 'Technology', 'is', 'safe', 'and', 'effective', 'in', 'subjects', 'with', 'non', '-', 'valvular', 'atrial', 'fibrillation', 'who', 'require', 'anticoagulation', 'therapy', 'for', 'potential', 'thrombus', 'formation', '.']","['O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O']",NCT01182441,NCT01182441,"Prospective Randomized Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation (AF) Versus Long Term Warfarin Therapy | This was a prospective, randomized, multicenter study to provide additional information on the safety and efficacy of the WATCHMAN LAA Closure Technology. The purpose of the PREVAIL study was to confirm the efficacy endpoint as demonstrated in the PROTECT AF pivotal study and to further demonstrate that the WATCHMAN LAA Closure Technology is safe and effective in subjects with non-valvular atrial fibrillation who require anticoagulation therapy for potential thrombus formation.","[(41, 68, 'SURGICAL', 'WATCHMAN LAA Closure Device'), (86, 105, 'CONDITION', 'Atrial Fibrillation'), (107, 109, 'CONDITION', 'AF'), (128, 136, 'DRUG', 'Warfarin'), (269, 300, 'SURGICAL', 'WATCHMAN LAA Closure Technology'), (403, 405, 'CONDITION', 'AF'), (456, 487, 'SURGICAL', 'WATCHMAN LAA Closure Technology'), (527, 559, 'CONDITION', 'non-valvular atrial fibrillation'), (610, 618, 'CONDITION', 'thrombus')]"
"['Effectiveness', 'of', 'Bio', '-', 'Electro', 'Stimulation', 'Therapy', 'for', 'the', 'Treatment', 'of', 'Motor', 'and', 'Non', '-', 'Motor', 'Symptoms', 'in', 'Parkinson', ""'s"", 'Disease', '-', 'A', 'Pilot', 'Study', '|', 'Parkinson', ""'s"", 'disease', '(', 'PD', ')', 'is', 'a', 'neurodegenerative', 'disorder', 'characterized', 'by', 'motor', 'dysfunction', 'and', 'non', '-', 'motor', 'symptoms', '.', 'Here', ',', 'the', 'investigators', 'propose', 'in', 'a', 'pilot', 'device', 'feasibility', 'trial', 'to', 'examine', 'whether', '""', 'Bio', 'Electro', 'Stimulation', 'Therapy', '""', '(', 'B.E.S.T.', ')', 'with', 'a', 'small', ',', 'non', '-', 'invasive', ',', 'handheld', 'electronic', 'device', 'designed', 'to', 'apply', 'micro', 'current', 'stimulation', 'to', 'a', 'person', ""'s"", 'hand', 'can', 'ameliorate', 'some', 'of', 'the', 'symptoms', 'of', 'PD', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT03014050,NCT03014050,"Effectiveness of Bio-Electro Stimulation Therapy for the Treatment of Motor and Non-Motor Symptoms in Parkinson's Disease - A Pilot Study | Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor dysfunction and non-motor symptoms. Here, the investigators propose in a pilot device feasibility trial to examine whether ""Bio Electro Stimulation Therapy"" (B.E.S.T.) with a small, non-invasive, handheld electronic device designed to apply micro current stimulation to a person's hand can ameliorate some of the symptoms of PD.","[(17, 48, 'OTHER', 'Bio-Electro Stimulation Therapy'), (102, 121, 'CONDITION', ""Parkinson's Disease""), (140, 159, 'CONDITION', ""Parkinson's disease""), (161, 163, 'CONDITION', 'PD'), (344, 375, 'OTHER', 'Bio Electro Stimulation Therapy'), (378, 386, 'OTHER', 'B.E.S.T.'), (545, 547, 'CONDITION', 'PD')]"
"['Combined', 'Virological', 'and', 'Immunological', 'Evaluation', 'of', 'Treatment', 'of', 'Patients', 'With', 'Early', 'HTLV-1', '-', 'Associated', 'Myelopathy', 'With', 'Recombinant', 'Human', 'Interferon', 'Beta-1a', '|', 'HTLV', 'stands', 'for', 'human', 'T', 'cell', 'leukemia', 'virus', '.', 'HTLV-1', 'is', 'a', 'virus', 'that', 'attacks', 'specific', 'kinds', 'of', 'white', 'blood', 'cells', 'called', 'T', 'cells', '.', 'T', 'cells', 'are', 'part', 'of', 'the', 'natural', 'defense', 'system', 'of', 'the', 'body', '.', 'HTLV-1', 'has', 'been', 'associated', 'with', 'leukemia', 'and', 'lymphoma', '.', 'In', 'addition', ',', 'approximately', '1', '%', 'of', 'all', 'patients', 'infected', 'with', 'HTLV-1', 'develops', 'a', 'condition', 'known', 'as', 'HTLV-1', 'associated', 'myelopathy', '(', 'HAM', ')', '/', 'tropical', 'spastic', 'paraparesis', '(', 'TSP', ')', '.', '\n\n', 'Currently', 'there', 'is', 'no', 'clearly', 'defined', ',', 'effective', 'treatment', 'for', 'patients', 'with', 'HAM', '/', 'TSP', '.', 'Steroids', 'have', 'been', 'used', 'as', 'therapy', 'but', 'have', 'only', 'been', 'able', 'to', 'provide', 'temporary', 'relief', 'of', 'symptoms', '.', 'Human', 'interferon', 'is', 'a', 'small', 'protein', 'released', 'from', 'different', 'kinds', 'of', 'cells', 'in', 'the', 'body', '.', 'Interferon', 'has', 'been', 'known', 'to', 'have', 'antiviral', 'and', 'immunological', 'effects', 'and', 'has', 'been', 'used', 'to', 'treat', 'hepatitis', 'and', 'multiple', 'sclerosis', '.', 'Interferon', 'Beta', 'is', 'released', 'from', 'cells', 'called', 'fibroblasts', '.', 'These', 'cells', 'play', 'a', 'role', 'in', 'the', 'production', 'of', 'connective', 'tissue', '.', '\n\n', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'the', 'possible', 'role', 'of', 'recombinant', 'interferon', 'beta', '(', 'Avonex', ')', 'in', 'treatment', 'of', 'HAM', '/', 'TSP', '.', 'The', 'study', 'is', 'broken', 'into', 'three', 'phases', ',', 'a', 'pre', '-', 'treatment', 'phase', ',', 'a', 'treatment', 'phase', ',', 'and', 'a', 'post', '-', 'treatment', 'phase', '.', 'The', 'total', 'duration', 'of', 'the', 'study', 'will', 'be', '44', 'weeks', '.', '\n\n', 'Patients', 'participating', 'in', 'this', 'study', 'will', 'receive', 'injections', 'of', 'Avonex', '1', 'to', '2', 'times', 'a', 'week', '.', 'Throughout', 'the', 'study', 'patients', 'will', 'regularly', 'submit', 'blood', 'samples', 'and', 'undergo', 'diagnostic', 'tests', 'such', 'as', 'MRI', 'and', 'measures', 'of', 'somatosensory', 'evoked', 'potentials', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00001785,NCT00001785,"Combined Virological and Immunological Evaluation of Treatment of Patients With Early HTLV-1-Associated Myelopathy With Recombinant Human Interferon Beta-1a | HTLV stands for human T cell leukemia virus. HTLV-1 is a virus that attacks specific kinds of white blood cells called T cells. T cells are part of the natural defense system of the body. HTLV-1 has been associated with leukemia and lymphoma. In addition, approximately 1% of all patients infected with HTLV-1 develops a condition known as HTLV-1 associated myelopathy (HAM) / tropical spastic paraparesis (TSP).

Currently there is no clearly defined, effective treatment for patients with HAM/TSP. Steroids have been used as therapy but have only been able to provide temporary relief of symptoms. Human interferon is a small protein released from different kinds of cells in the body. Interferon has been known to have antiviral and immunological effects and has been used to treat hepatitis and multiple sclerosis. Interferon Beta is released from cells called fibroblasts. These cells play a role in the production of connective tissue.

The purpose of this study is to evaluate the possible role of recombinant interferon beta (Avonex) in treatment of HAM/TSP. The study is broken into three phases, a pre-treatment phase, a treatment phase, and a post-treatment phase. The total duration of the study will be 44 weeks.

Patients participating in this study will receive injections of Avonex 1 to 2 times a week. Throughout the study patients will regularly submit blood samples and undergo diagnostic tests such as MRI and measures of somatosensory evoked potentials.","[(80, 114, 'CONDITION', 'Early HTLV-1-Associated Myelopathy'), (120, 156, 'DRUG', 'Recombinant Human Interferon Beta-1a'), (159, 163, 'CONDITION', 'HTLV'), (175, 202, 'CONDITION', 'human T cell leukemia virus'), (204, 210, 'CONDITION', 'HTLV-1'), (347, 353, 'CONDITION', 'HTLV-1'), (462, 468, 'CONDITION', 'HTLV-1'), (499, 527, 'CONDITION', 'HTLV-1 associated myelopathy'), (529, 532, 'CONDITION', 'HAM'), (536, 564, 'CONDITION', 'tropical spastic paraparesis'), (566, 569, 'CONDITION', 'TSP'), (650, 657, 'CONDITION', 'HAM/TSP'), (978, 993, 'DRUG', 'Interferon Beta'), (1164, 1191, 'DRUG', 'recombinant interferon beta'), (1193, 1199, 'DRUG', 'Avonex'), (1217, 1224, 'CONDITION', 'HAM/TSP'), (1450, 1456, 'DRUG', 'Avonex')]"
"['Electronic', 'Recording', 'of', 'Compliance', 'With', 'Occlusion', 'Therapy', 'for', 'Amblyopia', ':', '1', 'Effects', 'of', 'Patient', 'Education', 'on', 'Compliance', '2', 'Predictors', 'for', 'Non', '-', 'Compliance', '|', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'determine', 'whether', 'compliance', 'with', 'occlusion', 'therapy', 'for', 'amblyopia', 'could', 'be', 'improved', 'and', ',', 'secondly', ',', 'if', 'risk', 'factors', 'for', 'non', '-', 'compliance', 'could', 'be', 'identified', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00131729,NCT00131729,"Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance | The purpose of this study was to determine whether compliance with occlusion therapy for amblyopia could be improved and, secondly, if risk factors for non-compliance could be identified.","[(62, 71, 'CONDITION', 'Amblyopia'), (86, 103, 'BEHAVIOURAL', 'Patient Education'), (241, 250, 'CONDITION', 'amblyopia')]"
"['Hypoglossal', 'Acupuncture', 'for', 'Dysgeusia', 'in', 'Gynecologic', 'Cancer', 'Patients', 'Undergoing', 'Chemotherapy', ':', 'A', 'Randomized', 'Controlled', 'Trial', '|', 'This', 'randomized', 'controlled', 'trial', 'aims', 'to', 'investigate', 'hypoglossal', 'acupuncture', 'in', 'comparison', 'to', 'sham', 'acupuncture', 'and', 'standard', 'medical', 'treatment', '(', 'dietary', 'recommendations', ')', 'in', 'the', 'treatment', 'of', 'dysgeusia', 'in', 'cancer', 'patients', 'undergoing', 'chemotherapy', '.']","['B-OTHER', 'I-OTHER', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O']",NCT02304913,NCT02304913,Hypoglossal Acupuncture for Dysgeusia in Gynecologic Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial | This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.,"[(0, 23, 'OTHER', 'Hypoglossal Acupuncture'), (28, 37, 'CONDITION', 'Dysgeusia'), (41, 59, 'CONDITION', 'Gynecologic Cancer'), (80, 92, 'CONDITION', 'Chemotherapy'), (179, 202, 'OTHER', 'hypoglossal acupuncture'), (220, 236, 'CONTROL', 'sham acupuncture'), (269, 292, 'CONTROL', 'dietary recommendations'), (314, 323, 'CONDITION', 'dysgeusia'), (327, 333, 'CONDITION', 'cancer'), (354, 366, 'CONDITION', 'chemotherapy')]"
"['Optimizing', 'Vibrational', 'Therapy', 'to', 'Improve', 'Gait', 'and', 'Balance', 'in', 'Parkinson', ""'s"", 'Disease', '|', 'The', 'purpose', 'of', 'this', 'research', 'study', 'is', 'to', 'test', 'the', 'safety', ',', 'tolerability', ',', 'and', 'the', 'effect', 'of', 'vibration', '(', 'delivered', 'by', 'an', 'experimental', 'device', 'called', 'PDVibe2', ')', 'on', 'freezing', 'of', 'gait', '(', 'FOG', ')', 'in', 'persons', 'with', 'Parkinson', ""'s"", 'disease', '(', 'PD', ')', '.', 'The', 'PDVibe2', 'was', 'developed', 'by', 'Resonate', 'Forward', ',', 'LLC', '(', 'RF', ')', '.', 'This', 'PDVibe2', 'was', 'designed', 'to', 'administer', 'vibration', 'therapy', 'to', 'the', 'wearer', 'to', 'improve', 'gait', 'and', 'balance', 'in', 'persons', 'with', 'PD', 'while', 'wearing', 'the', 'device', '.']","['O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O']",NCT03883217,NCT03883217,"Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease | The purpose of this research study is to test the safety, tolerability, and the effect of vibration (delivered by an experimental device called PDVibe2) on freezing of gait (FOG) in persons with Parkinson's disease (PD). The PDVibe2 was developed by Resonate Forward, LLC (RF). This PDVibe2 was designed to administer vibration therapy to the wearer to improve gait and balance in persons with PD while wearing the device.","[(11, 30, 'OTHER', 'Vibrational Therapy'), (62, 81, 'CONDITION', ""Parkinson's Disease""), (174, 183, 'OTHER', 'vibration'), (228, 235, 'OTHER', 'PDVibe2'), (240, 256, 'CONDITION', 'freezing of gait'), (258, 261, 'CONDITION', 'FOG'), (279, 298, 'CONDITION', ""Parkinson's disease""), (300, 302, 'CONDITION', 'PD'), (309, 316, 'OTHER', 'PDVibe2'), (367, 374, 'OTHER', 'PDVibe2'), (402, 419, 'OTHER', 'vibration therapy'), (478, 480, 'CONDITION', 'PD')]"
"['A', 'Comparison', 'of', 'the', 'Efficacy', 'and', 'Safety', 'of', 'Topiramate', 'Versus', 'Placebo', 'for', 'the', 'Prophylaxis', 'of', 'Chronic', 'Migraine', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'assess', 'the', 'safety', 'and', 'effectiveness', 'of', 'topiramate', 'as', 'compared', 'to', 'placebo', 'for', 'the', 'prevention', 'of', 'headaches', 'in', 'patients', 'with', 'chronic', 'migraine', '.', 'Topiramate', 'has', 'been', 'approved', 'to', 'prevent', 'migraine', 'headaches', 'as', 'well', 'as', 'in', 'the', 'treatment', 'of', 'epilepsy', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00210912,NCT00210912,A Comparison of the Efficacy and Safety of Topiramate Versus Placebo for the Prophylaxis of Chronic Migraine | The purpose of this study is to assess the safety and effectiveness of topiramate as compared to placebo for the prevention of headaches in patients with chronic migraine. Topiramate has been approved to prevent migraine headaches as well as in the treatment of epilepsy.,"[(43, 53, 'DRUG', 'Topiramate'), (61, 68, 'CONTROL', 'Placebo'), (92, 108, 'CONDITION', 'Chronic Migraine'), (182, 192, 'DRUG', 'topiramate'), (208, 215, 'CONTROL', 'placebo'), (238, 247, 'CONDITION', 'headaches'), (265, 281, 'CONDITION', 'chronic migraine'), (283, 293, 'DRUG', 'Topiramate'), (323, 341, 'CONDITION', 'migraine headaches')]"
"['Translating', 'a', 'Dementia', 'Caregiver', 'Intervention', 'Into', 'a', 'Mobile', 'Application', '|', 'The', 'overall', 'goal', 'of', 'this', 'development', 'project', 'is', 'to', 'combine', 'elements', 'of', 'two', 'efficacious', 'interventions', 'into', 'a', 'mobile', 'health', '(', 'mHealth', ')', 'App', 'for', 'informal', 'dementia', 'caregivers', '.', 'The', 'investigators', 'will', 'conduct', 'a', '3', '-', 'month', 'feasibility', 'trial', 'of', 'the', 'newly', '-', 'developed', 'CARE', '-', 'Well', 'App', 'in', '40', 'dementia', 'caregivers', 'to', 'establish', 'acceptability', 'and', 'feasibility', 'of', 'the', 'intervention', ',', 'study', 'procedures', ',', 'and', 'outcome', 'measures', '.']","['O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04330482,NCT04330482,"Translating a Dementia Caregiver Intervention Into a Mobile Application | The overall goal of this development project is to combine elements of two efficacious interventions into a mobile health (mHealth) App for informal dementia caregivers. The investigators will conduct a 3-month feasibility trial of the newly-developed CARE-Well App in 40 dementia caregivers to establish acceptability and feasibility of the intervention, study procedures, and outcome measures.","[(14, 22, 'CONDITION', 'Dementia'), (53, 71, 'OTHER', 'Mobile Application'), (182, 209, 'OTHER', 'mobile health (mHealth) App'), (223, 231, 'CONDITION', 'dementia'), (326, 339, 'OTHER', 'CARE-Well App'), (346, 354, 'CONDITION', 'dementia')]"
"['A', 'Multicenter', 'Randomized', ',', 'Double', '-', 'Blind', ',', 'Controlled', 'Study', 'of', 'NGX-4010', 'for', 'the', 'Treatment', 'of', 'Postherpetic', 'Neuralgia', '|', 'The', 'purpose', 'of', 'the', 'study', 'is', 'to', 'assess', 'the', 'efficacy', 'and', 'safety', 'of', 'NGX-4010', 'applied', 'for', '60', 'minutes', 'for', 'the', 'treatment', 'of', 'postherpetic', 'neuralgia', '(', 'PHN', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT00300222,NCT00300222,"A Multicenter Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia | The purpose of the study is to assess the efficacy and safety of NGX-4010 applied for 60 minutes for the treatment of postherpetic neuralgia (PHN).","[(60, 68, 'DRUG', 'NGX-4010'), (90, 112, 'CONDITION', 'Postherpetic Neuralgia'), (180, 188, 'DRUG', 'NGX-4010'), (233, 255, 'CONDITION', 'postherpetic neuralgia'), (257, 260, 'CONDITION', 'PHN')]"
"['Burden', 'of', 'Obstructive', 'Sleep', 'Apnea', 'in', 'Stroke', '(', 'BOSAST', ')', '|', 'There', 'are', 'two', 'purposes', 'of', 'this', 'study', '.', 'The', 'first', 'purpose', 'is', 'to', 'define', 'the', 'frequency', 'of', 'obstructive', 'sleep', 'apnea', 'in', 'stroke', 'survivors', 'as', 'well', 'as', 'its', 'association', 'with', 'fatigue', 'and', 'quality', 'of', 'life', '.', 'The', 'second', 'purpose', 'is', 'to', 'determine', 'if', 'continuous', 'positive', 'airways', 'pressure', '(', 'CPAP', ')', 'treatment', 'can', 'have', 'a', 'beneficial', 'effect', 'on', 'these', 'patients', ""'"", 'fatigue', 'and', 'quality', 'of', 'life', '.']","['O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O']",NCT00952211,NCT00952211,Burden of Obstructive Sleep Apnea in Stroke (BOSAST) | There are two purposes of this study. The first purpose is to define the frequency of obstructive sleep apnea in stroke survivors as well as its association with fatigue and quality of life. The second purpose is to determine if continuous positive airways pressure (CPAP) treatment can have a beneficial effect on these patients' fatigue and quality of life.,"[(10, 33, 'CONDITION', 'Obstructive Sleep Apnea'), (37, 43, 'CONDITION', 'Stroke'), (141, 164, 'CONDITION', 'obstructive sleep apnea'), (168, 174, 'CONDITION', 'stroke'), (217, 224, 'CONDITION', 'fatigue'), (284, 320, 'OTHER', 'continuous positive airways pressure'), (322, 326, 'OTHER', 'CPAP'), (386, 393, 'CONDITION', 'fatigue')]"
"['Basic', 'Research', 'on', 'Carbon', 'Monoxide', ""'s"", 'Headache', 'Inducing', 'Characteristics', 'and', 'Effects', 'on', 'the', 'Cerebral', 'Arteries', 'and', 'Blood', 'Flow', 'in', 'a', 'Humane', 'Experimental', 'Headache', 'Model', '|', 'In', 'this', 'study', 'the', 'investigators', 'will', 'research', 'the', 'hypothesis', 'that', 'the', 'gas', 'carbon', 'monoxide', 'induces', 'headache', 'and', 'increases', 'the', 'blood', 'flow', 'velocity', 'in', 'the', 'middle', 'cerebral', 'artery', '.']","['O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02066558,NCT02066558,Basic Research on Carbon Monoxide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model | In this study the investigators will research the hypothesis that the gas carbon monoxide induces headache and increases the blood flow velocity in the middle cerebral artery.,"[(18, 44, 'CONDITION', ""Carbon Monoxide's Headache""), (147, 155, 'CONDITION', 'Headache'), (262, 270, 'CONDITION', 'headache')]"
"['An', 'Online', 'Self', '-', 'management', 'Program', 'for', 'Spinal', 'Cord', 'Injury', ':', 'Feasibility', 'Study', 'of', 'SCI&U', '|', 'Managing', 'a', 'spinal', 'cord', 'injury', '(', 'SCI', ')', 'is', 'a', 'life', '-', 'long', 'process', '.', 'Within', 'the', 'first', 'year', 'of', 'injury', ',', 'more', 'than', '50', '%', 'of', 'people', 'discharged', 'with', 'a', 'SCI', 'may', 'require', 're', '-', 'hospitalization', 'due', 'to', 'a', 'secondary', 'complication', ',', 'such', 'as', 'a', 'urinary', 'tract', 'infection', ',', 'pressure', 'ulcer', 'or', 'pneumonia', '.', 'Even', '20', 'years', 'post', '-', 'injury', ',', 're', '-', 'hospitalization', 'rates', 'remain', 'over', '30', '%', '.', 'While', 're', '-', 'hospitalization', 'rates', 'in', 'Canada', 'have', 'remained', 'high', 'for', 'more', 'than', '10', 'years', ',', 'the', 'length', 'of', 'stay', 'in', 'inpatient', 'rehabilitation', 'has', 'decreased', 'dramatically', ',', 'thereby', 'limiting', 'the', 'time', 'for', 'provision', 'of', 'health', 'information', 'and', 'skill', 'acquisition', 'in', 'the', 'inpatient', 'rehabilitation', 'setting', '.', 'There', 'is', 'growing', 'evidence', 'from', 'two', 'recent', 'pilot', 'trials', 'to', 'suggest', 'that', 'self', '-', 'management', 'programs', 'that', 'provide', 'appropriate', 'health', 'information', ',', 'skills', 'and', 'telephone', '-', 'based', 'support', 'for', 'community', '-', 'dwelling', 'patients', 'with', 'SCI', 'improves', 'health', 'behaviors', 'and', 'leads', 'to', 'reductions', 'in', 're', '-', 'hospitalization', '.', '\n\n', 'Goals', '/', 'Research', 'Aim', ':', 'To', 'conduct', 'a', 'pilot', 'RCT', '(', 'feasibility', 'study', ')', 'that', 'will', 'inform', 'the', 'design', 'of', 'a', 'definitive', 'RCT', 'to', 'determine', 'whether', 'an', 'online', 'self', '-', 'management', 'program', 'incorporating', 'trained', 'peer', 'health', 'coaches', '(', 'called', '""', 'SCI&U', '""', ')', 'compared', 'to', 'usual', 'care', 'will', 'result', 'in', 'improved', 'self', '-', 'management', 'skills', '(', 'short', '-', 'term', 'outcome', ')', 'and', 'lead', 'to', 'reduced', 'days', 'of', 'hospitalization', '(', 'long', '-', 'term', 'outcome', ')', 'due', 'to', 'secondary', 'complications', '.', 'This', 'pilot', 'study', 'is', 'a', 'two', '-', 'group', 'RCT', 'with', 'an', 'embedded', 'qualitative', 'component', '.', 'The', 'target', 'population', 'is', 'adults', 'with', 'SCI', 'who', 'have', 'been', 'discharged', 'from', 'inpatient', 'rehabilitation', 'and', 'living', 'in', 'the', 'community', '.', 'Sixty', 'subjects', 'will', 'be', 'recruited', 'from', 'across', 'Canada', 'with', 'a', 'focus', 'on', 'British', 'Columbia', 'and', 'Ontario', 'and', 'randomly', 'assigned', 'to', 'the', 'SCI&U', 'intervention', 'or', 'usual', 'care', '.', '\n\n', 'Evaluations', 'will', 'occur', 'at', 'baseline', ',', '2', ',', '6', ',', 'and', '12', 'months', '.']","['O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04474171,NCT04474171,"An Online Self-management Program for Spinal Cord Injury: Feasibility Study of SCI&U | Managing a spinal cord injury (SCI) is a life-long process. Within the first year of injury, more than 50% of people discharged with a SCI may require re-hospitalization due to a secondary complication, such as a urinary tract infection, pressure ulcer or pneumonia. Even 20 years post-injury, re-hospitalization rates remain over 30%. While re-hospitalization rates in Canada have remained high for more than 10 years, the length of stay in inpatient rehabilitation has decreased dramatically, thereby limiting the time for provision of health information and skill acquisition in the inpatient rehabilitation setting. There is growing evidence from two recent pilot trials to suggest that self-management programs that provide appropriate health information, skills and telephone-based support for community-dwelling patients with SCI improves health behaviors and leads to reductions in re-hospitalization.

Goals/Research Aim: To conduct a pilot RCT (feasibility study) that will inform the design of a definitive RCT to determine whether an online self-management program incorporating trained peer health coaches (called ""SCI&U"") compared to usual care will result in improved self-management skills (short-term outcome) and lead to reduced days of hospitalization (long-term outcome) due to secondary complications.This pilot study is a two-group RCT with an embedded qualitative component. The target population is adults with SCI who have been discharged from inpatient rehabilitation and living in the community. Sixty subjects will be recruited from across Canada with a focus on British Columbia and Ontario and randomly assigned to the SCI&U intervention or usual care.

Evaluations will occur at baseline, 2, 6, and 12 months.","[(3, 33, 'BEHAVIOURAL', 'Online Self-management Program'), (38, 56, 'CONDITION', 'Spinal Cord Injury'), (79, 84, 'BEHAVIOURAL', 'SCI&U'), (98, 116, 'CONDITION', 'spinal cord injury'), (118, 121, 'CONDITION', 'SCI'), (222, 225, 'CONDITION', 'SCI'), (920, 923, 'CONDITION', 'SCI'), (1133, 1163, 'BEHAVIOURAL', 'online self-management program'), (1178, 1205, 'BEHAVIOURAL', 'trained peer health coaches'), (1215, 1220, 'BEHAVIOURAL', 'SCI&U'), (1235, 1245, 'CONTROL', 'usual care'), (1522, 1525, 'CONDITION', 'SCI'), (1736, 1741, 'BEHAVIOURAL', 'SCI&U'), (1758, 1768, 'CONTROL', 'usual care')]"
"['Effects', 'of', 'Comprehensive', 'Augmented', 'and', 'Virtual', 'Reality', 'for', 'Upper', 'Limb', 'Rehabilitation', 'in', 'First', '-', 'Ever', 'Stroke', 'Patients', '|', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'efficacy', 'of', 'augmented', 'and', 'virtual', 'reality', '-', 'based', 'rehabilitation', 'programs', 'on', 'improving', 'upper', 'extremity', 'function', 'in', 'subacute', 'stroke', 'patients', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O']",NCT05193539,NCT05193539,Effects of Comprehensive Augmented and Virtual Reality for Upper Limb Rehabilitation in First-Ever Stroke Patients | The purpose of this study was to assess the efficacy of augmented and virtual reality-based rehabilitation programs on improving upper extremity function in subacute stroke patients.,"[(11, 54, 'OTHER', 'Comprehensive Augmented and Virtual Reality'), (88, 105, 'CONDITION', 'First-Ever Stroke'), (173, 232, 'OTHER', 'augmented and virtual reality-based rehabilitation programs'), (274, 289, 'CONDITION', 'subacute stroke')]"
"['A', 'Phase', '2', ',', 'Randomized', ',', 'Placebo', '-', 'Controlled', 'Study', 'to', 'Evaluate', 'Safety', ',', 'Tolerability', ',', 'and', 'Efficacy', 'of', 'TAK-079', 'in', 'Patients', 'With', 'Generalized', 'Myasthenia', 'Gravis', '|', 'Myasthenia', 'gravis', 'is', 'an', 'autoimmune', 'condition', 'that', 'causes', 'muscle', 'weakness', '.', 'Autoimmune', 'means', 'the', 'body', 'makes', 'antibodies', 'that', 'attack', 'its', 'own', 'cells', 'and', 'tissues', '.', 'These', 'types', 'of', 'antibodies', 'are', 'also', 'known', 'as', 'autoantibodies', '.', 'People', 'with', 'generalized', 'myasthenia', 'gravis', 'have', 'a', 'weakness', 'in', 'many', 'muscles', '.', '\n\n', 'TAK-079', 'is', 'a', 'medicine', 'to', 'help', 'people', 'with', 'generalized', 'myasthenia', 'gravis', '.', '\n\n', 'The', 'main', 'aim', 'of', 'this', 'study', 'is', 'to', 'check', 'if', 'people', 'with', 'generalized', 'myasthenia', 'gravis', 'have', 'side', 'effects', 'from', '2', 'doses', 'of', 'TAK-079', '.', 'Other', 'aims', 'are', 'to', 'learn', 'if', 'TAK-079', 'improves', 'their', 'clinical', 'condition', 'and', 'lowers', 'their', 'autoantibody', 'levels', '.', '\n\n', 'At', 'the', 'first', 'visit', ',', 'the', 'study', 'doctor', 'will', 'check', 'if', 'each', 'person', 'can', 'take', 'part', '.', 'For', 'those', 'who', 'can', 'take', 'part', ',', 'participants', 'will', 'continue', 'with', 'their', 'standard', 'medicines', 'for', 'this', 'condition', 'during', 'the', 'study', '.', 'Each', 'participant', 'will', 'have', 'a', 'check', '-', 'up', 'by', 'the', 'study', 'doctor', '.', '\n\n', 'Then', ',', 'the', 'participants', 'will', 'have', '1', 'of', '3', 'treatments', ':', '\n\n', 'A', 'low', 'dose', 'of', 'TAK-079', '.', '\n', 'A', 'high', 'dose', 'of', 'TAK-079', '.', '\n', 'A', 'placebo', '.', 'In', 'this', 'study', ',', 'a', 'placebo', 'looks', 'like', 'TAK-079', 'but', 'does', 'not', 'have', 'any', 'medicine', 'in', 'it', '.', '\n\n', 'Participants', 'will', 'not', 'know', 'which', 'treatment', 'they', 'received', ',', 'nor', 'will', 'their', 'study', 'doctors', '.', 'This', 'is', 'to', 'help', 'make', 'sure', 'the', 'results', 'are', 'more', 'reliable', '.', '\n\n', 'For', 'each', 'treatment', ',', 'participants', 'will', 'receive', 'injections', 'just', 'under', 'the', 'skin', ',', 'once', 'a', 'week', 'for', '8', 'weeks', '.', 'The', 'study', 'doctors', 'will', 'check', 'for', 'side', 'effects', 'from', 'the', 'study', 'treatments', '.', 'The', 'study', 'doctors', 'can', 'stop', 'or', 'delay', 'the', 'injections', 'in', 'each', 'participant', 'if', 'needed', '.', '\n\n', 'Then', ',', 'the', 'study', 'doctors', 'will', 'continue', 'to', 'check', 'for', 'side', 'effects', 'for', 'up', 'to', '24', 'weeks', 'after', 'treatment', '.', 'They', 'will', 'also', 'check', 'the', 'clinical', 'condition', 'of', 'the', 'participants', ',', 'including', 'their', 'autoantibody', 'levels', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04159805,NCT04159805,"A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis | Myasthenia gravis is an autoimmune condition that causes muscle weakness. Autoimmune means the body makes antibodies that attack its own cells and tissues. These types of antibodies are also known as autoantibodies. People with generalized myasthenia gravis have a weakness in many muscles.

TAK-079 is a medicine to help people with generalized myasthenia gravis.

The main aim of this study is to check if people with generalized myasthenia gravis have side effects from 2 doses of TAK-079. Other aims are to learn if TAK-079 improves their clinical condition and lowers their autoantibody levels.

At the first visit, the study doctor will check if each person can take part. For those who can take part, participants will continue with their standard medicines for this condition during the study. Each participant will have a check-up by the study doctor.

Then, the participants will have 1 of 3 treatments:

A low dose of TAK-079.
A high dose of TAK-079.
A placebo. In this study, a placebo looks like TAK-079 but does not have any medicine in it.

Participants will not know which treatment they received, nor will their study doctors. This is to help make sure the results are more reliable.

For each treatment, participants will receive injections just under the skin, once a week for 8 weeks. The study doctors will check for side effects from the study treatments. The study doctors can stop or delay the injections in each participant if needed.

Then, the study doctors will continue to check for side effects for up to 24 weeks after treatment. They will also check the clinical condition of the participants, including their autoantibody levels.","[(23, 30, 'CONTROL', 'Placebo'), (98, 105, 'DRUG', 'TAK-079'), (123, 152, 'CONDITION', 'Generalized Myasthenia Gravis'), (155, 172, 'CONDITION', 'Myasthenia gravis'), (383, 412, 'CONDITION', 'generalized myasthenia gravis'), (447, 454, 'DRUG', 'TAK-079'), (489, 518, 'CONDITION', 'generalized myasthenia gravis'), (575, 604, 'CONDITION', 'generalized myasthenia gravis'), (639, 646, 'DRUG', 'TAK-079'), (675, 682, 'DRUG', 'TAK-079'), (1084, 1091, 'DRUG', 'TAK-079'), (1108, 1115, 'DRUG', 'TAK-079'), (1119, 1126, 'CONTROL', 'placebo'), (1145, 1152, 'CONTROL', 'placebo'), (1164, 1171, 'DRUG', 'TAK-079')]"
"['A', 'Phase', 'II', ',', 'Double', '-', 'Blind', ',', 'Randomized', ',', 'Placebo', '-', 'Controlled', ',', 'Parallel', '-', 'Group', ',', 'Dose', '-', 'Ranging', 'Study', 'Assessing', 'the', 'Efficacy', 'and', 'Safety', 'of', 'AC-3933', 'Tablets', 'Twice', 'Daily', 'in', 'Adults', 'With', 'Mild', 'to', 'Moderate', 'Alzheimer', ""'s"", 'Disease', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'investigate', 'efficacy', 'and', 'safety', 'of', 'different', 'doses', 'of', 'AC-3933', 'in', 'patients', 'with', 'mild', 'to', 'moderate', 'Alzheimer', ""'s"", 'Disease', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT00359944,NCT00359944,"A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Assessing the Efficacy and Safety of AC-3933 Tablets Twice Daily in Adults With Mild to Moderate Alzheimer's Disease | The purpose of this study is to investigate efficacy and safety of different doses of AC-3933 in patients with mild to moderate Alzheimer's Disease.","[(38, 45, 'CONTROL', 'Placebo'), (130, 137, 'DRUG', 'AC-3933'), (173, 209, 'CONDITION', ""Mild to Moderate Alzheimer's Disease""), (298, 305, 'DRUG', 'AC-3933'), (323, 359, 'CONDITION', ""mild to moderate Alzheimer's Disease"")]"
"['Evaluation', 'of', 'the', 'Upper', 'Airway', 'Collapse', 'in', 'Patients', 'With', 'Obstructive', 'Sleep', 'Apnea', 'Syndrome', 'by', 'Drug', 'Induced', 'Sleep', 'Endoscopy', 'According', 'to', 'the', 'Munich', 'Sleep', 'Video', 'Protocol', '|', 'This', 'is', 'a', 'prospective', ',', 'interventional', 'cohort', 'study', 'of', 'drug', '-', 'induced', 'sleep', 'endoscopy', '(', 'DISE', ')', '.', 'The', 'goal', 'is', 'to', 'evaluate', 'the', 'upper', 'airway', 'in', 'a', 'cohort', 'of', 'patients', 'with', 'obstructive', 'sleep', 'apnea', 'hypopnea', 'syndrome', '(', 'OSAHS', ')', 'diagnosed', 'in', 'a', 'prior', 'polysomnography', '.', '\n\n', 'This', 'study', 'correlates', 'the', 'sedation', 'level', 'measured', 'by', 'entropy', 'during', 'DISE', 'using', 'propofol', 'via', 'a', 'TCI', 'pump', 'with', 'the', 'local', 'obstruction', 'patterns', 'of', 'the', 'upper', 'airway', 'according', 'to', 'the', 'VOTE', 'classification', '.', '\n\n', 'As', 'OSAHS', 'is', 'a', 'widespread', 'disease', 'and', 'the', 'DISE', 'procedure', 'has', 'become', 'a', 'common', 'tool', 'for', 'diagnosis', 'and', 'evaluation', 'of', 'further', 'treatment', ',', 'a', 'growing', 'number', 'of', 'research', 'articles', 'deal', 'with', 'this', 'topic', '.', 'These', 'articles', 'are', 'available', 'through', 'pubmed', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02588300,NCT02588300,"Evaluation of the Upper Airway Collapse in Patients With Obstructive Sleep Apnea Syndrome by Drug Induced Sleep Endoscopy According to the Munich Sleep Video Protocol | This is a prospective, interventional cohort study of drug-induced sleep endoscopy (DISE). The goal is to evaluate the upper airway in a cohort of patients with obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosed in a prior polysomnography.

This study correlates the sedation level measured by entropy during DISE using propofol via a TCI pump with the local obstruction patterns of the upper airway according to the VOTE classification.

As OSAHS is a widespread disease and the DISE procedure has become a common tool for diagnosis and evaluation of further treatment, a growing number of research articles deal with this topic. These articles are available through pubmed.","[(57, 89, 'CONDITION', 'Obstructive Sleep Apnea Syndrome'), (330, 371, 'CONDITION', 'obstructive sleep apnea hypopnea syndrome'), (373, 378, 'CONDITION', 'OSAHS'), (620, 625, 'CONDITION', 'OSAHS')]"
"['Behavioral', 'Treatment', 'of', 'Drug', 'Abuse', 'in', 'SPMI', 'Patients', '|', 'The', 'main', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'if', 'the', 'multifaceted', 'treatment', 'for', 'substance', 'abuse', 'in', 'dual', 'disordered', 'patients', 'is', 'more', 'effective', 'in', 'reducing', 'drug', 'use', 'than', 'a', 'supportive', 'control', 'treatment', '.', 'The', 'researchers', 'will', 'also', 'determine', 'if', 'adding', 'a', 'case', 'management', 'component', '(', 'Critical', 'Time', 'Intervention', ';', 'CTI', ')', 'to', 'the', 'intervention', 'will', 'increase', 'treatment', 'engagement', 'and', 'retention', '.']","['B-BEH', 'I-BEH', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00295139,NCT00295139,Behavioral Treatment of Drug Abuse in SPMI Patients | The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment. The researchers will also determine if adding a case management component (Critical Time Intervention; CTI) to the intervention will increase treatment engagement and retention.,"[(0, 20, 'BEHAVIOURAL', 'Behavioral Treatment'), (24, 34, 'CONDITION', 'Drug Abuse'), (38, 42, 'CONDITION', 'SPMI'), (108, 150, 'BEHAVIOURAL', 'multifaceted treatment for substance abuse'), (225, 253, 'CONTROL', 'supportive control treatment'), (303, 328, 'BEHAVIOURAL', 'case management component'), (330, 356, 'BEHAVIOURAL', 'Critical Time Intervention'), (358, 361, 'BEHAVIOURAL', 'CTI')]"
"['Preparation', 'for', 'End', '-', 'of', '-', 'Life', 'Decision', 'Making', 'in', 'Mild', 'Dementia', '|', 'The', 'proposed', 'study', 'will', 'adapt', 'and', 'pilot', 'test', 'an', 'efficacious', 'advance', 'care', 'planning', 'interventions', ',', 'Sharing', 'Patient', ""'s"", 'Illness', 'Representations', 'to', 'Increase', 'Trust', '(', 'SPIRIT', ')', ',', 'with', 'patients', 'with', 'mild', 'dementia', 'and', 'their', 'surrogates', 'to', 'promote', 'open', ',', 'honest', 'discussions', 'while', 'such', 'discussions', 'about', 'end', '-', 'of', '-', 'life', 'care', 'are', 'possible', '.', 'Patient', 'and', 'surrogate', 'decision', 'maker', 'dyads', 'will', 'participate', 'in', 'a', 'single', 'SPIRIT', 'session', 'and', 'will', 'then', 'have', 'a', 'follow', 'up', 'phone', 'call', '2', '-', '3', 'days', 'later', '.', 'One', 'year', 'after', 'the', 'SPIRIT', 'session', 'some', 'surrogates', 'will', 'be', 'contacted', 'to', 'provide', 'additional', 'feedback', 'about', 'the', 'intervention', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03311711,NCT03311711,"Preparation for End-of-Life Decision Making in Mild Dementia | The proposed study will adapt and pilot test an efficacious advance care planning interventions, Sharing Patient's Illness Representations to Increase Trust (SPIRIT), with patients with mild dementia and their surrogates to promote open, honest discussions while such discussions about end-of-life care are possible. Patient and surrogate decision maker dyads will participate in a single SPIRIT session and will then have a follow up phone call 2-3 days later. One year after the SPIRIT session some surrogates will be contacted to provide additional feedback about the intervention.","[(47, 60, 'CONDITION', 'Mild Dementia'), (160, 219, 'BEHAVIOURAL', ""Sharing Patient's Illness Representations to Increase Trust""), (221, 227, 'BEHAVIOURAL', 'SPIRIT'), (249, 262, 'CONDITION', 'mild dementia'), (452, 458, 'BEHAVIOURAL', 'SPIRIT'), (544, 550, 'BEHAVIOURAL', 'SPIRIT')]"
"['Carotid', 'Occlusion', 'Surgery', 'Study', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'if', 'extracranial', '-', 'intracranial', 'bypass', 'surgery', 'when', 'added', 'to', 'best', 'medical', 'therapy', 'can', 'reduce', 'the', 'subsequent', 'risk', 'of', 'ipsilateral', 'stroke', 'in', 'high', '-', 'risk', 'patients', 'with', 'recently', 'symptomatic', 'carotid', 'occlusion', 'and', 'increased', 'cerebral', 'oxygen', 'extraction', 'fraction', 'measured', 'by', 'positron', 'emission', 'tomography', '(', 'PET', ')', '.']","['B-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00029146,NCT00029146,Carotid Occlusion Surgery Study | The purpose of this study is to determine if extracranial-intracranial bypass surgery when added to best medical therapy can reduce the subsequent risk of ipsilateral stroke in high-risk patients with recently symptomatic carotid occlusion and increased cerebral oxygen extraction fraction measured by positron emission tomography (PET).,"[(0, 25, 'SURGICAL', 'Carotid Occlusion Surgery'), (79, 119, 'SURGICAL', 'extracranial-intracranial bypass surgery'), (189, 207, 'CONDITION', 'ipsilateral stroke'), (244, 273, 'CONDITION', 'symptomatic carotid occlusion')]"
"['Effect', 'of', 'Zydena', '(', 'Udenafil', ')', 'on', 'Cerebral', 'Blood', 'Flow', 'and', 'Peripheral', 'Blood', 'Viscosity', 'in', 'Normal', 'and', 'Subcortical', 'Vascular', 'Cognitive', 'Impairment', 'Subjects', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'whether', 'Zydena', '(', 'Udenafil', ')', 'has', 'effect', 'on', 'cerebral', 'blood', 'flow', 'and', 'peripheral', 'blood', 'viscosity', 'in', 'normal', 'and', 'subcortical', 'vascular', 'cognitive', 'impairment', 'subjects', '.']","['O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O']",NCT01466543,NCT01466543,Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity in Normal and Subcortical Vascular Cognitive Impairment Subjects | The purpose of this study is to determine whether Zydena (Udenafil) has effect on cerebral blood flow and peripheral blood viscosity in normal and subcortical vascular cognitive impairment subjects.,"[(10, 16, 'DRUG', 'Zydena'), (18, 26, 'DRUG', 'Udenafil'), (85, 137, 'CONDITION', 'Normal and Subcortical Vascular Cognitive Impairment'), (199, 205, 'DRUG', 'Zydena'), (207, 215, 'DRUG', 'Udenafil'), (285, 337, 'CONDITION', 'normal and subcortical vascular cognitive impairment')]"
"['The', 'Effect', 'of', 'Intravenous', 'Infusions', 'of', 'Lidocaine', 'and', 'Magnesium', 'Versus', 'Lidocaine', 'and', 'Ketamine', 'Versus', 'Lidocaine', 'Alone', 'on', 'Recovery', 'Profile', 'and', 'Postoperative', 'Pain', 'After', 'Elective', 'Gynecological', 'Surgery', '|', 'The', 'aim', 'of', 'this', 'study', 'will', 'be', 'to', 'investigate', 'the', 'effect', 'of', 'a', 'combination', 'of', 'intravenous', 'infusions', 'of', 'lidocaine', 'and', 'magnesium', 'versus', 'a', 'combination', 'of', 'intravenous', 'infusions', 'of', 'lidocaine', 'and', 'ketamine', 'versus', 'an', 'intravenous', 'infusion', 'of', 'lidocaine', 'alone', 'on', 'recovery', 'profile', ',', 'quality', 'of', 'recovery', 'and', 'postoperative', 'pain', 'after', 'elective', 'gynecological', 'surgery']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND']",NCT04622904,NCT04622904,"The Effect of Intravenous Infusions of Lidocaine and Magnesium Versus Lidocaine and Ketamine Versus Lidocaine Alone on Recovery Profile and Postoperative Pain After Elective Gynecological Surgery | The aim of this study will be to investigate the effect of a combination of intravenous infusions of lidocaine and magnesium versus a combination of intravenous infusions of lidocaine and ketamine versus an intravenous infusion of lidocaine alone on recovery profile, quality of recovery and postoperative pain after elective gynecological surgery","[(39, 48, 'DRUG', 'Lidocaine'), (53, 62, 'DRUG', 'Magnesium'), (70, 79, 'DRUG', 'Lidocaine'), (84, 92, 'DRUG', 'Ketamine'), (100, 109, 'DRUG', 'Lidocaine'), (140, 158, 'CONDITION', 'Postoperative Pain'), (165, 195, 'CONDITION', 'Elective Gynecological Surgery'), (299, 308, 'DRUG', 'lidocaine'), (313, 322, 'DRUG', 'magnesium'), (372, 381, 'DRUG', 'lidocaine'), (386, 394, 'DRUG', 'ketamine'), (429, 438, 'DRUG', 'lidocaine'), (490, 508, 'CONDITION', 'postoperative pain'), (515, 545, 'CONDITION', 'elective gynecological surgery')]"
"['Measurements', 'of', 'Displacement', 'Amplitude', 'and', 'Angular', 'Velocities', 'During', 'Passive', 'Extension', 'of', 'the', 'Wrist', 'and', 'Hand', 'Complex', 'in', 'Stroke', 'Patients', '|', 'The', 'main', 'objective', 'of', 'this', 'monocentric', 'prospective', 'study', 'is', 'to', 'evaluate', 'the', 'amplitudes', 'and', 'angular', 'velocities', 'of', 'extension', 'of', 'the', 'hand', 'and', 'wrist', 'joints', 'during', 'passive', 'mobilization', 'by', 'a', 'physiotherapist', 'in', 'healthy', 'subjects', 'and', 'stroke', 'patients', 'with', 'spastic', 'hands', '.', '\n\n', 'Secondary', 'objectives', ':', '\n\n', 'To', 'compare', 'amplitude', 'and', 'angular', 'velocity', 'values', 'between', 'the', 'group', 'of', 'stroke', 'patients', 'and', 'the', 'group', 'of', 'healthy', 'volunteers', ',', '\n', 'To', 'compare', 'amplitude', 'and', 'angular', 'velocity', 'values', 'according', 'to', 'the', 'two', 'types', 'of', 'mobilization', '(', 'i', ',', 'e', ',', 'thumb', 'or', 'fifth', 'finger', ')', ',', '\n', 'To', 'assess', 'pain', 'due', 'to', 'mobilization', 'in', 'stroke', 'patients', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O']",NCT04502927,NCT04502927,"Measurements of Displacement Amplitude and Angular Velocities During Passive Extension of the Wrist and Hand Complex in Stroke Patients | The main objective of this monocentric prospective study is to evaluate the amplitudes and angular velocities of extension of the hand and wrist joints during passive mobilization by a physiotherapist in healthy subjects and stroke patients with spastic hands.

Secondary objectives:

To compare amplitude and angular velocity values between the group of stroke patients and the group of healthy volunteers,
To compare amplitude and angular velocity values according to the two types of mobilization (i,e, thumb or fifth finger),
To assess pain due to mobilization in stroke patients.","[(120, 126, 'CONDITION', 'Stroke'), (363, 369, 'CONDITION', 'stroke'), (384, 391, 'CONDITION', 'spastic'), (493, 499, 'CONDITION', 'stroke'), (678, 682, 'CONDITION', 'pain'), (706, 712, 'CONDITION', 'stroke')]"
"['The', 'Effect', 'of', 'Vitamin', 'C', 'and', 'E', 'Therapy', 'on', 'Restless', 'Leg', 'Syndrome', 'in', 'Patients', 'With', 'End', 'Stage', 'Renal', 'Disease', 'on', 'Haemodialysis', '|', 'This', 'study', 'aims', 'to', 'measure', 'the', 'effectiveness', 'of', 'vitamins', 'C', 'and', 'E', 'on', 'relieving', 'RLS', 'symptoms', 'in', 'end', 'stage', 'renal', 'disease', 'patients', 'on', 'HD']","['O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'B-COND']",NCT05350124,NCT05350124,The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis | This study aims to measure the effectiveness of vitamins C and E on relieving RLS symptoms in end stage renal disease patients on HD,"[(14, 29, 'DRUG', 'Vitamin C and E'), (41, 62, 'CONDITION', 'Restless Leg Syndrome'), (80, 103, 'CONDITION', 'End Stage Renal Disease'), (107, 120, 'CONDITION', 'Haemodialysis'), (171, 187, 'DRUG', 'vitamins C and E'), (201, 204, 'CONDITION', 'RLS'), (217, 240, 'CONDITION', 'end stage renal disease'), (253, 255, 'CONDITION', 'HD')]"
"['Ultrasound', '-', 'Guided', 'Percutaneous', 'Electrical', 'Nerve', 'Stimulation', 'of', 'the', 'Median', 'Nerve', 'for', 'Carpal', 'Tunnel', 'Syndrome', '|', 'There', 'is', 'evidence', 'supporting', 'that', 'physical', 'therapy', 'interventions', 'can', 'be', 'effective', 'for', 'the', 'management', 'of', 'patients', 'with', 'CTS', '.', 'No', 'consensus', 'on', 'the', 'best', 'approach', 'exist', '.', 'It', 'seems', 'clear', 'that', 'the', 'median', 'nerve', 'is', 'affected', 'in', 'several', 'ways', '(', 'compression', ',', 'inflammation', ',', 'excursion', ')', 'in', 'carpal', 'tunnel', 'syndrome', '.', 'Percutaneous', 'Electrical', 'Nerve', 'Stimulation', 'is', 'a', 'treatment', 'approach', 'consisting', 'of', 'the', 'application', 'of', 'an', 'electrical', 'current', 'throughout', 'needling', 'filaments', 'placed', 'close', 'to', 'the', 'nerve', ',', 'in', 'this', 'case', 'the', 'median', 'nerve', '.', 'The', 'purpose', 'of', 'this', 'clinical', 'trial', 'is', 'to', 'compare', 'changes', 'in', 'function', ',', 'symptom', 'severity', 'and', 'the', 'intensity', 'of', 'pain', 'after', 'the', 'application', 'of', 'Percutaneous', 'Electrical', 'Nerve', 'Stimulation', 'vs.', 'endoscopic', 'surgery', 'in', 'women', 'with', 'CTS', 'at', 'short-', 'and', 'long', '-', 'term', 'follow', '-', 'up', 'periods', '.']","['B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04246216,NCT04246216,"Ultrasound-Guided Percutaneous Electrical Nerve Stimulation of the Median Nerve for Carpal Tunnel Syndrome | There is evidence supporting that physical therapy interventions can be effective for the management of patients with CTS. No consensus on the best approach exist. It seems clear that the median nerve is affected in several ways (compression, inflammation, excursion) in carpal tunnel syndrome. Percutaneous Electrical Nerve Stimulation is a treatment approach consisting of the application of an electrical current throughout needling filaments placed close to the nerve, in this case the median nerve. The purpose of this clinical trial is to compare changes in function, symptom severity and the intensity of pain after the application of Percutaneous Electrical Nerve Stimulation vs. endoscopic surgery in women with CTS at short- and long-term follow-up periods.","[(0, 59, 'OTHER', 'Ultrasound-Guided Percutaneous Electrical Nerve Stimulation'), (84, 106, 'CONDITION', 'Carpal Tunnel Syndrome'), (227, 230, 'CONDITION', 'CTS'), (380, 402, 'CONDITION', 'carpal tunnel syndrome'), (404, 445, 'OTHER', 'Percutaneous Electrical Nerve Stimulation'), (721, 725, 'CONDITION', 'pain'), (751, 792, 'OTHER', 'Percutaneous Electrical Nerve Stimulation'), (797, 815, 'CONTROL', 'endoscopic surgery'), (830, 833, 'CONDITION', 'CTS')]"
"['Rehabilitation', 'and', 'Cortical', 'Remodeling', 'After', 'Surgical', 'Intervention', 'for', 'Spinal', 'Cord', 'Injury', '|', 'The', 'aim', 'of', 'this', 'study', 'is', 'to', 'determine', 'the', 'effects', 'of', 'rehabilitation', 'on', 'dexterous', 'hand', 'movements', 'and', 'cortical', 'motor', 'map', 'changes', 'in', 'tetraplegic', 'patients', 'following', 'nerve', 'transfer', 'surgery', '.', 'The', 'working', 'hypothesis', 'is', 'that', 'robot', '-', 'assisted', ',', 'intensive', 'rehabilitation', 'will', 'support', 'the', 'return', 'of', 'hand', 'and', 'arm', 'function', 'and', 'strengthen', 'the', 'cortical', 'representations', 'of', 'targeted', 'muscles', '.', 'The', 'investigators', 'will', 'assess', 'this', 'through', 'TMS', 'mapping', 'and', 'clinical', 'measures', 'of', 'hand', 'and', 'arm', 'function', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04041063,NCT04041063,"Rehabilitation and Cortical Remodeling After Surgical Intervention for Spinal Cord Injury | The aim of this study is to determine the effects of rehabilitation on dexterous hand movements and cortical motor map changes in tetraplegic patients following nerve transfer surgery. The working hypothesis is that robot-assisted, intensive rehabilitation will support the return of hand and arm function and strengthen the cortical representations of targeted muscles. The investigators will assess this through TMS mapping and clinical measures of hand and arm function.","[(71, 89, 'CONDITION', 'Spinal Cord Injury'), (222, 233, 'CONDITION', 'tetraplegic'), (253, 275, 'CONDITION', 'nerve transfer surgery'), (308, 348, 'PHYSICAL', 'robot-assisted, intensive rehabilitation')]"
"['Effect', 'of', 'Unimodal', '(', 'EEG', ')', 'and', 'Bimodal', '(', 'EEG', '-', 'fMRI', ')', 'Neurofeedback', 'on', 'Upper', 'Limb', 'Recovery', 'After', 'Stroke', '|', 'Interventional', 'study', 'with', 'minimal', 'risks', 'and', 'constraints', ',', 'prospective', ',', 'monocentric', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03766113,NCT03766113,"Effect of Unimodal (EEG) and Bimodal (EEG-fMRI) Neurofeedback on Upper Limb Recovery After Stroke | Interventional study with minimal risks and constraints, prospective, monocentric.","[(10, 61, 'OTHER', 'Unimodal (EEG) and Bimodal (EEG-fMRI) Neurofeedback'), (85, 97, 'CONDITION', 'After Stroke')]"
"['Neurologic', 'Music', 'Therapy', 'for', 'Enhancing', 'Fine', 'Motor', 'Control', 'in', 'Parkinson', ""'s"", 'Disease', '|', 'Parkinson', ""'s"", 'Disease', '(', 'PD', ')', 'is', 'defined', 'by', 'characteristic', 'motor', 'symptoms', 'including', 'slow', 'movements', ',', 'small', 'movements', ',', 'difficulty', 'with', 'movement', 'initiation', 'and', 'disruptions', 'in', 'timing', '.', 'Besides', 'gross', 'motor', 'symptoms', ',', 'fine', 'motor', 'impairments', 'in', 'PD', 'cause', 'difficulties', 'with', 'everyday', 'tasks', 'such', 'as', 'writing', ',', 'self', '-', 'care', ',', 'and', 'fine', 'object', 'manipulation', '.', 'These', 'activity', 'limitations', 'can', 'lead', 'to', 'disability', ',', 'social', 'isolation', ',', 'and', 'a', 'reduced', 'quality', 'of', 'life', '.', 'In', 'a', 'series', 'of', 'breakthrough', 'studies', 'Michael', 'Thaut', 'and', 'colleagues', 'developed', 'Neurologic', 'Music', 'Therapy', '(', 'NMT', ')', 'and', 'found', 'it', 'can', 'address', 'many', 'gross', 'motor', 'impairments', 'and', 'improve', 'gait', 'and', 'balance', '.', 'Other', 'music', 'therapies', 'such', 'as', 'Music', '-', 'supported', 'Therapy', '(', 'MST', ')', 'have', 'proven', 'motor', 'benefits', 'in', 'stroke', 'patients', 'through', 'movement', 'exercises', 'with', 'musical', 'instruments', '.', 'However', ',', 'the', 'pathological', 'basal', 'ganglia', '(', 'BG', ')', 'in', 'PD', 'brains', 'leads', 'to', 'a', 'reduced', 'supply', 'of', 'those', 'internally', 'generated', 'movements', '.', 'In', 'contrast', ',', 'externally', 'cued', 'movements', '(', 'eg', '.', 'via', 'a', 'beat', 'or', 'a', 'rhythm', ')', 'during', 'NMT', 'sessions', 'are', 'instantaneously', 'entrained', 'to', 'the', 'period', 'of', 'a', 'rhythmic', 'stimulus', 'possibly', 'without', 'involvement', 'of', 'the', 'BG', '.', 'The', 'underlying', 'idea', 'is', 'that', 'rhythm', 'is', 'the', 'essential', 'component', 'relating', 'music', 'specifically', 'to', 'motor', 'behavior', '.', 'The', 'mechanism', 'of', 'action', 'is', 'called', '""', 'rhythmic', 'entrainment', '""', 'where', 'one', 'system', ""'s"", 'motion', 'or', 'signal', 'frequency', 'entrains', 'the', 'frequency', 'of', 'another', 'system', '.', 'The', 'effect', 'of', 'NMT', 'on', 'fine', 'motor', 'function', 'has', 'not', 'been', 'investigated', 'yet', '.', 'Music', 'activities', 'are', 'important', 'in', 'the', 'lives', 'of', 'many', 'older', 'adults', '.', 'Notably', ',', 'the', 'use', 'of', 'music', 'has', 'been', 'associated', 'with', 'increased', 'well', '-', 'being', 'for', 'older', 'adults', ',', 'as', 'it', 'fosters', 'social', 'connection', 'and', 'mood', 'regulation', '.', 'Furthermore', ',', 'many', 'musical', 'activities', 'have', 'limited', 'physical', 'demands', ',', 'making', 'them', 'attainable', 'for', 'individuals', 'who', 'are', 'living', 'with', 'mobility', 'impairments', 'or', 'other', 'physical', 'restrictions', '.', 'Based', 'on', 'the', 'literature', 'and', 'the', 'investigators', 'preliminary', 'studies', ',', 'the', 'investigators', 'propose', 'to', 'test', 'the', 'efficacy', 'of', 'Neurologic', 'Music', 'Therapy', 'in', 'comparison', 'to', 'Music', 'Supported', 'Therapy', 'and', 'Occupational', 'Therapy', '(', 'OT', ')', 'as', 'standard', 'of', 'care', 'on', 'adults', 'in', 'the', 'Parkinson', ""'s"", 'spectrum', '.', 'The', 'investigators', 'have', 'defined', 'a', 'working', 'plan', 'using', 'different', 'musical', 'instruments', 'and', 'growing', 'tempo', 'to', 'specifically', 'improve', 'fine', 'motor', 'movements', '.']","['B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'B-CTRL', 'I-CTRL', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03049033,NCT03049033,"Neurologic Music Therapy for Enhancing Fine Motor Control in Parkinson's Disease | Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called ""rhythmic entrainment"" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.","[(0, 24, 'OTHER', 'Neurologic Music Therapy'), (61, 80, 'CONDITION', ""Parkinson's Disease""), (83, 102, 'CONDITION', ""Parkinson's Disease""), (104, 106, 'CONDITION', 'PD'), (314, 316, 'CONDITION', 'PD'), (589, 613, 'OTHER', 'Neurologic Music Therapy'), (615, 618, 'OTHER', 'NMT'), (734, 757, 'CONTROL', 'Music-supported Therapy'), (759, 762, 'CONTROL', 'MST'), (911, 913, 'CONDITION', 'PD'), (1063, 1066, 'OTHER', 'NMT'), (1451, 1454, 'OTHER', 'NMT'), (2015, 2039, 'OTHER', 'Neurologic Music Therapy'), (2057, 2080, 'CONTROL', 'Music Supported Therapy'), (2085, 2105, 'CONTROL', 'Occupational Therapy'), (2107, 2109, 'CONTROL', 'OT'), (2148, 2168, 'CONDITION', ""Parkinson's spectrum"")]"
"['Pharmacokinetics', 'and', 'Nitrative', '-', 'Oxidative', 'Stress', 'Pharmacodynamics', 'in', 'Amyotrophic', 'Lateral', 'Sclerosis', 'Subjects', 'Taking', 'Daily', 'High', '-', 'Dose', 'R(+', ')', 'Pramipexole', 'Dihydrochloride', 'for', 'Six', 'Months', '|', 'R(+)pramipexole', 'is', 'administered', 'in', 'escalating', 'doses', 'to', 'patients', 'with', 'early', 'ALS', '.', 'Plasma', 'and', 'spinal', 'fluid', 'levels', 'of', 'R(+)PPX', 'are', 'monitored', ',', 'in', 'addition', 'to', 'biochemical', 'markers', 'of', 'oxidative', 'stress', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'I-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00600873,NCT00600873,"Pharmacokinetics and Nitrative-Oxidative Stress Pharmacodynamics in Amyotrophic Lateral Sclerosis Subjects Taking Daily High-Dose R(+) Pramipexole Dihydrochloride for Six Months | R(+)pramipexole is administered in escalating doses to patients with early ALS. Plasma and spinal fluid levels of R(+)PPX are monitored, in addition to biochemical markers of oxidative stress.","[(68, 97, 'CONDITION', 'Amyotrophic Lateral Sclerosis'), (130, 162, 'DRUG', 'R(+) Pramipexole Dihydrochloride'), (180, 195, 'DRUG', 'R(+)pramipexole'), (249, 258, 'CONDITION', 'early ALS'), (294, 301, 'DRUG', 'R(+)PPX')]"
"['The', 'Effect', 'of', 'Desflurane', 'Versus', 'Sevoflurane', 'on', 'Postoperative', 'Recovery', 'in', 'Patients', 'Undergoing', 'Minor-', 'to', 'Moderate', '-', 'risk', 'Noncardiac', 'Surgery', '-', 'a', 'Prospective', 'Double', '-', 'blinded', 'Randomized', 'Clinical', 'Trial', '|', 'Patients', 'over', 'the', 'age', 'of', '65', 'years', 'are', 'at', 'increased', 'risk', 'for', 'developing', 'delirium', 'and', 'cognitive', 'complications', 'in', 'the', 'immediate', 'postoperative', 'period', 'after', 'noncardiac', 'surgeries', ',', 'resulting', 'in', 'increased', 'morbidity', 'and', 'mortality', '.', 'Previous', 'small', 'studies', 'have', 'shown', 'beneficial', 'effects', 'of', 'desflurane', 'on', 'postoperative', 'cognitive', 'recovery', ',', 'which', 'has', 'been', 'explained', 'by', 'the', 'more', 'rapid', 'onset', 'and', 'offset', 'of', 'anesthesia', 'as', 'compared', 'to', 'sevoflurane', '.', 'However', ',', 'there', 'are', 'very', 'limited', 'data', 'on', 'the', 'effect', 'of', 'desflurane', 'on', 'postoperative', 'recovery', 'and', 'time', 'until', 'criteria', 'for', 'discharge', 'from', 'post', '-', 'anesthesia', 'care', 'unit', '(', 'PACU', ')', 'are', 'fulfilled', 'in', 'elderly', 'patients', 'undergoing', 'minor', '-', 'to', 'moderate', '-', 'risk', 'noncardiac', 'surgery', '.', 'Therefore', ',', 'the', 'investigators', 'will', 'test', 'the', 'primary', 'hypothesis', 'that', 'general', 'anesthesia', 'with', 'desflurane', 'significantly', 'reduces', 'the', 'time', 'between', 'discontinuation', 'of', 'volatile', 'anesthetics', 'after', 'the', 'end', 'of', 'surgery', 'and', 'reaching', 'ready', 'for', 'discharge', 'from', 'PACU', 'criteria', ',', 'which', 'are', 'defined', 'as', 'reaching', 'a', 'modified', 'Aldrete', 'score', '', '12', ',', 'as', 'compared', 'to', 'sevoflurane', 'in', 'patients', '', '65', 'years', 'of', 'age', 'undergoing', 'minor', '-', 'to', 'moderate', '-', 'risk', 'noncardiac', 'surgery', '.']","['O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT05331027,NCT05331027,"The Effect of Desflurane Versus Sevoflurane on Postoperative Recovery in Patients Undergoing Minor- to Moderate-risk Noncardiac Surgery - a Prospective Double-blinded Randomized Clinical Trial | Patients over the age of 65 years are at increased risk for developing delirium and cognitive complications in the immediate postoperative period after noncardiac surgeries, resulting in increased morbidity and mortality. Previous small studies have shown beneficial effects of desflurane on postoperative cognitive recovery, which has been explained by the more rapid onset and offset of anesthesia as compared to sevoflurane. However, there are very limited data on the effect of desflurane on postoperative recovery and time until criteria for discharge from post-anesthesia care unit (PACU) are fulfilled in elderly patients undergoing minor-to moderate-risk noncardiac surgery. Therefore, the investigators will test the primary hypothesis that general anesthesia with desflurane significantly reduces the time between discontinuation of volatile anesthetics after the end of surgery and reaching ready for discharge from PACU criteria, which are defined as reaching a modified Aldrete score  12, as compared to sevoflurane in patients  65 years of age undergoing minor-to moderate-risk noncardiac surgery.","[(14, 24, 'DRUG', 'Desflurane'), (32, 43, 'DRUG', 'Sevoflurane'), (93, 135, 'CONDITION', 'Minor- to Moderate-risk Noncardiac Surgery'), (266, 274, 'CONDITION', 'delirium'), (347, 367, 'CONDITION', 'noncardiac surgeries'), (473, 483, 'DRUG', 'desflurane'), (610, 621, 'DRUG', 'sevoflurane'), (677, 687, 'DRUG', 'desflurane'), (835, 876, 'CONDITION', 'minor-to moderate-risk noncardiac surgery'), (969, 979, 'DRUG', 'desflurane'), (1213, 1224, 'DRUG', 'sevoflurane'), (1266, 1307, 'CONDITION', 'minor-to moderate-risk noncardiac surgery')]"
"['Risperidone', 'Long', '-', 'Acting', 'for', 'Alcohol', 'and', 'Schizophrenia', 'Treatment', '(', 'R', '-', 'LAST', ')', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'compare', 'the', 'efficacy', 'of', 'oral', 'risperidone', '(', 'Risperdal', ')', 'to', 'risperidone', 'long', '-', 'acting', '(', 'Consta', ')', 'in', 'reducing', 'alcohol', 'use', 'in', 'persons', 'diagnosed', 'with', 'schizophrenia', 'or', 'schizoaffective', 'disorder', '.']","['B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O']",NCT00130923,NCT00130923,Risperidone Long-Acting for Alcohol and Schizophrenia Treatment (R-LAST) | The purpose of this study is to compare the efficacy of oral risperidone (Risperdal) to risperidone long-acting (Consta) in reducing alcohol use in persons diagnosed with schizophrenia or schizoaffective disorder.,"[(0, 11, 'DRUG', 'Risperidone'), (40, 53, 'CONDITION', 'Schizophrenia'), (136, 147, 'DRUG', 'risperidone'), (149, 158, 'DRUG', 'Risperdal'), (163, 174, 'DRUG', 'risperidone'), (188, 194, 'DRUG', 'Consta'), (208, 219, 'CONDITION', 'alcohol use'), (246, 259, 'CONDITION', 'schizophrenia'), (263, 287, 'CONDITION', 'schizoaffective disorder')]"
"['An', 'Open', '-', 'Label', ',', 'Randomized', ',', 'Two', '-', 'Period', 'Crossover', 'Study', 'to', 'Demonstrate', 'the', 'Bioequivalence', 'of', 'a', 'Tablet', 'Formulation', 'of', 'Rosiglitazone', 'XR', '(', 'BRL-049653', ')', '8', 'mg', 'Manufactured', 'at', 'Two', 'Different', 'Sites', 'in', 'Healthy', 'Volunteers', 'in', 'Fasting', 'Conditions', '|', 'The', 'present', 'pharmacokinetic', 'study', 'is', 'designed', 'to', 'compare', 'bioavailability', 'and', 'assess', 'bioequivalence', 'of', 'two', 'Rosiglitazone', 'XR', 'formulations', 'produced', 'at', 'two', 'different', 'sites', '.', 'Both', 'formulations', 'will', 'be', 'tested', 'in', 'fasting', 'healthy', 'volunteers']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00468897,NCT00468897,"An Open-Label, Randomized, Two-Period Crossover Study to Demonstrate the Bioequivalence of a Tablet Formulation of Rosiglitazone XR (BRL-049653) 8mg Manufactured at Two Different Sites in Healthy Volunteers in Fasting Conditions | The present pharmacokinetic study is designed to compare bioavailability and assess bioequivalence of two Rosiglitazone XR formulations produced at two different sites.Both formulations will be tested in fasting healthy volunteers","[(115, 128, 'DRUG', 'Rosiglitazone'), (133, 143, 'DRUG', 'BRL-049653'), (337, 350, 'DRUG', 'Rosiglitazone')]"
"['The', 'Role', 'of', 'Anxiety', 'Sensitivity', 'in', 'the', 'Maintenance', 'of', 'Chronic', 'Post', 'Concussion', 'Symptoms', '|', 'This', 'study', 'is', 'designed', 'to', 'investigate', 'factors', 'that', 'are', 'associated', 'with', 'prolonged', 'recovery', 'from', 'mild', 'head', 'injury', '.', 'The', 'investigators', 'are', 'particularly', 'interested', 'in', 'defining', 'the', 'impact', 'of', 'anxiety', 'related', 'variables', ',', 'such', 'as', 'health', 'anxiety', 'and', 'anxiety', 'sensitivity', 'in', 'the', 'maintenance', 'of', 'symptoms', '.', '\n\n', 'A', 'further', 'goal', 'of', 'the', 'study', 'is', 'the', 'evaluation', 'of', 'two', 'treatment', 'methods', 'that', 'have', 'been', 'proposed', 'to', 'be', 'effective', 'in', 'reducing', 'the', 'impact', 'of', 'post', 'concussion', 'symptoms', '.', 'The', 'investigators', 'hypothesize', 'that', 'a', 'treatment', 'which', 'is', 'directly', 'focused', 'on', 'changing', 'these', 'anxiety', 'related', 'variables', 'will', 'be', 'more', 'effective', 'than', 'one', 'that', 'does', 'not', '.']","['O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00871884,NCT00871884,"The Role of Anxiety Sensitivity in the Maintenance of Chronic Post Concussion Symptoms | This study is designed to investigate factors that are associated with prolonged recovery from mild head injury. The investigators are particularly interested in defining the impact of anxiety related variables, such as health anxiety and anxiety sensitivity in the maintenance of symptoms.

A further goal of the study is the evaluation of two treatment methods that have been proposed to be effective in reducing the impact of post concussion symptoms. The investigators hypothesize that a treatment which is directly focused on changing these anxiety related variables will be more effective than one that does not.","[(12, 19, 'CONDITION', 'Anxiety'), (54, 77, 'CONDITION', 'Chronic Post Concussion'), (184, 200, 'CONDITION', 'mild head injury'), (274, 281, 'CONDITION', 'anxiety'), (316, 323, 'CONDITION', 'anxiety'), (328, 335, 'CONDITION', 'anxiety'), (518, 533, 'CONDITION', 'post concussion'), (635, 642, 'CONDITION', 'anxiety')]"
"['Clinical', 'Outcomes', 'of', 'Human', 'Amniotic', 'Membrane', 'and', 'Allogeneic', 'Mesenchymal', 'Stem', 'Cells', 'Composite', 'Augmentation', 'for', 'Nerve', 'Transfer', 'Procedure', 'in', 'Brachial', 'Plexus', 'Injury', 'Patients', '|', 'The', 'purpose', 'of', 'this', 'clinical', 'trial', 'is', 'to', 'investigate', 'the', 'utility', 'of', 'composite', 'wrapping', 'comprising', 'human', 'amniotic', 'membrane', 'and', 'allogeneic', 'adipose', '-', 'derived', 'mesenchymal', 'stem', 'cells', '(', 'HAM', '-', 'AdMSC', ')', 'for', 'augmentation', 'of', 'nerve', 'transfer', 'procedure', 'in', 'upper', 'TBPI', 'patients']","['O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'B-SURG', 'I-SURG', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'I-SURG', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'O', 'O', 'B-COND', 'I-COND', 'O']",NCT04654286,NCT04654286,Clinical Outcomes of Human Amniotic Membrane and Allogeneic Mesenchymal Stem Cells Composite Augmentation for Nerve Transfer Procedure in Brachial Plexus Injury Patients | The purpose of this clinical trial is to investigate the utility of composite wrapping comprising human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells (HAM-AdMSC) for augmentation of nerve transfer procedure in upper TBPI patients,"[(21, 105, 'SURGICAL', 'Human Amniotic Membrane and Allogeneic Mesenchymal Stem Cells Composite Augmentation'), (110, 124, 'SURGICAL', 'Nerve Transfer'), (138, 160, 'CONDITION', 'Brachial Plexus Injury'), (270, 347, 'SURGICAL', 'human amniotic membrane and allogeneic adipose-derived mesenchymal stem cells'), (349, 358, 'SURGICAL', 'HAM-AdMSC'), (380, 394, 'SURGICAL', 'nerve transfer'), (408, 418, 'CONDITION', 'upper TBPI')]"
"['The', 'RETORNUS', 'Study', ':', 'Dual', 'Training', 'to', 'Restore', 'the', 'Function', 'of', 'Respiratory', 'Muscles', 'in', 'Stroke', 'Patients', '|', 'This', 'study', 'is', 'divided', 'for', 'development', 'in', 'two', 'complementary', 'work', 'packages', 'justified', 'by', 'the', 'need', 'to', 'incorporate', 'new', 'strategies', 'to', 'optimize', 'rehabilitation', 'outcomes', 'in', 'stroke', 'patients', '.', 'The', 'general', 'objectives', 'are', ':', '1', ')', 'to', 'determine', 'the', 'prevalence', 'of', 'respiratory', 'muscle', 'dysfunction', 'in', 'stroke', 'patients', ';', '2', ')', 'to', 'identify', 'the', 'existence', 'of', 'a', 'potential', 'amino', 'acid', 'marker', 'of', 'increased', 'risk', 'of', 'muscle', 'dysfunction', 'after', 'suffering', 'a', 'stroke', ';', '3', ')', 'to', 'evaluate', 'the', 'effectiveness', 'of', 'incorporating', 'the', 'respiratory', 'muscle', 'training', 'as', 'an', 'innovative', 'adjuvant', 'therapy', 'in', 'stroke', 'rehabilitation', 'program', 'that', 'may', 'decrease', 'the', 'incidence', 'of', 'morbidity', 'and', 'mortality', 'in', 'the', 'medium', 'and', 'long', 'term', ';', 'and', '4', ')', 'to', 'quantify', 'the', 'potential', 'impact', 'of', 'respiratory', 'muscle', 'training', 'on', 'the', 'costs', 'of', 'care', 'for', 'stroke', 'patients', '.']","['O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O']",NCT02125760,NCT02125760,The RETORNUS Study: Dual Training to Restore the Function of Respiratory Muscles in Stroke Patients | This study is divided for development in two complementary work packages justified by the need to incorporate new strategies to optimize rehabilitation outcomes in stroke patients. The general objectives are: 1) to determine the prevalence of respiratory muscle dysfunction in stroke patients; 2) to identify the existence of a potential amino acid marker of increased risk of muscle dysfunction after suffering a stroke; 3) to evaluate the effectiveness of incorporating the respiratory muscle training as an innovative adjuvant therapy in stroke rehabilitation program that may decrease the incidence of morbidity and mortality in the medium and long term; and 4) to quantify the potential impact of respiratory muscle training on the costs of care for stroke patients.,"[(20, 33, 'PHYSICAL', 'Dual Training'), (84, 90, 'CONDITION', 'Stroke'), (266, 272, 'CONDITION', 'stroke'), (379, 385, 'CONDITION', 'stroke'), (516, 522, 'CONDITION', 'stroke'), (578, 605, 'PHYSICAL', 'respiratory muscle training'), (643, 649, 'CONDITION', 'stroke'), (804, 831, 'PHYSICAL', 'respiratory muscle training'), (857, 863, 'CONDITION', 'stroke')]"
"['Placebo', '-', 'controlled', ',', 'Double', '-', 'blind', ',', 'Parallel', 'Group', ',', 'Fixed', 'Dose', 'Study', 'of', 'KW-6002', '(', 'Istradefylline', ')', 'in', 'the', 'Treatment', 'of', 'Parkinson', ""'s"", 'Disease', '(', 'Phase', '2', 'Study', ')', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'establish', 'the', 'efficacy', 'of', '20', 'mg', '/', 'day', 'and', '40', 'mg', '/', 'day', 'doses', 'of', 'istradefylline', 'for', 'reducing', 'the', 'mean', 'total', 'hours', 'of', 'awake', 'time', 'per', 'day', 'spent', 'in', 'the', 'OFF', 'state', 'in', 'patients', 'with', 'advanced', 'Parkinson', ""'s"", 'disease', '(', 'PD', ')', 'treated', 'with', 'levodopa', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'B-COND', 'O']",NCT00455507,NCT00455507,"Placebo-controlled, Double-blind, Parallel Group, Fixed Dose Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease (Phase 2 Study) | The purpose of this study is to establish the efficacy of 20 mg/day and 40 mg/day doses of istradefylline for reducing the mean total hours of awake time per day spent in the OFF state in patients with advanced Parkinson's disease (PD) treated with levodopa.","[(70, 77, 'DRUG', 'KW-6002'), (79, 93, 'DRUG', 'Istradefylline'), (115, 134, 'CONDITION', ""Parkinson's Disease""), (244, 258, 'DRUG', 'istradefylline'), (355, 383, 'CONDITION', ""advanced Parkinson's disease""), (385, 387, 'CONDITION', 'PD'), (402, 410, 'CONDITION', 'levodopa')]"
"['Stroke', 'Telemedicine', 'for', 'Arizona', 'Rural', 'Residents', 'Trial', '|', 'The', 'STARR', 'network', 'registry', 'consists', 'of', 'a', '4', 'spoke', '1', 'hub', 'system', '.', 'Which', 'will', 'consist', 'of', 'prospective', 'collection', ',', 'recording', ',', 'and', 'regular', 'analysis', 'of', 'telestroke', 'patient', 'consultation', 'and', 'care', 'data', 'for', 'the', 'purpose', 'of', 'quality', 'measure', 'assessment', 'and', 'improvement', 'and', 'benchmarking', 'against', 'other', 'national', 'and', 'international', 'telestroke', 'programs', '.']","['B-COND', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O']",NCT00829361,NCT00829361,"Stroke Telemedicine for Arizona Rural Residents Trial | The STARR network registry consists of a 4 spoke 1 hub system. Which will consist of prospective collection, recording, and regular analysis of telestroke patient consultation and care data for the purpose of quality measure assessment and improvement and benchmarking against other national and international telestroke programs.","[(0, 6, 'CONDITION', 'Stroke'), (7, 19, 'OTHER', 'Telemedicine'), (200, 231, 'OTHER', 'telestroke patient consultation'), (333, 385, 'CONTROL', 'other national and international telestroke programs')]"
"['Assessing', 'the', 'Effect', 'of', '1072', 'nm', 'Infrared', '(', 'IR', ')', 'Phototherapy', 'on', 'the', 'Behavioral', 'and', 'Cognitive', 'Symptoms', 'Associated', 'With', 'Early', 'and', 'Mid', '-', 'stage', 'Dementia', ':', 'a', 'Randomized', 'Placebo', '-', 'controlled', 'Clinical', 'Trial', '.', '|', 'This', 'study', 'will', 'employ', 'a', 'double', '-', 'blind', ',', 'placebo', '-', 'controlled', 'approach', 'to', 'assess', 'the', 'effect', 'of', '1072', 'nm', 'infrared', '(', 'IR', ')', 'phototherapy', 'on', 'the', 'behavioral', 'and', 'cognitive', 'symptoms', 'associated', 'with', 'early', 'and', 'mid', '-', 'stage', 'dementia', '.']","['O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT01059877,NCT01059877,"Assessing the Effect of 1072nm Infrared (IR) Phototherapy on the Behavioral and Cognitive Symptoms Associated With Early and Mid-stage Dementia: a Randomized Placebo-controlled Clinical Trial. | This study will employ a double-blind, placebo-controlled approach to assess the effect of 1072nm infrared (IR) phototherapy on the behavioral and cognitive symptoms associated with early and mid-stage dementia.","[(24, 57, 'OTHER', '1072nm Infrared (IR) Phototherapy'), (115, 144, 'CONDITION', 'Early and Mid-stage Dementia:'), (234, 241, 'CONTROL', 'placebo'), (286, 319, 'OTHER', '1072nm infrared (IR) phototherapy'), (377, 405, 'CONDITION', 'early and mid-stage dementia')]"
"['Investigating', 'the', 'Effects', 'of', 'Combining', 'rTMS', 'With', 'Visual', 'Feedback', 'Training', 'to', 'Improve', 'Movements', 'in', 'the', 'Paretic', 'Lower', 'Limb', 'and', 'Gait', 'Performance', '|', 'After', 'stroke', ',', 'patients', 'often', 'experience', 'motor', 'deficits', 'that', 'interrupt', 'normal', 'lower', 'extremity', 'movement', 'and', 'gait', 'function', '.', 'Recent', 'developments', 'in', 'neuroimaging', 'have', 'focus', 'on', 'the', 'reasons', 'why', 'some', 'patients', 'recover', 'well', 'while', 'some', 'do', 'poorly', '.', 'However', ',', 'there', 'is', 'still', 'no', 'consensus', 'on', 'the', 'exact', 'mechanisms', 'involved', 'in', 'regaining', 'the', 'functions', 'after', 'rehabilitation', '.', 'Application', 'of', 'repetitive', 'transcranial', 'magnetic', 'stimulation', '(', 'rTMS', ')', 'to', 'facilitate', 'neural', 'plasticity', 'during', 'stroke', 'treatment', 'has', 'recently', 'gained', 'considerable', 'attention', '.', 'The', 'possible', 'mechanism', 'through', 'which', 'rTMS', 'acts', 'is', 'based', 'on', 'the', 'interhemispheric', 'competition', '(', 'IHC', ')', 'model', ',', 'which', 'explains', 'that', 'patients', 'with', 'stroke', 'experience', 'alterations', 'in', 'cortical', 'excitability', 'and', 'exhibit', 'abnormally', 'high', 'interhemispheric', 'inhibition', 'from', 'the', 'unaffected', 'hemisphere', 'to', 'the', 'affected', 'hemisphere', '.', 'The', 'visual', 'feedback', 'training', 'can', 'improve', 'postural', 'control', 'and', 'enhance', 'motor', 'performance', '.', 'Several', 'rTMS', 'studies', 'have', 'evaluated', 'the', 'lower', 'extremity', 'dysfunction', 'following', 'stroke', ',', 'but', 'few', 'studies', 'have', 'explored', 'the', 'efficacy', 'of', 'applying', 'rTMS', 'on', 'the', 'lower', 'extremities', '.', 'We', 'expect', 'the', 'study', 'can', 'help', 'us', 'to', 'further', 'exploration', 'of', 'the', 'change', 'of', 'clinical', 'function', 'and', 'cortical', 'excitability', 'following', 'rTMS', 'and', 'visual', 'feedback', 'training', 'in', 'subjects', 'with', 'stroke', '.', 'In', 'addition', ',', 'the', 'results', 'of', 'this', 'project', 'will', 'be', 'provided', 'for', 'further', 'rehabilitation', 'programs', 'in', 'people', 'with', 'stroke', '.']","['O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT03689491,NCT03689491,"Investigating the Effects of Combining rTMS With Visual Feedback Training to Improve Movements in the Paretic Lower Limb and Gait Performance | After stroke, patients often experience motor deficits that interrupt normal lower extremity movement and gait function. Recent developments in neuroimaging have focus on the reasons why some patients recover well while some do poorly. However, there is still no consensus on the exact mechanisms involved in regaining the functions after rehabilitation. Application of repetitive transcranial magnetic stimulation (rTMS) to facilitate neural plasticity during stroke treatment has recently gained considerable attention. The possible mechanism through which rTMS acts is based on the interhemispheric competition (IHC) model, which explains that patients with stroke experience alterations in cortical excitability and exhibit abnormally high interhemispheric inhibition from the unaffected hemisphere to the affected hemisphere. The visual feedback training can improve postural control and enhance motor performance. Several rTMS studies have evaluated the lower extremity dysfunction following stroke, but few studies have explored the efficacy of applying rTMS on the lower extremities. We expect the study can help us to further exploration of the change of clinical function and cortical excitability following rTMS and visual feedback training in subjects with stroke. In addition, the results of this project will be provided for further rehabilitation programs in people with stroke.","[(39, 43, 'OTHER', 'rTMS'), (49, 73, 'OTHER', 'Visual Feedback Training'), (150, 156, 'CONDITION', 'stroke'), (514, 558, 'OTHER', 'repetitive transcranial magnetic stimulation'), (560, 564, 'OTHER', 'rTMS'), (605, 611, 'CONDITION', 'stroke'), (703, 707, 'OTHER', 'rTMS'), (805, 811, 'CONDITION', 'stroke'), (979, 1003, 'OTHER', 'visual feedback training'), (1072, 1076, 'OTHER', 'rTMS'), (1142, 1148, 'CONDITION', 'stroke'), (1205, 1209, 'OTHER', 'rTMS'), (1362, 1366, 'OTHER', 'rTMS'), (1371, 1395, 'OTHER', 'visual feedback training'), (1413, 1419, 'CONDITION', 'stroke'), (1530, 1536, 'CONDITION', 'stroke')]"
"['Assessment', 'of', 'the', 'Effect', 'of', 'Treatment', 'Pathways', ',', 'Adherence', ',', 'and', 'Treatment', 'Efficacy', 'in', 'Parkinson', ""'s"", 'Disease', 'Subjects', 'Randomized', 'to', 'SPECT', 'Imaging', 'of', 'the', 'Dopamine', 'Transporter', '(', 'Ioflupane', 'I123', 'Injection', ')', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'the', 'impact', 'of', 'imaging', 'the', 'brain', 'as', 'a', 'diagnostic', 'tool', 'in', 'the', 'management', 'of', 'early', 'Parkinson', ""'s"", 'disease', '(', 'PD', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT01788696,NCT01788696,"Assessment of the Effect of Treatment Pathways, Adherence, and Treatment Efficacy in Parkinson's Disease Subjects Randomized to SPECT Imaging of the Dopamine Transporter (Ioflupane I123 Injection) | The purpose of this study is to evaluate the impact of imaging the brain as a diagnostic tool in the management of early Parkinson's disease (PD).","[(85, 104, 'CONDITION', ""Parkinson's Disease""), (314, 339, 'CONDITION', ""early Parkinson's disease""), (341, 343, 'CONDITION', 'PD')]"
"['A', 'Phase', '2', 'Multicenter', ',', 'Randomized', ',', 'Double', '-', 'Blind', ',', 'Placebo', '-', 'Controlled', ',', 'Cross', '-', 'Over', 'Study', 'Of', 'The', 'Safety', 'And', 'Efficacy', 'Of', 'PF-03654746', 'In', 'Adults', 'With', 'Tourette', ""'s"", 'Syndrome', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'the', 'safety', 'and', 'efficacy', 'of', 'an', 'investigational', 'compound', 'designated', 'PF-03654746', 'compared', 'to', 'placebo', 'in', 'the', 'treatment', 'of', 'adults', 'with', 'Tourette', ""'s"", 'Syndrome', '.', 'The', 'study', 'will', 'also', 'explore', 'the', 'pharmacokinetics', 'of', 'PF-03654746', 'in', 'adults', 'with', 'Tourette', ""'s"", 'Syndrome', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O']",NCT01475383,NCT01475383,"A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study Of The Safety And Efficacy Of PF-03654746 In Adults With Tourette's Syndrome | The purpose of this study is to evaluate the safety and efficacy of an investigational compound designated PF-03654746 compared to placebo in the treatment of adults with Tourette's Syndrome. The study will also explore the pharmacokinetics of PF-03654746 in adults with Tourette's Syndrome.","[(49, 56, 'CONTROL', 'Placebo'), (116, 127, 'DRUG', 'PF-03654746'), (143, 162, 'CONDITION', ""Tourette's Syndrome""), (272, 283, 'DRUG', 'PF-03654746'), (296, 303, 'CONTROL', 'placebo'), (336, 355, 'CONDITION', ""Tourette's Syndrome""), (409, 420, 'DRUG', 'PF-03654746'), (436, 455, 'CONDITION', ""Tourette's Syndrome"")]"
"['A', 'Phase', '4', ',', 'Open', '-', 'Label', 'Study', 'to', 'Evaluate', 'the', 'Safety', 'and', 'Tolerability', 'of', 'Daily', 'Dosing', 'of', 'Rimegepant', 'in', 'Episodic', 'Migraine', 'Prevention', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'further', 'evaluate', 'the', 'long', '-', 'term', 'safety', 'and', 'tolerability', 'of', 'daily', 'dosing', 'of', 'rimegepant', 'for', 'the', 'prevention', 'of', 'episodic', 'migraine', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O']",NCT05207865,NCT05207865,"A Phase 4, Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention | The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.","[(87, 97, 'DRUG', 'Rimegepant'), (101, 118, 'CONDITION', 'Episodic Migraine'), (238, 248, 'DRUG', 'rimegepant'), (271, 288, 'CONDITION', 'episodic migraine')]"
"['Diet', 'Induced', 'Ketosis', 'for', 'Brain', 'Injury', '-', 'A', 'Feasibility', 'Study', ':', 'A', 'Ketogenic', 'Diet', 'With', 'MCT', 'Supplementation', 'as', 'a', 'Potential', 'Treatment', 'for', 'Brain', 'Injury', 'in', 'Adults', '|', 'Each', 'year', ',', 'approx', '.', '100', 'patients', 'with', 'severe', 'brain', 'injury', 'is', 'admitted', 'to', 'the', 'Clinic', 'for', 'Neurorehabilitation', '/', 'TBI', 'Unit', ',', 'Rigshospitalet', '.', 'Severe', 'brain', 'injury', 'results', 'in', 'local', 'oxygen', 'deficiency', 'and', 'acid', 'formation', 'in', 'the', 'brain', ',', 'which', 'together', 'destroys', 'brain', 'cells', '.', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'investigate', 'whether', 'it', 'is', 'possible', 'to', 'carry', 'out', 'a', 'ketogenic', 'diet', 'therapy', 'for', 'patients', 'with', 'severe', 'brain', 'injury', 'for', 'six', 'weeks', '.', 'Ketosis', 'has', 'been', 'shown', 'to', 'be', 'neuroprotective', 'during', 'and', 'after', 'severe', 'brain', 'injury', '.']","['B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O']",NCT04308577,NCT04308577,"Diet Induced Ketosis for Brain Injury - A Feasibility Study: A Ketogenic Diet With MCT Supplementation as a Potential Treatment for Brain Injury in Adults | Each year, approx. 100 patients with severe brain injury is admitted to the Clinic for Neurorehabilitation/TBI Unit, Rigshospitalet. Severe brain injury results in local oxygen deficiency and acid formation in the brain, which together destroys brain cells. The purpose of this study is to investigate whether it is possible to carry out a ketogenic diet therapy for patients with severe brain injury for six weeks. Ketosis has been shown to be neuroprotective during and after severe brain injury.","[(0, 20, 'OTHER', 'Diet Induced Ketosis'), (25, 37, 'CONDITION', 'Brain Injury'), (63, 77, 'OTHER', 'Ketogenic Diet'), (83, 102, 'OTHER', 'MCT Supplementation'), (132, 144, 'CONDITION', 'Brain Injury'), (194, 213, 'CONDITION', 'severe brain injury'), (290, 309, 'CONDITION', 'Severe brain injury'), (497, 519, 'OTHER', 'ketogenic diet therapy'), (538, 557, 'CONDITION', 'severe brain injury'), (573, 580, 'OTHER', 'Ketosis'), (635, 654, 'CONDITION', 'severe brain injury')]"
"['Rapid', 'Response', 'to', 'Day', 'Hospital', 'Treatment', 'in', 'Bulimia', 'Nervosa', 'and', 'Purging', 'Disorder', ':', 'A', 'Randomized', 'Controlled', 'Trial', 'of', 'an', 'Intervention', 'to', 'Facilitate', 'Early', 'Symptom', 'Change', '|', 'Treatments', 'for', 'bulimia', 'nervosa', '(', 'BN', ')', 'have', 'relatively', 'high', 'rates', 'of', 'nonremission', 'and', 'relapse', ',', 'meaning', 'that', 'improving', 'treatments', 'is', 'a', 'high', 'priority', 'in', 'this', 'area', '.', 'Rapid', 'response', 'to', 'treatment', '-cessation', 'of', 'binge', 'eating', 'and', 'vomiting', 'symptoms', 'within', 'the', 'first', 'weeks', 'of', 'treatment', '-', 'is', 'a', 'robust', 'predictor', 'of', 'improved', 'post', '-', 'treatment', 'outcomes', 'and', 'lower', 'relapse', 'rates', ',', 'but', 'no', 'study', 'has', 'tried', 'to', 'facilitate', 'rapid', 'response', 'as', 'a', 'means', 'of', 'improving', 'treatment', 'outcomes', '.', 'The', 'present', 'study', 'responds', 'to', 'this', 'gap', 'in', 'the', 'literature', 'by', 'testing', 'a', '4', '-', 'session', 'CBT', '-', 'based', 'individual', 'intervention', 'for', 'rapid', 'response', '(', 'i.e.', ',', '""', 'CBT', '-', 'RR', '""', ')', ',', 'designed', 'to', 'augment', 'standard', 'day', 'hospital', '(', 'DH', ')', 'treatment', 'for', 'BN', 'and', 'Purging', 'Disorder', '(', 'PD', ')', 'by', 'focusing', 'on', 'strategies', 'and', 'skills', 'for', 'rapid', 'symptom', 'interruption', '.', 'CBT', '-', 'RR', 'will', 'be', 'compared', 'to', 'a', 'matched', '-', 'intensity', 'augmentative', 'motivational', 'interviewing', '(', 'MI', ')', 'intervention', '.', 'Participants', 'will', 'be', 'recruited', 'from', 'a', 'hospital', '-', 'based', 'day', 'program', 'for', 'eating', 'disorders', ',', 'and', 'will', 'be', 'randomly', 'assigned', 'to', 'one', 'of', 'the', 'two', 'conditions', 'in', 'addition', 'to', 'the', 'DH', 'as', 'usual', '.', 'participants', 'will', 'be', 'assessed', 'at', 'pre', '-', 'intervention', ',', 'post', '-', 'intervention', ',', 'week', '4', 'of', 'DH', ',', 'post', '-', 'DH', ',', 'and', '6', 'months', 'follow', '-', 'up', '.', 'It', 'is', 'hypothesized', 'that', 'compared', 'to', 'those', 'who', 'receive', 'MI', ',', 'patients', 'who', 'receive', 'CBT', '-', 'RR', 'will', 'be', 'more', 'likely', 'to', 'exhibit', 'a', 'rapid', 'response', 'to', 'day', 'hospital', 'treatment', '(', 'i.e.', ',', '<', '/=', '3', 'binge', 'eating', 'and/or', 'vomiting', 'episodes', 'in', 'the', 'first', '4', 'weeks', ')', '.', 'It', 'is', 'further', 'hypothesized', 'that', 'patients', 'who', 'receive', 'CBT', '-', 'RR', 'will', 'exhibit', 'fewer', 'binge', 'eating', 'and/or', 'vomiting', 'episodes', 'at', 'post', '-', 'DH', 'and', 'at', '6', '-', 'month', 'follow', '-', 'up', '.', 'Potential', 'mediators', 'and', 'moderators', 'of', 'these', 'hypothesized', 'treatment', 'effects', 'will', 'be', 'examined', 'on', 'an', 'exploratory', 'basis', ',', 'including', 'self', '-', 'efficacy', ',', 'motivation', ',', 'and', 'hope', '(', 'potential', 'mediators', ')', ',', 'and', 'emotion', 'regulation', ',', 'depression', ',', 'cognitive', 'psychopathology', 'of', 'eating', 'disorders', ',', 'and', 'working', 'alliance', 'with', 'the', 'therapist', '(', 'potential', 'moderators', ')', '.']","['B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02444065,NCT02444065,"Rapid Response to Day Hospital Treatment in Bulimia Nervosa and Purging Disorder: A Randomized Controlled Trial of an Intervention to Facilitate Early Symptom Change | Treatments for bulimia nervosa (BN) have relatively high rates of nonremission and relapse, meaning that improving treatments is a high priority in this area. Rapid response to treatment -cessation of binge eating and vomiting symptoms within the first weeks of treatment - is a robust predictor of improved post-treatment outcomes and lower relapse rates, but no study has tried to facilitate rapid response as a means of improving treatment outcomes. The present study responds to this gap in the literature by testing a 4-session CBT-based individual intervention for rapid response (i.e., ""CBT-RR""), designed to augment standard day hospital (DH) treatment for BN and Purging Disorder (PD) by focusing on strategies and skills for rapid symptom interruption. CBT-RR will be compared to a matched-intensity augmentative motivational interviewing (MI) intervention. Participants will be recruited from a hospital-based day program for eating disorders, and will be randomly assigned to one of the two conditions in addition to the DH as usual. participants will be assessed at pre-intervention, post-intervention, week 4 of DH, post-DH, and 6 months follow-up. It is hypothesized that compared to those who receive MI, patients who receive CBT-RR will be more likely to exhibit a rapid response to day hospital treatment (i.e., </= 3 binge eating and/or vomiting episodes in the first 4 weeks). It is further hypothesized that patients who receive CBT-RR will exhibit fewer binge eating and/or vomiting episodes at post-DH and at 6-month follow-up. Potential mediators and moderators of these hypothesized treatment effects will be examined on an exploratory basis, including self-efficacy, motivation, and hope (potential mediators), and emotion regulation, depression, cognitive psychopathology of eating disorders, and working alliance with the therapist (potential moderators).","[(0, 40, 'BEHAVIOURAL', 'Rapid Response to Day Hospital Treatment'), (44, 59, 'CONDITION', 'Bulimia Nervosa'), (64, 80, 'CONDITION', 'Purging Disorder'), (183, 198, 'CONDITION', 'bulimia nervosa'), (200, 202, 'CONDITION', 'BN'), (327, 365, 'BEHAVIOURAL', 'Rapid response to treatment -cessation'), (562, 576, 'BEHAVIOURAL', 'rapid response'), (701, 753, 'BEHAVIOURAL', 'CBT-based individual intervention for rapid response'), (762, 768, 'BEHAVIOURAL', 'CBT-RR'), (833, 835, 'CONDITION', 'BN'), (840, 856, 'CONDITION', 'Purging Disorder'), (858, 860, 'CONDITION', 'PD'), (931, 937, 'BEHAVIOURAL', 'CBT-RR'), (960, 1016, 'CONTROL', 'matched-intensity augmentative motivational interviewing'), (1018, 1020, 'CONTROL', 'MI'), (1105, 1121, 'CONDITION', 'eating disorders'), (1385, 1387, 'CONTROL', 'MI'), (1410, 1416, 'BEHAVIOURAL', 'CBT-RR'), (1618, 1624, 'BEHAVIOURAL', 'CBT-RR'), (1970, 1986, 'CONDITION', 'eating disorders')]"
"['Oxidative', 'Stress', 'in', 'Sleep', 'Apnea', 'and', 'Cardiac', 'Disease', '|', 'Sleep', '-', 'disordered', 'breathing', '(', 'SDB', ')', 'is', 'a', 'condition', 'in', 'which', 'a', 'person', 'experiences', 'frequent', 'breathing', 'pauses', 'during', 'sleep', ',', 'also', 'known', 'as', 'sleep', 'apnea', '.', 'There', 'is', 'evidence', 'that', 'the', 'recurrent', 'sleep', 'arousal', 'and', 'associated', 'shortage', 'of', 'oxygen', 'in', 'the', 'body', 'may', 'increase', 'risk', 'for', 'cardiovascular', 'disease', '(', 'CVD', ')', '.', 'It', 'is', 'believed', 'that', 'treatment', 'with', 'continuous', 'positive', 'airway', 'pressure', '(', 'CPAP', ')', 'may', 'reduce', 'certain', 'risk', 'factors', 'for', 'heart', 'disease', ',', 'including', 'markers', 'of', 'inflammation', 'and', 'oxidative', 'stress', '.', 'This', 'study', 'will', 'evaluate', 'the', 'effectiveness', 'of', 'CPAP', 'in', 'reducing', 'CVD', 'risk', 'factors', 'in', 'people', 'with', 'SDB', '.']","['O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT00607893,NCT00607893,"Oxidative Stress in Sleep Apnea and Cardiac Disease | Sleep-disordered breathing (SDB) is a condition in which a person experiences frequent breathing pauses during sleep, also known as sleep apnea. There is evidence that the recurrent sleep arousal and associated shortage of oxygen in the body may increase risk for cardiovascular disease (CVD). It is believed that treatment with continuous positive airway pressure (CPAP) may reduce certain risk factors for heart disease, including markers of inflammation and oxidative stress. This study will evaluate the effectiveness of CPAP in reducing CVD risk factors in people with SDB.","[(20, 31, 'CONDITION', 'Sleep Apnea'), (36, 51, 'CONDITION', 'Cardiac Disease'), (54, 80, 'CONDITION', 'Sleep-disordered breathing'), (82, 85, 'CONDITION', 'SDB'), (186, 197, 'CONDITION', 'sleep apnea'), (318, 340, 'CONDITION', 'cardiovascular disease'), (342, 345, 'CONDITION', 'CVD'), (383, 418, 'OTHER', 'continuous positive airway pressure'), (420, 424, 'OTHER', 'CPAP'), (462, 475, 'CONDITION', 'heart disease'), (579, 583, 'OTHER', 'CPAP'), (596, 599, 'CONDITION', 'CVD'), (628, 631, 'CONDITION', 'SDB')]"
"['A', 'Phase', 'II', 'Multicenter', ',', 'Randomized', '-', 'Controlled', 'Study', 'to', 'Evaluate', 'the', 'Safety', 'and', 'Efficacy', 'of', 'Autologous', 'Incubated', 'Macrophages', 'for', 'the', 'Treatment', 'of', 'Patients', 'With', 'Complete', 'Spinal', 'Cord', 'Injuries', '|', 'Autologous', 'Incubated', 'Macrophages', '(', 'ProCord', ')', 'is', 'being', 'developed', 'as', 'a', 'therapy', 'for', 'acute', ',', 'complete', 'spinal', 'cord', 'injury', '(', 'SCI', ')', '.', 'The', 'therapy', 'is', 'intended', 'to', 'reverse', 'the', 'loss', 'of', 'motor', 'and', 'sensory', 'function', '.', '\n\n', 'Following', 'non', '-', 'CNS', 'tissue', 'injury', ',', 'macrophages', 'quickly', 'arrive', 'on', 'the', 'scene', ',', 'where', 'they', 'clean', 'up', 'cell', 'debris', ',', 'secrete', 'different', 'molecules', 'thus', 'promoting', 'a', 'controlled', 'inflammatory', 'reaction', 'that', 'forms', 'the', 'first', 'phase', 'of', 'the', 'wound', 'healing', 'process', '.', 'While', 'this', 'process', 'occurs', 'in', 'most', 'tissues', ',', 'including', 'peripheral', 'nerves', ',', 'it', 'does', 'not', 'occur', 'in', 'the', 'CNS', ',', 'where', 'macrophages', 'and', 'other', 'immune', 'cells', 'are', 'relatively', 'rare', ',', 'and', 'their', 'activities', 'curtailed', 'by', 'a', 'biochemical', 'mechanism', 'known', 'as', '""', 'immune', 'privilege', '.', '""', '\n\n', 'In', 'animal', 'studies', ',', 'it', 'appears', 'that', 'incubated', 'macrophages', 'circumvent', 'the', 'immune', 'privilege', ',', 'thus', 'supporting', 'the', 'regrowth', 'of', 'axons', 'through', 'the', 'injury', 'site', 'and', 'enabling', 'the', 'recovery', 'of', 'neurological', 'function', '.', 'The', 'concept', 'derives', 'from', 'the', 'pioneering', 'research', 'of', 'Prof.', 'Michal', 'Schwartz', 'at', 'the', 'Weizmann', 'Institute', 'of', 'Science', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-SURG', 'I-SURG', 'I-SURG', 'O', 'B-SURG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00073853,NCT00073853,"A Phase II Multicenter, Randomized-Controlled Study to Evaluate the Safety and Efficacy of Autologous Incubated Macrophages for the Treatment of Patients With Complete Spinal Cord Injuries | Autologous Incubated Macrophages (ProCord) is being developed as a therapy for acute, complete spinal cord injury (SCI). The therapy is intended to reverse the loss of motor and sensory function.

Following non-CNS tissue injury, macrophages quickly arrive on the scene, where they clean up cell debris, secrete different molecules thus promoting a controlled inflammatory reaction that forms the first phase of the wound healing process. While this process occurs in most tissues, including peripheral nerves, it does not occur in the CNS, where macrophages and other immune cells are relatively rare, and their activities curtailed by a biochemical mechanism known as ""immune privilege.""

In animal studies, it appears that incubated macrophages circumvent the immune privilege, thus supporting the regrowth of axons through the injury site and enabling the recovery of neurological function. The concept derives from the pioneering research of Prof. Michal Schwartz at the Weizmann Institute of Science.","[(91, 123, 'SURGICAL', 'Autologous Incubated Macrophages'), (159, 188, 'CONDITION', 'Complete Spinal Cord Injuries'), (191, 223, 'SURGICAL', 'Autologous Incubated Macrophages'), (225, 232, 'SURGICAL', 'ProCord'), (270, 304, 'CONDITION', 'acute, complete spinal cord injury'), (306, 309, 'CONDITION', 'SCI')]"
"['Leaving', 'the', 'Wheelchair', 'Behind', '-', 'Treating', 'CRPS', '-', 'II', 'With', 'Exposure', 'Therapy', 'Combined', 'With', 'Cortical', 'Interventions', ':', 'a', 'Series', 'of', 'Case', 'Reports', '|', 'Consecutive', 'patients', 'with', 'long', '-', 'standing', 'complex', 'regional', 'pain', 'syndrome', 'II', 'in', 'a', 'lower', 'limb', 'are', 'treated', 'with', 'graded', 'exposure', 'therapy', 'in', 'vivo', 'in', 'combination', 'with', 'methods', 'targeting', 'cortical', 'reorganisation', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O']",NCT03174249,NCT03174249,Leaving the Wheelchair Behind - Treating CRPS-II With Exposure Therapy Combined With Cortical Interventions: a Series of Case Reports | Consecutive patients with long-standing complex regional pain syndrome II in a lower limb are treated with graded exposure therapy in vivo in combination with methods targeting cortical reorganisation.,"[(41, 48, 'CONDITION', 'CRPS-II'), (54, 70, 'OTHER', 'Exposure Therapy'), (85, 107, 'OTHER', 'Cortical Interventions'), (176, 209, 'CONDITION', 'complex regional pain syndrome II'), (243, 266, 'OTHER', 'graded exposure therapy'), (295, 336, 'OTHER', 'methods targeting cortical reorganisation')]"
"['Perceptual', '-', 'Cognitive', 'Training', 'After', 'a', 'Mild', 'Traumatic', 'Brain', 'Injury', ':', 'Towards', 'a', 'Sensitive', 'Marker', 'for', 'Recovery', '|', 'This', 'study', 'is', 'part', 'of', 'a', 'larger', ',', 'multi', '-', 'centered', 'project', 'done', 'with', 'the', 'collaboration', 'of', 'University', 'Of', 'Victoria', '.', 'This', 'study', 'holds', 'three', 'separate', 'studies', 'on', 'the', 'mild', 'traumatic', 'brain', 'injured', 'population', 'and', 'the', 'use', 'of', 'perceptual', '-', 'cognitive', 'training', '(', '3D', '-', 'MOT', ')', '.']","['B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O']",NCT03213730,NCT03213730,"Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery | This study is part of a larger, multi-centered project done with the collaboration of University Of Victoria. This study holds three separate studies on the mild traumatic brain injured population and the use of perceptual-cognitive training (3D-MOT).","[(0, 29, 'BEHAVIOURAL', 'Perceptual-Cognitive Training'), (38, 65, 'CONDITION', 'Mild Traumatic Brain Injury'), (266, 294, 'CONDITION', 'mild traumatic brain injured'), (321, 350, 'BEHAVIOURAL', 'perceptual-cognitive training'), (352, 358, 'BEHAVIOURAL', '3D-MOT')]"
"['A', 'Long', '-', 'Term', 'Study', 'of', 'XP13512', 'Versus', 'Placebo', 'Treatment', 'Assessing', 'Maintenance', 'of', 'Efficacy', 'and', 'Safety', 'in', 'Patients', 'With', 'Restless', 'Legs', 'Syndrome', '.', '|', 'The', 'primary', 'objective', 'of', 'this', 'trial', 'is', 'to', 'assess', 'the', 'maintenance', 'of', 'efficacy', 'of', 'gabapentin', 'enacarbil', '(', 'GEn', ',', 'XP13512', ')', 'taken', 'once', 'daily', 'in', 'the', 'long', '-', 'term', 'treatment', 'of', 'patients', 'suffering', 'from', 'Restless', 'Legs', 'Syndrome', '(', 'RLS', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT00311363,NCT00311363,"A Long-Term Study of XP13512 Versus Placebo Treatment Assessing Maintenance of Efficacy and Safety in Patients With Restless Legs Syndrome. | The primary objective of this trial is to assess the maintenance of efficacy of gabapentin enacarbil (GEn, XP13512) taken once daily in the long-term treatment of patients suffering from Restless Legs Syndrome (RLS).","[(21, 28, 'DRUG', 'XP13512'), (36, 43, 'CONTROL', 'Placebo'), (116, 138, 'CONDITION', 'Restless Legs Syndrome'), (222, 242, 'DRUG', 'gabapentin enacarbil'), (244, 247, 'DRUG', 'GEn'), (249, 256, 'DRUG', 'XP13512'), (329, 351, 'CONDITION', 'Restless Legs Syndrome'), (353, 356, 'CONDITION', 'RLS')]"
"['Evaluation', 'of', 'Spa', 'Therapy', 'in', 'the', 'Treatment', 'of', 'Fibromyalgia', ':', 'a', 'Randomized', ',', 'Controlled', ',', 'Open', 'Multicenter', 'Study', '|', 'Fibromyalgia', 'is', 'a', 'common', 'health', 'problem', 'that', 'causes', 'widespread', 'pain', 'and', 'tenderness', '(', 'sensitive', 'to', 'touch', ')', '.', 'The', 'pain', 'and', 'tenderness', 'tend', 'to', 'come', 'and', 'go', ',', 'and', 'move', 'about', 'the', 'body', '.', 'There', 'is', 'no', 'cure', 'for', 'fibromyalgia', '.', 'Complementary', 'and', 'alternative', 'therapy', 'such', 'as', 'acupuncture', ',', 'chiropractic', 'and', 'massage', 'therapy', ',', 'can', 'be', 'useful', 'to', 'manage', 'fibromyalgia', 'symptoms', '.', 'Many', 'of', 'these', 'treatments', 'have', 'not', 'been', 'well', 'tested', 'in', 'patients', 'with', 'fibromyalgia', '.', 'Fibromyalgia', 'affect', '3', 'to', '4', '%', 'of', 'the', 'general', 'population', 'and', '14', '%', 'of', 'patients', 'with', 'rheumatologic', 'disease', '.', 'Fibromyalgia', 'is', 'most', 'common', 'in', 'women', '90', '%', 'in', 'many', 'studies', '.', 'It', 'most', 'often', 'starts', 'in', 'middle', 'adulthood', '.', 'A', 'chronic', 'evolution', 'occured', 'for', 'Fibromyalgic', 'patients', 'with', 'a', 'major', 'alteration', 'of', 'quality', 'of', 'life', '.', '\n\n', 'Thermalgi', 'is', 'a', 'randomized', ',', 'multicentre', ',', 'open', 'label', 'trial', 'wich', 'aims', 'to', 'evaluate', 'the', 'effects', 'of', 'spa', 'therapy', 'in', 'rheumatologia', 'on', 'evolution', 'of', 'disability', 'in', 'daily', 'life', 'of', 'patients', 'with', 'fibromyalgia', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT02265029,NCT02265029,"Evaluation of Spa Therapy in the Treatment of Fibromyalgia : a Randomized, Controlled, Open Multicenter Study | Fibromyalgia is a common health problem that causes widespread pain and tenderness (sensitive to touch). The pain and tenderness tend to come and go, and move about the body. There is no cure for fibromyalgia. Complementary and alternative therapy such as acupuncture, chiropractic and massage therapy, can be useful to manage fibromyalgia symptoms. Many of these treatments have not been well tested in patients with fibromyalgia. Fibromyalgia affect 3 to 4% of the general population and 14 % of patients with rheumatologic disease. Fibromyalgia is most common in women 90 % in many studies. It most often starts in middle adulthood. A chronic evolution occured for Fibromyalgic patients with a major alteration of quality of life.

Thermalgi is a randomized, multicentre, open label trial wich aims to evaluate the effects of spa therapy in rheumatologia on evolution of disability in daily life of patients with fibromyalgia.","[(14, 25, 'OTHER', 'Spa Therapy'), (46, 58, 'CONDITION', 'Fibromyalgia'), (112, 124, 'CONDITION', 'Fibromyalgia'), (175, 179, 'CONDITION', 'pain'), (184, 194, 'CONDITION', 'tenderness'), (221, 225, 'CONDITION', 'pain'), (230, 240, 'CONDITION', 'tenderness'), (308, 320, 'CONDITION', 'fibromyalgia'), (368, 379, 'OTHER', 'acupuncture'), (381, 393, 'OTHER', 'chiropractic'), (398, 413, 'OTHER', 'massage therapy'), (439, 451, 'CONDITION', 'fibromyalgia'), (530, 542, 'CONDITION', 'fibromyalgia'), (544, 556, 'CONDITION', 'Fibromyalgia'), (624, 645, 'CONDITION', 'rheumatologic disease'), (647, 659, 'CONDITION', 'Fibromyalgia'), (780, 792, 'CONDITION', 'Fibromyalgic'), (941, 952, 'OTHER', 'spa therapy'), (1028, 1040, 'CONDITION', 'fibromyalgia')]"
"['Impact', 'of', 'an', 'Orthotic', 'Garment', 'on', 'Gross', 'Motor', 'Skill', 'Acquisition', 'for', 'Infants', 'With', 'Down', 'Syndrome', '|', 'Infants', 'with', 'Down', 'syndrome', '(', 'DS', ')', 'develop', 'slower', 'than', 'their', 'typically', 'developing', 'peers', '.', 'Physical', 'therapist', '(', 'PT', ')', 'supervised', 'home', 'programs', 'have', 'the', 'potential', 'to', 'optimize', 'gross', 'motor', 'development', 'in', 'a', 'financially', 'feasible', 'way', '.', 'An', 'inexpensive', 'orthotic', 'garment', '(', 'Hip', 'Helpers', '짰', ')', 'is', 'commonly', 'employed', 'by', 'PTs', 'as', 'a', 'home', 'program', 'supplement', ',', 'but', 'its', 'effectiveness', 'has', 'not', 'yet', 'been', 'investigated', '.', 'The', 'garment', 'is', 'worn', 'as', 'pliable', 'shorts', 'over', 'a', 'child', ""'s"", 'lower', 'extremities', 'to', 'keep', 'upper', 'legs', 'together', ',', 'promoting', 'a', 'narrow', 'base', 'of', 'support', '.', 'This', 'encourages', 'activation', 'of', 'upright', 'postural', 'muscles', 'to', 'improve', 'gross', 'motor', 'skill', 'development', '.', 'The', 'purpose', 'of', 'this', 'randomized', 'controlled', 'study', 'is', 'to', 'investigate', 'the', 'impact', 'of', 'a', 'home', 'program', 'using', 'the', 'Hip', 'Helpers', '짰', 'orthotic', 'garment', 'on', 'gross', 'motor', 'skill', 'acquisition', 'in', 'infants', 'with', 'DS', '.', 'We', 'hypothesize', 'that', 'the', 'addition', 'of', 'a', 'structured', 'home', 'program', 'using', 'Hip', 'Helpers', '짰', ',', 'supervised', 'by', 'a', 'PT', 'and', 'implemented', 'by', 'parents', ',', 'will', 'increase', 'the', 'rate', 'at', 'which', 'infants', 'with', 'DS', 'acquire', 'gross', 'motor', 'skills', '.', 'Thirty', '-', 'four', 'participants', ',', 'consisting', 'of', 'children', 'who', 'are', 'at', 'least', 'three', '-', 'months', '-', 'old', 'and', 'are', 'not', 'yet', 'able', 'maintain', 'sitting', 'independently', ',', 'will', 'be', 'randomly', 'assigned', 'to', 'a', 'control', '(', 'n=17', ')', 'or', 'intervention', 'group', '(', 'n=17', ')', '.', 'PTs', 'at', 'pediatric', 'therapy', 'agencies', 'will', 'initiate', 'the', 'home', 'program', 'and', 'administer', 'the', 'Gross', 'Motor', 'Function', 'Measure-88', '(', 'GMFM-88', ')', 'at', 'regular', 'intervals', 'to', 'monitor', 'gross', 'motor', 'skill', 'acquisition', 'until', 'the', 'child', 'is', 'able', 'to', 'take', 'three', 'independent', 'steps', '.', 'Groups', 'will', 'be', 'compared', 'on', 'the', 'length', 'of', 'time', 'elapsed', 'between', 'the', 'acquisition', 'of', 'identified', 'gross', 'motor', 'skills', 'using', 'independent', 't', '-', 'tests', '.', 'GMFM-88', 'scores', 'will', 'be', 'compared', 'between', 'the', 'two', 'groups', 'at', 'different', 'ages', 'to', 'identify', 'trends', 'using', 'independent', 't', '-', 'tests', '.', 'The', 'contribution', 'of', 'this', 'project', 'will', 'be', 'significant', 'by', 'informing', 'physical', 'therapists', 'about', 'the', 'effectiveness', 'of', 'an', 'inexpensive', 'orthotic', 'garment', 'used', 'in', 'a', 'supervised', 'home', 'program', 'on', 'gross', 'motor', 'outcomes', 'in', 'infants', 'with', 'DS', '.']","['O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O']",NCT04603352,NCT04603352,"Impact of an Orthotic Garment on Gross Motor Skill Acquisition for Infants With Down Syndrome | Infants with Down syndrome (DS) develop slower than their typically developing peers. Physical therapist (PT) supervised home programs have the potential to optimize gross motor development in a financially feasible way. An inexpensive orthotic garment (Hip Helpers짰) is commonly employed by PTs as a home program supplement, but its effectiveness has not yet been investigated. The garment is worn as pliable shorts over a child's lower extremities to keep upper legs together, promoting a narrow base of support. This encourages activation of upright postural muscles to improve gross motor skill development. The purpose of this randomized controlled study is to investigate the impact of a home program using the Hip Helpers짰 orthotic garment on gross motor skill acquisition in infants with DS. We hypothesize that the addition of a structured home program using Hip Helpers짰, supervised by a PT and implemented by parents, will increase the rate at which infants with DS acquire gross motor skills. Thirty-four participants, consisting of children who are at least three-months-old and are not yet able maintain sitting independently, will be randomly assigned to a control (n=17) or intervention group (n=17). PTs at pediatric therapy agencies will initiate the home program and administer the Gross Motor Function Measure-88 (GMFM-88) at regular intervals to monitor gross motor skill acquisition until the child is able to take three independent steps. Groups will be compared on the length of time elapsed between the acquisition of identified gross motor skills using independent t-tests. GMFM-88 scores will be compared between the two groups at different ages to identify trends using independent t-tests. The contribution of this project will be significant by informing physical therapists about the effectiveness of an inexpensive orthotic garment used in a supervised home program on gross motor outcomes in infants with DS.","[(13, 29, 'OTHER', 'Orthotic Garment'), (80, 93, 'CONDITION', 'Down Syndrome'), (109, 122, 'CONDITION', 'Down syndrome'), (124, 126, 'CONDITION', 'DS'), (182, 230, 'PHYSICAL', 'Physical therapist (PT) supervised home programs'), (332, 348, 'OTHER', 'orthotic garment'), (350, 361, 'OTHER', 'Hip Helpers'), (397, 409, 'PHYSICAL', 'home program'), (790, 802, 'PHYSICAL', 'home program'), (813, 842, 'OTHER', 'Hip Helpers짰 orthotic garment'), (892, 894, 'CONDITION', 'DS'), (945, 957, 'PHYSICAL', 'home program'), (964, 975, 'OTHER', 'Hip Helpers'), (1070, 1072, 'CONDITION', 'DS'), (1268, 1275, 'CONTROL', 'control'), (1365, 1377, 'PHYSICAL', 'home program'), (1943, 1959, 'OTHER', 'orthotic garment'), (1981, 1993, 'PHYSICAL', 'home program'), (2034, 2036, 'CONDITION', 'DS')]"
"['Open', '-', 'label', 'Biomarker', 'Study', 'of', 'Rosuvastatin', '(', 'Crestor', ')', 'for', 'the', 'Treatment', 'of', 'Patients', 'With', 'Friedreich', 'Ataxia', '|', 'This', 'study', 'is', 'an', 'exploratory', 'open', '-', 'label', 'clinical', 'trial', 'of', 'Rosuvastatin', 'in', 'patients', 'with', 'Friedreich', 'ataxia', '(', 'FRDA', ')', '.', 'This', 'is', 'an', 'outpatient', 'trial', 'with', 'the', 'goal', 'of', 'enrolling', '10', 'evaluable', 'adults', 'with', 'genetically', 'confirmed', 'FRDA', 'who', 'are', 'between', 'the', 'ages', 'of', '18', '-', '65', '.', 'Subjects', 'will', 'receive', '10', 'mg', 'of', 'oral', 'Rosuvastatin', 'daily', 'for', 'three', 'months', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O']",NCT02705547,NCT02705547,Open-label Biomarker Study of Rosuvastatin (Crestor) for the Treatment of Patients With Friedreich Ataxia | This study is an exploratory open-label clinical trial of Rosuvastatin in patients with Friedreich ataxia (FRDA). This is an outpatient trial with the goal of enrolling 10 evaluable adults with genetically confirmed FRDA who are between the ages of 18-65. Subjects will receive 10mg of oral Rosuvastatin daily for three months.,"[(30, 42, 'DRUG', 'Rosuvastatin'), (44, 51, 'DRUG', 'Crestor'), (88, 105, 'CONDITION', 'Friedreich Ataxia'), (166, 178, 'DRUG', 'Rosuvastatin'), (196, 213, 'CONDITION', 'Friedreich ataxia'), (215, 219, 'CONDITION', 'FRDA'), (324, 328, 'CONDITION', 'FRDA'), (399, 411, 'DRUG', 'Rosuvastatin')]"
"['Accuracy', 'of', 'Pulse', 'Oximetry', 'to', 'Detect', 'Sleep', 'Apnea', 'in', 'Frail', 'Hospitalized', 'Patients', '|', 'Sleep', 'apnea', 'syndrome', 'is', 'common', 'and', 'increases', 'with', 'age', '.', 'In', 'the', 'elderly', ',', 'symptoms', 'might', 'be', 'different', 'than', 'in', 'the', 'youngest', 'people', ',', 'and', 'its', 'consequences', 'might', 'be', 'severe', 'and', 'atypical', '(', 'falls', ',', 'functional', 'and', 'cognitive', 'decline', ')', '.', '\n\n', 'Today', ',', 'there', 'is', 'no', 'specific', 'tool', 'to', 'detect', 'sleep', 'apnea', 'in', 'the', 'elderly', '.', 'The', 'goal', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'the', 'accuracy', 'of', 'oximetry', 'for', 'detection', 'of', 'respiratory', 'disturbances', 'in', 'sleep', 'apnea', 'in', 'the', 'hospitalized', 'elderly', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O']",NCT01294137,NCT01294137,"Accuracy of Pulse Oximetry to Detect Sleep Apnea in Frail Hospitalized Patients | Sleep apnea syndrome is common and increases with age. In the elderly, symptoms might be different than in the youngest people, and its consequences might be severe and atypical (falls, functional and cognitive decline).

Today, there is no specific tool to detect sleep apnea in the elderly. The goal of this study is to evaluate the accuracy of oximetry for detection of respiratory disturbances in sleep apnea in the hospitalized elderly.","[(37, 48, 'CONDITION', 'Sleep Apnea'), (82, 102, 'CONDITION', 'Sleep apnea syndrome'), (347, 358, 'CONDITION', 'sleep apnea'), (455, 479, 'CONDITION', 'respiratory disturbances'), (483, 494, 'CONDITION', 'sleep apnea')]"
"['Impacting', 'Children', ""'s"", 'Physical', 'and', 'Mental', 'Health', 'Through', 'Kinesiology', 'Support', 'in', 'Clinical', 'Care', '|', 'Over', 'the', 'past', 'four', 'decades', ',', 'it', 'has', 'become', 'clear', 'that', 'childhood', 'physical', 'activity', 'carries', 'with', 'it', 'a', 'myriad', 'of', 'beneficial', 'effects', '.', 'It', 'is', 'closely', 'linked', 'to', 'quality', 'of', 'life', 'and', 'the', 'recognized', 'benefits', 'include', ',', 'but', 'are', 'not', 'limited', 'to', ',', 'optimal', 'growth', 'and', 'development', ',', 'a', 'healthier', 'self', '-', 'concept', ',', 'enhanced', 'peer', 'socialization', ',', 'and', 'decreased', 'anxiety', 'and', 'depression', '.', 'Long', 'term', ',', 'an', 'active', 'lifestyle', 'decreases', 'the', 'risk', 'of', 'many', 'important', 'physical', 'and', 'mental', 'morbidities', '.', 'Thus', ',', 'the', 'observation', 'that', 'children', 'living', 'with', 'medical', 'conditions', 'and', 'disabilities', '(', 'MC&D', ')', 'today', ',', 'although', 'surviving', 'longer', 'thanks', 'to', 'advances', 'in', 'medical', 'care', ',', 'are', 'much', 'less', 'active', 'than', 'their', 'peers', 'is', 'a', 'matter', 'of', 'significant', 'concern', '.', 'Research', 'indicates', 'that', 'the', '350,000', 'Ontario', 'children', 'with', 'MC&D', 'have', 'lower', 'levels', 'of', 'physical', 'activity', ',', 'higher', 'screen', 'time', 'and', 'more', 'frequent', 'sleep', 'problems', '.', '\n\n', 'While', 'the', 'reasons', 'underlying', 'this', 'reality', 'are', 'complex', ',', 'previous', 'research', 'has', 'identified', 'a', 'substantial', 'subset', 'of', 'children', 'who', 'are', 'motivated', 'to', 'be', 'active', 'but', 'lack', 'the', 'confidence', 'to', 'do', 'so', '.', 'Fear', 'of', 'pain', ',', 'concern', 'for', 'MC&D', 'exacerbation', 'and', 'a', 'lack', 'of', 'confidence', 'in', 'individual', 'physical', 'movement', 'capacity', 'contribute', 'to', 'their', 'hesitation', '.', 'Clinical', 'experience', 'suggests', 'that', 'these', 'children', 'represent', '50', '%', 'to', '70', '%', 'of', 'inactive', 'patients', '.', 'Research', 'indicates', 'that', 'being', 'motivated', 'to', 'make', 'a', 'change', 'and', 'having', 'the', 'confidence', 'that', 'the', 'desired', 'change', 'can', 'be', 'achieved', 'are', 'the', 'essential', 'precursors', 'upon', 'which', 'successful', 'behaviour', 'change', 'initiatives', 'are', 'built', '.', 'This', 'randomized', ',', 'controlled', 'trial', 'will', 'explore', 'whether', 'group', 'sessions', 'with', 'a', 'Registered', 'Kinesiologist', 'lead', 'to', 'a', 'direct', 'bolstering', 'of', 'physical', 'activity', 'confidence', ',', 'and', 'in', 'turn', 'to', 'increased', 'and', 'sustained', 'physical', 'activity', 'in', 'these', 'children', '.', 'Such', 'an', 'approach', 'holds', 'the', 'promise', 'of', 'a', 'nonpharmacologic', ',', 'low', 'cost', 'and', 'accessible', 'means', 'of', 'enhancing', 'health', 'that', 'shall', 'be', 'met', 'with', 'a', 'high', 'level', 'of', 'patient', 'and', 'family', 'support', 'while', 'bringing', 'a', 'significant', 'societal', 'and', 'medical', 'return', 'on', 'investment', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04106154,NCT04106154,"Impacting Children's Physical and Mental Health Through Kinesiology Support in Clinical Care | Over the past four decades, it has become clear that childhood physical activity carries with it a myriad of beneficial effects. It is closely linked to quality of life and the recognized benefits include, but are not limited to, optimal growth and development, a healthier self-concept, enhanced peer socialization, and decreased anxiety and depression. Long term, an active lifestyle decreases the risk of many important physical and mental morbidities. Thus, the observation that children living with medical conditions and disabilities (MC&D) today, although surviving longer thanks to advances in medical care, are much less active than their peers is a matter of significant concern. Research indicates that the 350,000 Ontario children with MC&D have lower levels of physical activity, higher screen time and more frequent sleep problems.

While the reasons underlying this reality are complex, previous research has identified a substantial subset of children who are motivated to be active but lack the confidence to do so. Fear of pain, concern for MC&D exacerbation and a lack of confidence in individual physical movement capacity contribute to their hesitation. Clinical experience suggests that these children represent 50% to 70% of inactive patients. Research indicates that being motivated to make a change and having the confidence that the desired change can be achieved are the essential precursors upon which successful behaviour change initiatives are built. This randomized, controlled trial will explore whether group sessions with a Registered Kinesiologist lead to a direct bolstering of physical activity confidence, and in turn to increased and sustained physical activity in these children. Such an approach holds the promise of a nonpharmacologic, low cost and accessible means of enhancing health that shall be met with a high level of patient and family support while bringing a significant societal and medical return on investment.","[(56, 75, 'PHYSICAL', 'Kinesiology Support'), (1631, 1677, 'PHYSICAL', 'group sessions with a Registered Kinesiologist')]"
"['A', 'Comparison', 'Between', 'Two', 'Different', 'Oral', 'Appliance', 'Therapies', ':', 'Somnodent', 'vs', 'Herbst', 'Appliance', 'in', 'Patients', 'With', 'Mild', 'and', 'Moderate', 'OSA', '|', 'Obstructive', 'sleep', 'apnea', '(', 'OSA', ')', 'is', 'a', 'common', 'chronic', 'sleep', 'disorder', 'that', 'often', 'requires', 'lifelong', 'care', '.', 'The', 'prevalence', 'in', 'the', 'Netherlands', 'is', 'estimated', 'around', '300.000', 'patients', '.', 'Due', 'to', 'longer', 'life', 'expectancy', 'and', 'increase', 'in', 'weight', 'in', 'the', 'general', 'population', ',', 'its', 'prevalence', 'is', 'expected', 'to', 'rise', '.', 'Patients', 'with', 'mild', 'and', 'moderate', 'OSA', 'are', 'treated', 'primarily', 'with', 'an', 'oral', 'appliance', 'at', 'present', 'time', '.', 'Different', 'oral', 'appliances', 'are', 'available', ',', 'but', 'most', 'used', 'is', 'the', 'mandibular', 'advancement', 'device', '(', 'MAD', ')', '.', 'This', 'study', 'focuses', 'on', 'two', 'different', 'types', 'of', 'MAD', ':', 'the', 'classic', 'Herbst', 'appliance', ',', 'which', 'is', 'attached', 'to', 'the', 'mandible', 'and', 'the', 'maxilla', 'and', 'has', 'an', 'iron', 'bar', 'to', 'regulate', 'the', 'open', 'space', ';', 'and', 'the', 'Somnodent', ',', 'which', 'consists', 'of', 'two', 'separate', 'splints', ',', 'fixed', 'on', 'the', 'mandible', 'and', 'the', 'maxilla', ',', 'but', 'has', 'no', 'iron', 'bar', 'attached', '.']","['O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02724865,NCT02724865,"A Comparison Between Two Different Oral Appliance Therapies: Somnodent vs Herbst Appliance in Patients With Mild and Moderate OSA | Obstructive sleep apnea (OSA) is a common chronic sleep disorder that often requires lifelong care. The prevalence in the Netherlands is estimated around 300.000 patients. Due to longer life expectancy and increase in weight in the general population, its prevalence is expected to rise. Patients with mild and moderate OSA are treated primarily with an oral appliance at present time. Different oral appliances are available, but most used is the mandibular advancement device (MAD). This study focuses on two different types of MAD: the classic Herbst appliance, which is attached to the mandible and the maxilla and has an iron bar to regulate the open space; and the Somnodent, which consists of two separate splints, fixed on the mandible and the maxilla, but has no iron bar attached.","[(35, 59, 'OTHER', 'Oral Appliance Therapies'), (61, 70, 'OTHER', 'Somnodent'), (74, 90, 'OTHER', 'Herbst Appliance'), (108, 129, 'CONDITION', 'Mild and Moderate OSA'), (132, 155, 'CONDITION', 'Obstructive sleep apnea'), (157, 160, 'CONDITION', 'OSA'), (434, 455, 'CONDITION', 'mild and moderate OSA'), (486, 500, 'OTHER', 'oral appliance'), (528, 543, 'OTHER', 'oral appliances'), (580, 609, 'OTHER', 'mandibular advancement device'), (611, 614, 'OTHER', 'MAD'), (662, 665, 'OTHER', 'MAD'), (679, 695, 'OTHER', 'Herbst appliance'), (803, 812, 'OTHER', 'Somnodent')]"
"['Effects', 'of', 'Mechanical', 'Insufflation', '-', 'exsufflation', 'in', 'Stroke', 'Patients', 'With', 'Dysphagia', '-', 'Pilot', 'Study', '|', 'Stroke', 'patients', 'with', 'dysphagia', 'have', 'restrictive', 'lung', 'dysfunction', 'and', 'impaired', 'cough', 'response', '.', 'This', 'pilot', 'study', 'was', 'performed', 'to', 'determine', 'if', 'Mechanical', 'Insufflation', 'Exsufflation', '(', 'MIE', ')', 'therapy', 'can', 'help', 'recover', 'impaired', 'cough', 'function', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O']",NCT02080806,NCT02080806,Effects of Mechanical Insufflation-exsufflation in Stroke Patients With Dysphagia - Pilot Study | Stroke patients with dysphagia have restrictive lung dysfunction and impaired cough response. This pilot study was performed to determine if Mechanical Insufflation Exsufflation (MIE) therapy can help recover impaired cough function.,"[(11, 47, 'OTHER', 'Mechanical Insufflation-exsufflation'), (51, 57, 'CONDITION', 'Stroke'), (72, 81, 'CONDITION', 'Dysphagia'), (98, 104, 'CONDITION', 'Stroke'), (119, 128, 'CONDITION', 'dysphagia'), (146, 162, 'CONDITION', 'lung dysfunction'), (167, 190, 'CONDITION', 'impaired cough response'), (239, 275, 'OTHER', 'Mechanical Insufflation Exsufflation'), (277, 280, 'OTHER', 'MIE'), (307, 330, 'CONDITION', 'impaired cough function')]"
"['The', 'Impact', 'of', 'Three', 'Distinct', 'Exercise', 'Types', 'on', 'Fatigue', ',', 'Anxiety', ',', 'and', 'Depression', 'in', 'Parkinson', ""'s"", 'Disease', '|', 'The', 'purpose', 'of', 'the', 'study', 'is', 'to', 'learn', 'about', 'the', 'impact', 'of', 'exercise', 'on', 'fatigue', ',', 'anxiety', ',', 'and', 'depression', 'in', 'Parkinson', ""'s"", 'disease', '.', 'It', 'is', 'well', 'established', 'that', 'exercise', 'improves', 'the', 'motor', 'symptoms', 'of', 'Parkinson', ""'s"", 'disease', '.', 'However', ',', 'it', 'is', 'not', 'clear', 'which', 'types', 'of', 'exercise', 'are', 'most', 'beneficial', 'for', 'specific', 'non', '-', 'motor', 'symptoms', '.']","['O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'B-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02885285,NCT02885285,"The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease | The purpose of the study is to learn about the impact of exercise on fatigue, anxiety, and depression in Parkinson's disease. It is well established that exercise improves the motor symptoms of Parkinson's disease. However, it is not clear which types of exercise are most beneficial for specific non-motor symptoms.","[(29, 37, 'PHYSICAL', 'Exercise'), (47, 54, 'CONDITION', 'Fatigue'), (56, 63, 'CONDITION', 'Anxiety'), (69, 79, 'CONDITION', 'Depression'), (83, 102, 'CONDITION', ""Parkinson's Disease""), (162, 170, 'PHYSICAL', 'exercise'), (174, 181, 'CONDITION', 'fatigue'), (183, 190, 'CONDITION', 'anxiety'), (196, 206, 'CONDITION', 'depression'), (210, 229, 'CONDITION', ""Parkinson's disease""), (259, 267, 'PHYSICAL', 'exercise'), (299, 318, 'CONDITION', ""Parkinson's disease""), (360, 368, 'PHYSICAL', 'exercise')]"
"['A', 'Randomized', ',', 'Open', 'Label', 'Clinical', 'Trial', 'of', 'Sustained', 'Hypernatremia', 'for', 'the', 'Prevention', 'and', 'Treatment', 'of', 'Cerebral', 'Edema', 'in', 'Traumatic', 'Brain', 'Injury', '|', 'Cerebral', 'edema', 'is', 'seen', 'heterogenous', 'group', 'of', 'neurological', 'disease', 'states', 'that', 'mainly', 'fall', 'under', 'the', 'categories', 'of', 'metabolic', ',', 'infectious', ',', 'neoplasia', ',', 'cerebrovascular', ',', 'and', 'traumatic', 'brain', 'injury', 'disease', 'states', '.', 'Regardless', 'of', 'the', 'driving', 'force', ',', 'cerebral', 'edema', 'is', 'defined', 'as', 'the', 'accumulation', 'of', 'fluid', 'in', 'the', 'brain', ""'s"", 'intracellular', 'and', 'extracellular', 'spaces', '.', 'This', 'occurs', 'secondary', 'to', 'alterations', 'in', 'the', 'complex', 'interplay', 'between', 'four', 'distinct', 'fluid', 'compartments', 'within', 'the', 'cranium', '.', 'In', 'any', 'human', 'cranium', ';', 'fluid', 'is', 'contained', 'in', 'the', 'blood', ',', 'the', 'cerebrospinal', 'fluid', ',', 'interstitial', 'fluid', 'of', 'the', 'brain', 'parenchyma', ',', 'and', 'the', 'intracellular', 'fluid', 'of', 'the', 'neurons', 'and', 'glia', '.', 'Fluid', 'movement', 'occurs', 'normally', 'between', 'these', 'compartments', 'and', 'depends', 'on', 'specific', 'concentrations', 'of', 'solutes', '(', 'such', 'as', 'sodium', ')', 'and', 'water', '.', 'In', 'brain', '-', 'injured', 'states', ',', 'the', 'normal', 'regulation', 'of', 'this', 'process', 'is', 'disturbed', 'and', 'cerebral', 'edema', 'can', 'develop', '.', 'Cerebral', 'edema', 'leads', 'to', 'increased', 'intracranial', 'pressure', 'and', 'mortality', 'secondary', 'to', 'brain', 'tissue', 'compression', ',', 'given', 'the', 'confines', 'of', 'the', 'fixed', '-', 'volume', 'cranium', '.', 'Additionally', ',', 'secondary', 'neuronal', 'dysfunction', 'or', 'death', 'can', 'occur', 'at', 'the', 'cellular', 'level', 'secondary', 'to', 'the', 'disruption', 'of', 'ion', 'gradients', 'that', 'control', 'metabolism', 'and', 'function', '.', '\n\n', 'While', 'studies', 'utilizing', 'bolus', 'dosing', 'of', 'hyperosmolar', 'therapy', 'to', 'target', 'signs', 'or', 'symptoms', 'of', 'increased', 'intracranial', 'pressure', 'secondary', 'to', 'cerebral', 'edema', 'are', 'numerous', ',', 'there', 'is', 'a', 'paucity', 'of', 'studies', 'relating', 'to', 'continuous', 'infusion', 'of', 'hyperosmolar', 'therapy', 'for', 'targeted', 'sustained', 'hypernatremia', 'for', 'the', 'prevention', 'and', 'treatment', 'of', 'cerebral', 'edema', '.', 'The', 'investigators', 'hypothesize', 'that', 'induced', ',', 'sustained', 'hypernatremia', 'following', 'traumatic', 'brain', 'injury', 'will', 'decrease', 'the', 'rate', 'of', 'cerebral', 'edema', 'formation', 'and', 'improve', 'patient', 'outcomes', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O']",NCT01605357,NCT01605357,"A Randomized, Open Label Clinical Trial of Sustained Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury | Cerebral edema is seen heterogenous group of neurological disease states that mainly fall under the categories of metabolic, infectious, neoplasia, cerebrovascular, and traumatic brain injury disease states. Regardless of the driving force, cerebral edema is defined as the accumulation of fluid in the brain's intracellular and extracellular spaces. This occurs secondary to alterations in the complex interplay between four distinct fluid compartments within the cranium. In any human cranium; fluid is contained in the blood, the cerebrospinal fluid, interstitial fluid of the brain parenchyma, and the intracellular fluid of the neurons and glia. Fluid movement occurs normally between these compartments and depends on specific concentrations of solutes (such as sodium) and water. In brain-injured states, the normal regulation of this process is disturbed and cerebral edema can develop. Cerebral edema leads to increased intracranial pressure and mortality secondary to brain tissue compression, given the confines of the fixed-volume cranium. Additionally, secondary neuronal dysfunction or death can occur at the cellular level secondary to the disruption of ion gradients that control metabolism and function.

While studies utilizing bolus dosing of hyperosmolar therapy to target signs or symptoms of increased intracranial pressure secondary to cerebral edema are numerous, there is a paucity of studies relating to continuous infusion of hyperosmolar therapy for targeted sustained hypernatremia for the prevention and treatment of cerebral edema. The investigators hypothesize that induced, sustained hypernatremia following traumatic brain injury will decrease the rate of cerebral edema formation and improve patient outcomes.","[(43, 66, 'OTHER', 'Sustained Hypernatremia'), (103, 117, 'CONDITION', 'Cerebral Edema'), (121, 143, 'CONDITION', 'Traumatic Brain Injury'), (146, 160, 'CONDITION', 'Cerebral edema'), (315, 337, 'CONDITION', 'traumatic brain injury'), (387, 401, 'CONDITION', 'cerebral edema'), (936, 949, 'CONDITION', 'brain-injured'), (1013, 1027, 'CONDITION', 'cerebral edema'), (1041, 1055, 'CONDITION', 'Cerebral edema'), (1505, 1519, 'CONDITION', 'cerebral edema'), (1599, 1619, 'OTHER', 'hyperosmolar therapy'), (1633, 1656, 'OTHER', 'sustained hypernatremia'), (1693, 1707, 'CONDITION', 'cerebral edema'), (1753, 1776, 'OTHER', 'sustained hypernatremia'), (1787, 1809, 'CONDITION', 'traumatic brain injury'), (1836, 1850, 'CONDITION', 'cerebral edema')]"
"['Molecular', 'Profile', 'of', 'the', 'Evolution', 'of', 'Inclusion', 'Body', 'Myositis', '|', 'This', 'study', 'aims', 'at', 'assessing', 'the', 'gene', 'expression', 'in', 'the', 'muscles', 'of', 'patients', 'suffering', 'from', 'sporadic', 'Inclusion', 'Body', 'Myositis', '(', 'sIBM', ')', 'at', 'various', 'stages', 'of', 'the', 'disease', ',', 'by', 'comparison', 'with', 'muscles', 'of', 'control', 'subject', '.', 'The', 'investigators', 'use', 'the', 'RNA', '-', 'seq', 'technique', 'to', 'analyze', 'the', 'gene', 'expression', 'levels', 'and', 'potential', 'alternate', 'transcripts', ',', 'including', 'long', 'non', '-', 'coding', 'RNAs', '(', 'lncRNAs', ')', ',', 'in', 'muscle', 'tissue', 'samples', '.', 'The', 'gene', 'expression', 'profiles', 'will', 'point', 'to', 'the', 'genes', 'of', 'interest', 'that', 'can', 'then', 'become', 'the', 'object', 'of', 'future', 'studies', ',', 'in', 'which', 'epigenetic', 'changes', 'of', 'these', 'genes', 'will', 'be', 'explored', 'further', '.', 'The', 'value', 'of', 'those', 'possible', 'biomarkers', 'will', 'be', 'assessed', '.', 'The', 'investigators', 'will', 'also', 'evaluate', 'the', 'correlation', 'between', 'the', 'gene', 'expression', 'profile', ',', 'the', 'degree', 'of', 'functional', 'impairment', ',', 'the', 'histological', 'picture', 'and', 'the', 'presence', 'or', 'absence', 'of', 'autoantibodies', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03299335,NCT03299335,"Molecular Profile of the Evolution of Inclusion Body Myositis | This study aims at assessing the gene expression in the muscles of patients suffering from sporadic Inclusion Body Myositis (sIBM) at various stages of the disease, by comparison with muscles of control subject. The investigators use the RNA-seq technique to analyze the gene expression levels and potential alternate transcripts, including long non-coding RNAs (lncRNAs), in muscle tissue samples. The gene expression profiles will point to the genes of interest that can then become the object of future studies, in which epigenetic changes of these genes will be explored further. The value of those possible biomarkers will be assessed. The investigators will also evaluate the correlation between the gene expression profile, the degree of functional impairment, the histological picture and the presence or absence of autoantibodies.","[(38, 61, 'CONDITION', 'Inclusion Body Myositis'), (155, 187, 'CONDITION', 'sporadic Inclusion Body Myositis'), (189, 193, 'CONDITION', 'sIBM')]"
"['Feasibility', 'and', 'Effectiveness', 'of', 'a', 'Specific', 'App', 'to', 'Delivery', 'Mindfulness', 'Sessions', 'to', 'Patients', 'With', 'Different', 'Kinds', 'of', 'Pain', 'Condition', ':', 'a', 'Pilot', 'Study', '|', 'A', 'standardized', 'behavioural', 'approach', 'based', 'on', 'mindfulness', 'delivered', 'mainly', 'by', 'a', 'specific', 'APP', 'on', 'android', 'will', 'be', 'developed', 'and', 'applied', 'for', 'patients', 'with', 'chronic', 'pain', 'conditions', ',', 'as', 'migraine', 'and', 'neuropathic', 'pain', '.', '\n\n', 'The', 'aim', 'of', 'this', 'pilot', 'study', ':', '\n\n', 'The', 'investigators', 'propose', 'a', 'pilot', 'study', 'to', 'enforce', 'the', 'application', 'of', 'a', 'Home', '-', 'program', 'for', 'patients', 'with', 'different', 'pain', 'conditions', ',', 'to', 'learn', 'mindfulness', 'practice', ',', 'added', 'to', 'a', 'regular', 'mindfulness', 'guided', 'face', '-', 'to', '-', 'face', 'program', ',', 'by', 'using', 'the', 'technology', 'with', 'android', 'to', 'receive', 'mindfulness', 'sessions', 'for', 'daily', 'practice', 'and', 'to', 'assess', 'the', 'feasibility', 'and', 'the', 'effectiveness', 'of', 'behavioural', 'approach', 'base', 'on', 'mindfulness', 'delivered', 'with', 'this', 'modality', '.']","['O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'O']",NCT05101837,NCT05101837,"Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions to Patients With Different Kinds of Pain Condition: a Pilot Study | A standardized behavioural approach based on mindfulness delivered mainly by a specific APP on android will be developed and applied for patients with chronic pain conditions, as migraine and neuropathic pain.

The aim of this pilot study:

The investigators propose a pilot study to enforce the application of a Home-program for patients with different pain conditions, to learn mindfulness practice, added to a regular mindfulness guided face-to-face program, by using the technology with android to receive mindfulness sessions for daily practice and to assess the feasibility and the effectiveness of behavioural approach base on mindfulness delivered with this modality.","[(35, 80, 'OTHER', 'Specific App to Delivery Mindfulness Sessions'), (117, 121, 'CONDITION', 'Pain'), (194, 240, 'OTHER', 'mindfulness delivered mainly by a specific APP'), (300, 312, 'CONDITION', 'chronic pain'), (328, 336, 'CONDITION', 'migraine'), (341, 357, 'CONDITION', 'neuropathic pain'), (462, 474, 'BEHAVIOURAL', 'Home-program'), (503, 507, 'CONDITION', 'pain'), (529, 540, 'BEHAVIOURAL', 'mindfulness'), (570, 609, 'BEHAVIOURAL', 'mindfulness guided face-to-face program'), (659, 670, 'BEHAVIOURAL', 'mindfulness'), (783, 794, 'BEHAVIOURAL', 'mindfulness')]"
"['A', 'Double', '-', 'blind', ',', 'Double', '-', 'dummy', ',', 'Randomised', ',', 'Placebo', '-', 'controlled', ',', 'Four', '-', 'way', 'Crossover', 'Study', 'to', 'Investigate', 'the', 'Effect', 'of', 'Single', 'Oral', 'Doses', 'of', 'SB-649868', 'and', 'of', 'Zolpidem', 'in', 'a', 'Model', 'of', 'Noise', 'Induced', 'Situational', 'Insomnia', 'in', 'Healthy', 'Male', 'Volunteers', '.', '|', 'Subjects', 'will', 'be', 'screened', 'within', '28', 'days', '.', 'Each', 'treatment', 'session', 'will', 'consist', 'of', '2', 'PSG', 'nights', ',', 'study', 'drug', 'administration', 'and', 'noise', 'model', 'is', 'conducted', 'on', 'second', 'night', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00440323,NCT00440323,"A Double-blind, Double-dummy, Randomised, Placebo-controlled,Four-way Crossover Study to Investigate the Effect of Single Oral Doses of SB-649868 and of Zolpidem in a Model of Noise Induced Situational Insomnia in Healthy Male Volunteers. | Subjects will be screened within 28 days. Each treatment session will consist of 2 PSG nights, study drug administration and noise model is conducted on second night.","[(42, 49, 'CONTROL', 'Placebo'), (136, 145, 'DRUG', 'SB-649868'), (153, 161, 'DRUG', 'Zolpidem'), (176, 210, 'CONDITION', 'Noise Induced Situational Insomnia')]"
"['Collaborative', 'Care', 'for', 'Anxiety', 'and', 'Depression', 'in', 'Posttraumatic', 'Epilepsy', '|', 'The', 'purpose', 'of', 'this', 'research', 'is', 'to', 'evaluate', 'a', '6', 'month', 'change', 'in', 'quality', 'of', 'life', 'in', 'subjects', 'who', 'receive', 'collaborative', 'care', 'calls', 'compared', 'to', 'those', 'subjects', 'who', 'receive', 'usual', 'neurology', 'care', '.', 'This', 'is', 'a', '2', '-', 'site', 'trial', 'comparing', 'a', '24', 'week', 'neurology', '-', 'based', 'collaborative', 'care', 'program', 'to', 'usual', 'neurology', 'care', 'among', 'a', 'total', 'of', '60', 'adults', 'with', 'post', '-', 'traumatic', 'epilepsy', '.']","['B-OTHER', 'I-OTHER', 'O', 'B-COND', 'O', 'B-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT05353452,NCT05353452,Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy | The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.,"[(0, 18, 'OTHER', 'Collaborative Care'), (23, 30, 'CONDITION', 'Anxiety'), (35, 45, 'CONDITION', 'Depression'), (49, 71, 'CONDITION', 'Posttraumatic Epilepsy'), (178, 196, 'OTHER', 'collaborative care'), (242, 262, 'OTHER', 'usual neurology care'), (307, 341, 'OTHER', 'neurology-based collaborative care'), (353, 373, 'OTHER', 'usual neurology care'), (406, 429, 'CONDITION', 'post-traumatic epilepsy')]"
"['Target', 'Controlled', 'Infusion', 'of', 'Etomidate', 'or', 'Propofol', 'for', 'Anesthesia', 'of', 'Thoracoscopic', 'Mitral', 'Valve', 'Replacement', 'Surgery', ',', 'A', 'Randomized', 'Controlled', 'Double', '-', 'Blinded', 'Study', '|', 'For', 'patients', 'requiring', 'the', 'heart', 'valve', 'replacement', 'surgery', ',', 'heart', 'function', 'is', 'injured', 'in', 'different', 'degree', '.', 'Thus', ',', 'minimizing', 'the', 'impact', 'of', 'the', 'anesthesia', 'drug', 'on', 'the', 'cardiovascular', 'system', 'has', 'important', 'clinical', 'meanings', '.', 'Etomidate', 'has', 'slight', 'effect', 'on', 'the', 'cardiovascular', 'system', ',', 'often', 'used', 'in', 'the', 'induction', 'of', 'anesthesia', ',', 'however', 'target', 'controlled', 'infusion', 'etomidate', 'in', 'maintenance', 'of', 'anesthesia', 'is', 'less', 'used', '.', 'So', ',', 'the', 'trial', 'is', 'designed', 'to', 'observe', 'the', 'application', 'value', 'of', 'TCI', 'etomidate', 'in', 'thoracoscopic', 'mitral', 'valve', 'replacement', 'surgery', '.']","['O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O']",NCT02644980,NCT02644980,"Target Controlled Infusion of Etomidate or Propofol for Anesthesia of Thoracoscopic Mitral Valve Replacement Surgery,A Randomized Controlled Double-Blinded Study | For patients requiring the heart valve replacement surgery, heart function is injured in different degree.Thus, minimizing the impact of the anesthesia drug on the cardiovascular system has important clinical meanings. Etomidate has slight effect on the cardiovascular system, often used in the induction of anesthesia, however target controlled infusion etomidate in maintenance of anesthesia is less used. So, the trial is designed to observe the application value of TCI etomidate in thoracoscopic mitral valve replacement surgery.","[(30, 39, 'DRUG', 'Etomidate'), (43, 51, 'DRUG', 'Propofol'), (70, 108, 'CONDITION', 'Thoracoscopic Mitral Valve Replacement'), (191, 214, 'CONDITION', 'heart valve replacement'), (383, 392, 'DRUG', 'Etomidate'), (519, 528, 'DRUG', 'etomidate'), (638, 647, 'DRUG', 'etomidate'), (651, 689, 'CONDITION', 'thoracoscopic mitral valve replacement')]"
"['Fingolimod', 'as', 'a', 'Treatment', 'of', 'Cerebral', 'Edema', 'After', 'Intracerebral', 'Hemorrhage', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'test', 'the', 'safety', 'and', 'effectiveness', 'of', 'a', 'single', 'dose', 'of', 'fingolimod', 'in', 'patients', 'with', 'primary', 'spontaneous', 'intracerebral', 'hemorrhage', '(', 'ICH', ')', '.']","['B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT04088630,NCT04088630,Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage | The purpose of this study is to test the safety and effectiveness of a single dose of fingolimod in patients with primary spontaneous intracerebral hemorrhage (ICH).,"[(0, 10, 'DRUG', 'Fingolimod'), (29, 43, 'CONDITION', 'Cerebral Edema'), (50, 74, 'CONDITION', 'Intracerebral Hemorrhage'), (163, 173, 'DRUG', 'fingolimod'), (191, 235, 'CONDITION', 'primary spontaneous intracerebral hemorrhage'), (237, 240, 'CONDITION', 'ICH')]"
"['A', 'Phase', '3', ',', 'Randomized', ',', 'Double', '-', 'Blind', ',', 'Placebo', '-', 'Controlled', ',', 'Parallel', ',', 'Fixed', '-', 'Dose', 'Study', 'to', 'Assess', 'the', 'Efficacy', ',', 'Safety', ',', 'and', 'Tolerability', 'of', 'NBI-98854', 'for', 'the', 'Treatment', 'of', 'Tardive', 'Dyskinesia', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'the', 'efficacy', ',', 'safety', ',', 'and', 'tolerability', 'of', 'NBI-98854', 'administered', 'once', 'daily', 'for', 'the', 'treatment', 'of', 'Tardive', 'Dyskinesia', '(', 'TD', ')', 'symptoms', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'O']",NCT02274558,NCT02274558,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of NBI-98854 for the Treatment of Tardive Dyskinesia | The purpose of this study is to evaluate the efficacy, safety, and tolerability of NBI-98854 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.","[(37, 44, 'CONTROL', 'Placebo'), (136, 145, 'DRUG', 'NBI-98854'), (167, 185, 'CONDITION', 'Tardive Dyskinesia'), (271, 280, 'DRUG', 'NBI-98854'), (326, 344, 'CONDITION', 'Tardive Dyskinesia'), (346, 348, 'CONDITION', 'TD')]"
"['Electro', 'Physiological', 'Responses', 'to', 'Kabat', 'Motor', 'Control', 'Re', '-', 'education', 'on', 'Bell', ""'s"", 'Palsy', ':', 'A', 'Randomized', 'Controlled', 'Study', '|', 'To', 'investigate', 'the', 'Effect', 'of', 'Kabat', 'motor', 'control', 're', '-', 'education', 'therapy', 'on', 'facial', 'nerve', 'Electro', 'physiological', 'responses', 'and', 'facial', 'muscles', 'function', 'in', 'bell', ""'s"", 'palsy', '.', '\n\n', 'BACKGROUND', ':', 'facial', 'nerve', 'recovery', 'in', 'children', 'could', 'be', 'improved', 'through', 'facilitation', 'of', 'nerve', 'regeneration', 'which', 'can', 'be', 'enhanced', 'through', 'Kabat', 'motor', 'control', 're', '-', 'education', 'therapy', '.']","['O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O']",NCT04894513,NCT04894513,"Electro Physiological Responses to Kabat Motor Control Re-education on Bell's Palsy: A Randomized Controlled Study | To investigate the Effect of Kabat motor control re-education therapy on facial nerve Electro physiological responses and facial muscles function in bell's palsy.

BACKGROUND: facial nerve recovery in children could be improved through facilitation of nerve regeneration which can be enhanced through Kabat motor control re-education therapy.","[(35, 67, 'PHYSICAL', 'Kabat Motor Control Re-education'), (71, 83, 'CONDITION', ""Bell's Palsy""), (146, 186, 'PHYSICAL', 'Kabat motor control re-education therapy'), (266, 278, 'CONDITION', ""bell's palsy""), (418, 458, 'PHYSICAL', 'Kabat motor control re-education therapy')]"
"['Comparison', 'of', 'Aquatic', 'and', 'Land', '-', 'based', 'Group', 'Exercise', 'for', 'Individuals', 'With', 'Parkinson', 'Disease', '|', 'This', 'study', 'will', 'investigate', 'the', 'impact', 'of', 'land', 'based', 'or', 'aquatic', 'based', 'group', 'exercise', 'on', 'the', 'balance', ',', 'walking', ',', 'balance', 'confidence', ',', 'and', 'quality', 'of', 'life', 'of', 'people', 'with', 'idiopathic', 'Parkinson', 'disease', '.', 'Participants', 'will', 'be', 'randomized', 'to', 'participate', 'in', 'a', 'land', 'based', 'or', 'aquatic', 'based', 'group', 'exercise', 'program', '2', 'times', 'per', 'week', 'for', '12', 'weeks', '.', 'Prior', 'to', 'and', 'after', 'participation', ',', 'balance', ',', 'walking', ',', 'quality', 'of', 'life', ',', 'and', 'balance', 'confidence', 'will', 'be', 'measured', 'by', 'a', 'blinded', 'examiner', '.']","['O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT04291027,NCT04291027,"Comparison of Aquatic and Land-based Group Exercise for Individuals With Parkinson Disease | This study will investigate the impact of land based or aquatic based group exercise on the balance, walking, balance confidence, and quality of life of people with idiopathic Parkinson disease. Participants will be randomized to participate in a land based or aquatic based group exercise program 2 times per week for 12 weeks. Prior to and after participation, balance, walking, quality of life, and balance confidence will be measured by a blinded examiner.","[(14, 51, 'PHYSICAL', 'Aquatic and Land-based Group Exercise'), (73, 90, 'CONDITION', 'Parkinson Disease'), (135, 177, 'PHYSICAL', 'land based or aquatic based group exercise'), (258, 286, 'CONDITION', 'idiopathic Parkinson disease'), (340, 390, 'PHYSICAL', 'land based or aquatic based group exercise program')]"
"['Multimodal', 'Treatment', 'of', 'Phonological', 'Alexia', ':', 'Behavioral', '&', 'fMRI', 'Outcomes', '|', 'This', 'study', 'offers', '90', '-', '120', 'hours', 'of', '1:1', 'training', 'to', 'improve', 'reading', 'skills', 'in', 'adults', 'who', 'have', 'poor', 'reading', 'skills', 'following', 'a', 'stroke', '.', 'Specifically', ',', 'this', 'study', 'is', 'designed', 'to', 'improve', 'skill', 'in', 'sounding', 'out', 'words', 'for', 'reading', 'and', 'spelling', '.', 'The', 'overall', 'time', 'commitment', 'for', 'participation', 'in', 'this', 'study', 'is', 'approximately', '11', '-', '30', 'weeks', '.']","['O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT00827268,NCT00827268,"Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes | This study offers 90-120 hours of 1:1 training to improve reading skills in adults who have poor reading skills following a stroke. Specifically, this study is designed to improve skill in sounding out words for reading and spelling. The overall time commitment for participation in this study is approximately 11-30 weeks.","[(24, 43, 'CONDITION', 'Phonological Alexia'), (108, 146, 'OTHER', '1:1 training to improve reading skills'), (198, 204, 'CONDITION', 'stroke')]"
"['CoMBat', 'Insomnia', ':', 'A', 'Randomized', 'Controlled', 'Trial', 'of', 'Cognitive', '-', 'Behavioral', 'vs.', 'Mindfulness', '-', 'Based', 'Treatment', 'for', 'TBI', '-', 'Related', 'Insomnia', 'and', 'Post', '-', 'Traumatic', 'Stress', 'Symptoms', '|', 'This', 'study', 'is', 'a', 'prospective', 'two', '-', 'arm', ',', 'single', 'blind', 'randomized', 'controlled', 'trial', 'design', 'to', 'compare', 'the', 'clinical', 'effectiveness', 'of', 'telemedicine', '-', 'delivered', ',', '6', '-', 'session', ',', 'standardized', 'cognitive', 'behavioral', 'therapy', 'for', 'insomnia', '(', 'CBT', '-', 'I', ')', 'and', 'mindfulness', '-', 'based', 'treatment', 'for', 'insomnia', '(', 'MBTI', ')', 'in', 'treating', 'insomnia', 'symptoms', 'and', 'ameliorating', 'depressive', 'symptoms', 'in', 'persons', 'with', 'mild', 'to', 'moderate', 'TBI', 'and', 'comorbid', 'Post', '-', 'Traumatic', 'Stress', 'Symptoms', '(', 'PTSS', ')', 'and', 'insomnia', 'symptoms', 'in', 'a', '360', 'patients', '.', 'Participants', 'will', 'undergo', 'assessment', '(', 'psychosocial', 'questionnaires', ',', 'neurocognitive', 'testing', ',', 'sleep', 'monitoring', ')', 'at', 'baseline', ',', 'at', 'the', 'end', 'of', 'treatment', ',', 'and', 'at', '6-', 'and', '12', '-', 'weeks', 'post', '-', 'treatment', '.', 'The', 'primary', 'outcome', 'is', 'sleep', 'as', 'measured', 'by', 'the', 'Insomnia', 'Severity', 'Index', '(', 'ISI', ')', '.']","['O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'O', 'B-COND', 'O', 'B-BEH', 'O', 'O', 'O', 'O', 'B-BEH', 'I-BEH', 'I-BEH', 'I-BEH', 'O', 'B-COND', 'O', 'B-BEH', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05663034,NCT05663034,"CoMBat Insomnia: A Randomized Controlled Trial of Cognitive-Behavioral vs. Mindfulness-Based Treatment for TBI-Related Insomnia and Post-Traumatic Stress Symptoms | This study is a prospective two-arm, single blind randomized controlled trial design to compare the clinical effectiveness of telemedicine-delivered, 6-session, standardized cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based treatment for insomnia (MBTI) in treating insomnia symptoms and ameliorating depressive symptoms in persons with mild to moderate TBI and comorbid Post-Traumatic Stress Symptoms (PTSS) and insomnia symptoms in a 360 patients. Participants will undergo assessment (psychosocial questionnaires, neurocognitive testing, sleep monitoring) at baseline, at the end of treatment, and at 6- and 12-weeks post-treatment. The primary outcome is sleep as measured by the Insomnia Severity Index (ISI).","[(7, 15, 'CONDITION', 'Insomnia'), (50, 102, 'BEHAVIOURAL', 'Cognitive-Behavioral vs. Mindfulness-Based Treatment'), (107, 127, 'CONDITION', 'TBI-Related Insomnia'), (132, 153, 'CONDITION', 'Post-Traumatic Stress'), (339, 367, 'BEHAVIOURAL', 'cognitive behavioral therapy'), (372, 380, 'CONDITION', 'insomnia'), (382, 385, 'BEHAVIOURAL', 'CBT'), (393, 420, 'BEHAVIOURAL', 'mindfulness-based treatment'), (425, 433, 'CONDITION', 'insomnia'), (435, 439, 'BEHAVIOURAL', 'MBTI'), (453, 461, 'CONDITION', 'insomnia'), (488, 498, 'CONDITION', 'depressive'), (524, 544, 'CONDITION', 'mild to moderate TBI'), (558, 588, 'CONDITION', 'Post-Traumatic Stress Symptoms'), (590, 594, 'CONDITION', 'PTSS'), (600, 608, 'CONDITION', 'insomnia')]"
"['Interventional', ',', 'Open', '-', 'label', ',', 'Multiple', '-', 'immunization', 'Extension', 'Study', 'on', 'the', 'Safety', ',', 'Tolerability', 'and', 'Immunogenicity', 'of', 'Lu', 'AF20513', '/', 'Adjuvant', 'in', 'Patients', 'With', 'Alzheimer', ""'s"", 'Disease', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'determine', 'if', 'multiple', 'immunizations', 'with', 'Lu', 'AF20513', 'is', 'tolerable', 'and', 'safe', 'in', 'patients', 'with', 'mild', 'Alzheimer', ""'s"", 'disease', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'B-CTRL', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O']",NCT02388152,NCT02388152,"Interventional, Open-label, Multiple-immunization Extension Study on the Safety, Tolerability and Immunogenicity of Lu AF20513/Adjuvant in Patients With Alzheimer's Disease | The purpose of this study is to determine if multiple immunizations with Lu AF20513 is tolerable and safe in patients with mild Alzheimer's disease.","[(116, 126, 'DRUG', 'Lu AF20513'), (127, 135, 'CONTROL', 'Adjuvant'), (153, 172, 'CONDITION', ""Alzheimer's Disease""), (248, 258, 'DRUG', 'Lu AF20513'), (298, 322, 'CONDITION', ""mild Alzheimer's disease"")]"
"['Effect', 'of', 'Technological', 'Processes', 'on', 'Nutritional', 'Quality', 'of', 'Meat', 'Proteins', '|', 'This', 'project', 'aims', 'to', 'assess', 'the', 'impact', 'of', 'technological', 'processes', 'of', 'meat', ',', 'as', 'cooking', 'conditions', ',', 'on', 'amino', 'acid', 'bioavailability', 'and', 'protein', 'metabolism', '.', 'The', 'hypothesis', 'is', 'that', ',', 'even', 'if', 'meat', 'is', 'considered', 'as', 'a', 'good', 'provider', 'of', 'fast', 'proteins', 'and', 'so', 'could', 'be', 'useful', 'to', 'prevent', 'sarcopenia', 'in', 'aged', 'people', ',', 'the', 'manner', 'it', 'is', 'cooked', 'can', 'change', 'its', 'digestion', 'rate', 'and', 'amino', 'acids', 'bioavailability', 'for', 'muscle', 'synthesis', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02157805,NCT02157805,"Effect of Technological Processes on Nutritional Quality of Meat Proteins | This project aims to assess the impact of technological processes of meat, as cooking conditions, on amino acid bioavailability and protein metabolism. The hypothesis is that, even if meat is considered as a good provider of fast proteins and so could be useful to prevent sarcopenia in aged people, the manner it is cooked can change its digestion rate and amino acids bioavailability for muscle synthesis.","[(10, 73, 'OTHER', 'Technological Processes on Nutritional Quality of Meat Proteins'), (118, 149, 'OTHER', 'technological processes of meat'), (349, 359, 'CONDITION', 'sarcopenia')]"
"['A', 'Phase', 'IIa', 'Trial', 'to', 'Evaluate', 'the', 'Safety', ',', 'Tolerability', ',', 'and', 'Biological', 'Activity', 'of', 'LAM-002A', '(', 'Apilimod', 'Dimesylate', 'Capsules', ')', 'in', 'C9ORF72', '-', 'Associated', 'Amyotrophic', 'Lateral', 'Sclerosis', '|', 'This', 'is', 'a', 'clinical', 'trial', 'to', 'evaluate', 'the', 'safety', ',', 'tolerability', ',', 'and', 'biological', 'effect', 'of', 'LAM-002A', 'in', 'adults', 'with', 'C9ORF72', '-', 'associated', 'ALS', '(', 'C9ALS', ')', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'B-DRUG', 'I-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'B-COND', 'O', 'O']",NCT05163886,NCT05163886,"A Phase IIa Trial to Evaluate the Safety, Tolerability, and Biological Activity of LAM-002A (Apilimod Dimesylate Capsules) in C9ORF72-Associated Amyotrophic Lateral Sclerosis | This is a clinical trial to evaluate the safety, tolerability, and biological effect of LAM-002A in adults with C9ORF72-associated ALS (C9ALS).","[(83, 91, 'DRUG', 'LAM-002A'), (93, 112, 'DRUG', 'Apilimod Dimesylate'), (126, 174, 'CONDITION', 'C9ORF72-Associated Amyotrophic Lateral Sclerosis'), (265, 273, 'DRUG', 'LAM-002A'), (289, 311, 'CONDITION', 'C9ORF72-associated ALS'), (313, 318, 'CONDITION', 'C9ALS')]"
"['The', 'Contribution', 'of', 'a', 'Speech', 'Perception', 'Intervention', 'to', 'the', 'Prevention', 'of', 'Phonological', 'Awareness', 'Deficits', 'in', 'Children', 'With', 'Speech', 'Sound', 'Disorders', '|', 'Recent', 'research', 'reveals', 'genetic', 'and', 'symptomatic', 'overlap', 'among', 'children', 'with', 'speech', 'sound', 'disorders', '(', 'i.e.', ',', 'those', 'who', '(', 'misarticulate', 'more', 'sounds', 'than', 'would', 'be', 'expected', 'for', 'their', 'age', ')', 'and', 'children', 'with', 'dyslexia', '(', 'i.e.', ',', 'those', 'who', 'struggle', 'to', 'learn', 'to', 'read', ')', '.', 'Children', 'who', 'have', 'speech', 'sound', 'disorders', 'as', 'preschoolers', 'are', 'at', 'risk', 'for', 'the', 'later', 'emergence', 'of', 'dyslexia', ',', 'a', 'risk', 'that', 'often', 'reveals', 'itself', 'in', 'the', 'form', 'of', 'poor', 'phonological', 'awareness', 'skills', 'during', 'the', 'preschool', 'period', '.', 'Traditional', 'speech', 'therapy', 'methods', 'focus', 'on', 'articulation', 'accuracy', 'and', 'do', 'not', 'focus', 'on', 'the', 'child', ""'s"", 'more', 'abstract', 'knowledge', 'of', 'the', 'sound', 'system', 'of', 'the', 'language', '.', 'The', 'ultimate', 'objective', 'of', 'this', 'research', 'program', 'is', 'to', 'prevent', 'reading', 'disability', 'in', 'children', 'who', 'present', 'with', 'speech', 'sounds', 'disorders', '.', 'The', 'relative', 'effectiveness', 'of', 'different', 'interventions', 'to', 'help', 'these', 'children', 'achieve', 'age', '-', 'appropriate', 'phonological', 'processing', 'skills', 'prior', 'to', 'school', 'entry', 'will', 'be', 'investigated', '.', 'It', 'is', 'expected', 'that', 'a', 'combination', 'of', 'treatment', 'approaches', 'that', 'focus', 'on', 'speech', 'perception', 'skills', 'and', 'vocabulary', 'knowledge', 'will', 'have', 'a', 'superior', 'impact', 'on', 'phonological', 'awareness', 'in', 'comparison', 'with', 'a', 'treatment', 'approach', 'that', 'focuses', 'solely', 'on', 'articulation', 'accuracy', '.']","['O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O']",NCT00818428,NCT00818428,"The Contribution of a Speech Perception Intervention to the Prevention of Phonological Awareness Deficits in Children With Speech Sound Disorders | Recent research reveals genetic and symptomatic overlap among children with speech sound disorders (i.e., those who (misarticulate more sounds than would be expected for their age) and children with dyslexia (i.e., those who struggle to learn to read). Children who have speech sound disorders as preschoolers are at risk for the later emergence of dyslexia, a risk that often reveals itself in the form of poor phonological awareness skills during the preschool period. Traditional speech therapy methods focus on articulation accuracy and do not focus on the child's more abstract knowledge of the sound system of the language. The ultimate objective of this research program is to prevent reading disability in children who present with speech sounds disorders. The relative effectiveness of different interventions to help these children achieve age-appropriate phonological processing skills prior to school entry will be investigated. It is expected that a combination of treatment approaches that focus on speech perception skills and vocabulary knowledge will have a superior impact on phonological awareness in comparison with a treatment approach that focuses solely on articulation accuracy.","[(22, 52, 'OTHER', 'Speech Perception Intervention'), (123, 145, 'CONDITION', 'Speech Sound Disorders'), (224, 246, 'CONDITION', 'speech sound disorders'), (419, 441, 'CONDITION', 'speech sound disorders'), (888, 911, 'CONDITION', 'speech sounds disorders'), (1111, 1210, 'OTHER', 'combination of treatment approaches that focus on speech perception skills and vocabulary knowledge'), (1286, 1349, 'OTHER', 'treatment approach that focuses solely on articulation accuracy')]"
"['An', 'Open', '-', 'Label', ',', 'Safety', 'and', 'Tolerability', 'Study', 'of', 'Chronic', 'Intermittent', 'Use', 'of', 'Diazepam', 'Buccal', 'Film', '(', 'DBF', ')', 'in', 'Pediatric', ',', 'Adolescent', 'and', 'Adult', 'Subjects', 'With', 'Epilepsy', '|', 'This', 'Phase', '3', ',', 'multicenter', ',', 'open', '-', 'label', 'study', 'of', 'chronic', ',', 'intermittent', 'use', 'of', 'study', 'drug', '(', 'DBF', ')', 'is', 'designed', 'to', 'evaluate', 'the', 'safety', 'and', 'tolerability', 'of', 'the', 'buccal', 'formulation', 'of', 'diazepam', 'in', 'children', ',', 'adolescents', 'and', 'adults', 'with', 'intermittent', ',', 'stereotypic', 'episodes', 'of', 'frequent', 'seizure', 'activity', '(', 'eg', ',', 'seizure', 'clusters', ')', 'that', 'are', 'distinct', 'from', 'the', 'subject', ""'s"", 'usual', 'seizure', 'pattern', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DRUG', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O']",NCT03428360,NCT03428360,"An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy | This Phase 3, multicenter, open-label study of chronic, intermittent use of study drug (DBF) is designed to evaluate the safety and tolerability of the buccal formulation of diazepam in children, adolescents and adults with intermittent, stereotypic episodes of frequent seizure activity (eg, seizure clusters) that are distinct from the subject's usual seizure pattern.","[(76, 84, 'DRUG', 'Diazepam'), (98, 101, 'DRUG', 'DBF'), (152, 160, 'CONDITION', 'Epilepsy'), (251, 254, 'DRUG', 'DBF'), (337, 345, 'DRUG', 'diazepam'), (387, 450, 'CONDITION', 'intermittent, stereotypic episodes of frequent seizure activity'), (456, 472, 'CONDITION', 'seizure clusters'), (517, 524, 'CONDITION', 'seizure')]"
"['The', 'Effect', 'of', 'Kinesiotaping', 'on', 'Glenohumeral', 'Shoulder', 'Subluxation', 'in', 'Post', '-', 'stroke', 'Patients', '|', 'To', 'evaluate', 'the', 'effectiveness', 'of', 'the', 'kinesiotaping', 'on', 'pain', ',', 'recovery', 'of', 'movement', 'and', 'daily', 'life', 'activities', 'in', 'Turkish', 'hemiplegic', 'patients', '.']","['O', 'O', 'O', 'B-OTHER', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O']",NCT04468750,NCT04468750,"The Effect of Kinesiotaping on Glenohumeral Shoulder Subluxation in Post-stroke Patients | To evaluate the effectiveness of the kinesiotaping on pain, recovery of movement and daily life activities in Turkish hemiplegic patients.","[(14, 27, 'OTHER', 'Kinesiotaping'), (31, 64, 'CONDITION', 'Glenohumeral Shoulder Subluxation'), (73, 79, 'CONDITION', 'stroke'), (128, 141, 'OTHER', 'kinesiotaping'), (145, 149, 'CONDITION', 'pain'), (209, 219, 'CONDITION', 'hemiplegic')]"
"['Comparison', 'of', 'Inspiratory', 'Muscle', 'Training', 'and', 'Usual', 'Care', 'in', 'Individuals', 'Post', '-', 'Liver', 'Transplant', '|', 'Individuals', 'with', 'chronic', 'liver', 'disease', 'develop', 'significant', 'muscle', 'wasting', 'that', 'remains', 'post', '-', 'liver', 'transplant', '.', 'The', 'transplant', 'surgery', 'additionally', 'challenges', 'respiratory', 'mechanics', '.', 'Respiratory', 'muscle', 'strength', 'has', 'been', 'measured', 'to', 'be', 'impaired', 'in', 'individuals', 'post', 'liver', 'transplant', '.', 'This', 'study', 'proposes', 'an', '8', 'week', 'intervention', 'designed', 'to', 'increase', 'respiratory', 'muscle', 'strength', 'and', 'pulmonary', 'function', 'that', 'we', 'hypothesize', 'will', 'correlate', 'to', 'improved', 'functional', 'performance', 'and', 'quality', 'of', 'life', 'post', '-', 'liver', 'transplant', '.', '\n\n', 'Pre', '-', 'test', 'post', '-', 'test', 'design', ',', 'that', 'will', 'randomize', 'subjects', 'into', 'an', 'experimental', 'group', 'that', 'will', 'receive', 'the', 'inspiratory', 'muscle', 'strengthening', 'exercise', 'in', 'addition', 'to', 'usual', 'post', '-', 'liver', 'transplant', 'care', 'and', 'a', 'control', 'group', 'that', 'will', 'only', 'receive', 'the', 'usual', 'post', '-', 'transplant', 'care', '.', '\n\n', 'Up', 'to', '50', 'subjects', 'will', 'be', 'recruited', 'from', 'the', 'Post', '-', 'Liver', 'Transplant', 'Outpatient', 'Clinic', 'at', 'the', 'Miami', 'Transplant', 'Institute', '.', '\n\n', 'The', 'subjects', 'will', 'have', 'repeated', 'measurements', 'of', 'respiratory', 'muscle', 'strength', ',', 'pulmonary', 'function', ',', 'functional', 'mobility', 'performance', ',', 'and', 'quality', 'of', 'life', 'at', 'baseline', ',', '4', 'weeks', ',', 'and', '8', 'weeks', '.']","['O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-CTRL', 'I-CTRL', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT03130608,NCT03130608,"Comparison of Inspiratory Muscle Training and Usual Care in Individuals Post-Liver Transplant | Individuals with chronic liver disease develop significant muscle wasting that remains post-liver transplant. The transplant surgery additionally challenges respiratory mechanics. Respiratory muscle strength has been measured to be impaired in individuals post liver transplant. This study proposes an 8 week intervention designed to increase respiratory muscle strength and pulmonary function that we hypothesize will correlate to improved functional performance and quality of life post-liver transplant.

Pre-test post-test design, that will randomize subjects into an experimental group that will receive the inspiratory muscle strengthening exercise in addition to usual post-liver transplant care and a control group that will only receive the usual post-transplant care.

Up to 50 subjects will be recruited from the Post-Liver Transplant Outpatient Clinic at the Miami Transplant Institute.

The subjects will have repeated measurements of respiratory muscle strength, pulmonary function, functional mobility performance, and quality of life at baseline, 4 weeks, and 8 weeks.","[(14, 41, 'PHYSICAL', 'Inspiratory Muscle Training'), (46, 56, 'CONTROL', 'Usual Care'), (72, 93, 'CONDITION', 'Post-Liver Transplant'), (113, 134, 'CONDITION', 'chronic liver disease'), (183, 204, 'CONDITION', 'post-liver transplant'), (352, 373, 'CONDITION', 'post liver transplant'), (580, 601, 'CONDITION', 'post-liver transplant'), (709, 750, 'PHYSICAL', 'inspiratory muscle strengthening exercise'), (766, 798, 'OTHER', 'usual post-liver transplant care'), (842, 872, 'CONTROL', 'the usual post-transplant care'), (920, 941, 'CONDITION', 'Post-Liver Transplant')]"
"['Video', 'Game', 'Rehabilitation', 'for', 'Outpatient', 'Stroke', '(', 'VIGoROUS', '):', 'A', 'Multi', '-', 'center', 'Comparative', 'Effectiveness', 'Trial', 'of', 'In', '-', 'home', 'Gamified', 'Constraint', '-', 'induced', 'Movement', 'Therapy', 'for', 'Rehabilitation', 'of', 'Chronic', 'Upper', 'Extremity', 'Hemiparesis', '.', '|', 'The', 'current', 'proposal', 'aims', 'to', 'conduct', 'a', 'multi', '-', 'site', 'randomized', 'controlled', 'trial', 'comparing', 'virtual', '-', 'reality', 'gaming', 'delivery', 'of', 'Constraint', 'Induced', 'Movement', 'therapy', '(', 'CI', 'therapy', ')', 'with', '(', '1', ')', 'traditional', 'clinic', '-', 'based', 'CI', 'therapy', 'of', 'equal', 'total', 'active', 'therapy', 'duration', 'and', '(', '2', ')', 'a', 'control', 'group', 'equating', 'the', 'dose', 'of', 'in', '-', 'person', 'therapy', '.', 'Individuals', 'with', 'chronic', 'stroke', 'will', 'be', 'randomized', 'to', 'one', 'of', 'four', 'different', 'interventions', ':', '(', '1', ')', 'traditional', 'clinic', '-', 'based', 'CI', 'therapy', '(', '35', 'therapist', '/', 'client', 'contact', 'hours', ')', ',', '(', '2', ')', 'therapist', '-', 'as', '-', 'consultant', 'virtual', 'reality', 'CI', 'therapy', '(', '5', 'therapist', '/', 'client', 'contact', 'hours', 'in', 'the', 'clinic', 'and', '15', 'hours', 'of', 'independent', 'game', 'play', 'at', 'home', ')', ',', '(', '3', ')', 'therapist', '-', 'as', '-', 'consultant', 'virtual', 'reality', 'CI', 'therapy', 'with', 'additional', 'therapist', 'contact', 'via', 'telerehabilitation', '(', '5', 'therapist', '/', 'client', 'contact', 'hours', 'in', 'the', 'clinic', ',', '2.6', 'therapist', 'contact', 'hours', 'via', 'teleconference', ',', 'and', '15', 'hours', 'of', 'independent', 'game', 'play', 'in', 'the', 'home', ')', ',', 'and', '(', '4', ')', '5', 'hours', 'of', 'standard', 'occupational', 'therapy', '(', 'OT', ')', '/', 'physical', 'therapy', '(', 'PT', ')', '.', 'After', '6', '-', 'month', 'follow', '-', 'up', ',', 'individuals', 'assigned', 'to', 'standard', 'OT', '/', 'PT', 'will', 'cross', 'over', 'to', 'a', 'modified', 'gaming', 'therapy', 'condition', '(', 'a', 'stand', '-', 'alone', 'application', 'of', 'the', 'rehabilitation', 'game', 'without', 'additional', 'therapist', 'contact', ')', '.']","['O', 'O', 'O', 'O', 'O', 'B-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'B-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'I-CTRL', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'I-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'B-OTHER', 'O', 'O', 'B-PHYS', 'I-PHYS', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'B-PHYS', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O']",NCT02631850,NCT02631850,"Video Game Rehabilitation for Outpatient Stroke (VIGoROUS): A Multi-center Comparative Effectiveness Trial of In-home Gamified Constraint-induced Movement Therapy for Rehabilitation of Chronic Upper Extremity Hemiparesis. | The current proposal aims to conduct a multi-site randomized controlled trial comparing virtual-reality gaming delivery of Constraint Induced Movement therapy (CI therapy) with (1) traditional clinic-based CI therapy of equal total active therapy duration and (2) a control group equating the dose of in-person therapy. Individuals with chronic stroke will be randomized to one of four different interventions: (1) traditional clinic-based CI therapy (35 therapist/client contact hours), (2) therapist-as-consultant virtual reality CI therapy (5 therapist/client contact hours in the clinic and 15 hours of independent game play at home), (3) therapist-as-consultant virtual reality CI therapy with additional therapist contact via telerehabilitation (5 therapist/client contact hours in the clinic, 2.6 therapist contact hours via teleconference, and 15 hours of independent game play in the home), and (4) 5 hours of standard occupational therapy (OT) / physical therapy (PT). After 6-month follow-up, individuals assigned to standard OT/PT will cross over to a modified gaming therapy condition (a stand-alone application of the rehabilitation game without additional therapist contact).","[(41, 47, 'CONDITION', 'Stroke'), (118, 162, 'PHYSICAL', 'Gamified Constraint-induced Movement Therapy'), (185, 220, 'CONDITION', 'Chronic Upper Extremity Hemiparesis'), (312, 334, 'OTHER', 'virtual-reality gaming'), (347, 382, 'PHYSICAL', 'Constraint Induced Movement therapy'), (384, 394, 'PHYSICAL', 'CI therapy'), (405, 440, 'CONTROL', 'traditional clinic-based CI therapy'), (561, 575, 'CONDITION', 'chronic stroke'), (639, 674, 'CONTROL', 'traditional clinic-based CI therapy'), (716, 766, 'PHYSICAL', 'therapist-as-consultant virtual reality CI therapy'), (867, 917, 'PHYSICAL', 'therapist-as-consultant virtual reality CI therapy'), (956, 974, 'OTHER', 'telerehabilitation'), (1152, 1172, 'OTHER', 'occupational therapy'), (1174, 1176, 'OTHER', 'OT'), (1180, 1196, 'PHYSICAL', 'physical therapy'), (1198, 1200, 'PHYSICAL', 'PT'), (1261, 1263, 'OTHER', 'OT'), (1264, 1266, 'PHYSICAL', 'PT'), (1288, 1311, 'OTHER', 'modified gaming therapy'), (1356, 1375, 'OTHER', 'rehabilitation game')]"
"['Effects', 'of', 'Remote', 'Ischemic', 'Preconditioning', 'on', 'Biochemical', 'Markers', 'and', 'Neurological', 'Outcomes', 'in', 'Patients', 'Undergoing', 'Elective', 'Cervical', 'Decompression', 'Surgery', '|', 'The', 'purpose', 'of', 'this', 'study', 'is', 'to', 'assess', 'whether', 'a', 'large', 'clinical', 'trial', 'testing', 'the', 'effect', 'of', 'RIPC', 'on', 'neurologic', 'outcome', 'in', 'patients', 'undergoing', 'elective', 'cervical', 'decompression', 'surge', 'is', 'warranted', '.']","['O', 'O', 'B-OTHER', 'I-OTHER', 'I-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-OTHER', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-COND', 'I-COND', 'I-COND', 'O', 'O', 'O']",NCT00778323,NCT00778323,Effects of Remote Ischemic Preconditioning on Biochemical Markers and Neurological Outcomes in Patients Undergoing Elective Cervical Decompression Surgery | The purpose of this study is to assess whether a large clinical trial testing the effect of RIPC on neurologic outcome in patients undergoing elective cervical decompression surge is warranted.,"[(11, 42, 'OTHER', 'Remote Ischemic Preconditioning'), (124, 154, 'CONDITION', 'Cervical Decompression Surgery'), (249, 253, 'OTHER', 'RIPC'), (308, 336, 'CONDITION', 'cervical decompression surge')]"
"['Brain', 'Diseases', 'on', '7.0', 'T', 'Magnetic', 'Resonance', 'Imaging', '|', 'This', 'clinical', 'trial', 'studies', 'the', 'use', 'of', '7', '-', 'Tesla', '(', '7T)and', '3', 'T', 'magnetic', 'resonance', 'imaging', '(', 'MRI', ')', 'in', 'detecting', 'brain', 'diseases', '.', '7', 'T', 'MRI', 'has', 'increased', 'detection', 'sensitivity', ',', 'including', 'more', 'accurate', 'lesion', 'delineation', ',', 'higher', 'inter', '-', 'rater', 'agreement', '.', 'Diagnostic', 'procedures', 'such', 'as', '7', 'T', 'MRI', 'may', 'help', 'ultimately', 'improved', 'diagnostic', 'and', 'therapies', 'confidence', 'to', 'inform', 'decision', 'making', 'than', 'standard', '3', 'T', 'MRI', '.']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']",NCT05287750,NCT05287750,"Brain Diseases on 7.0T Magnetic Resonance Imaging | This clinical trial studies the use of 7-Tesla (7T)and 3T magnetic resonance imaging (MRI) in detecting brain diseases. 7T MRI has increased detection sensitivity, including more accurate lesion delineation, higher inter-rater agreement. Diagnostic procedures such as 7T MRI may help ultimately improved diagnostic and therapies confidence to inform decision making than standard 3T MRI.",[]
